Voya Financial (VOYA) 10-Q 4 May 23 2023 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - $ / shares	3 Months Ended
	Mar. 31, 2023	Apr. 28, 2023	May 01, 2020
Entity Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2023
Document Transition Report	false
Entity File Number	001-35897
Entity Registrant Name	Voya Financial, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	52-1222820
Entity Address, Address Line One	230 Park Avenue
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10169
City Area Code	212
Local Phone Number	309-8200
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		98,270,292
Common stock, par value (usd per share)	$ 0.01		$ 0.01
Entity Central Index Key	0001535929
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q1
Amendment Flag	false
Common Stock, $.01 par value
Entity Information [Line Items]
Title of 12(b) Security	Common Stock, $.01 par value
Trading Symbol	VOYA
Security Exchange Name	NYSE
Depositary Shares, each representing a 1/40th
Entity Information [Line Items]
Title of 12(b) Security	Depositary Shares, each representing a 1/40th
Trading Symbol	VOYAPrB
Security Exchange Name	NYSE

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Investments:
Short-term investments under securities loan agreements, including collateral delivered	$ 1,246	$ 1,179
Accrued investment income	445	425
Premiums Receivable And Reinsurance Recoverables, Including Reinsurance Premium Paid	12,438	12,426
Deferred policy acquisition costs and Value of business acquired	2,333	2,363
Deferred income taxes	2,122	2,223
Goodwill	646	327
Other Intangible Assets, Net	905	631
Assets held in separate accounts	84,569	80,174
Total assets	151,208	146,606
Liabilities:
Future policy benefits	9,784	9,719
Contract owner account balances	41,709	42,455
Payables under securities loan and repurchase agreements, including collateral held	1,328	1,302
Short-term debt	143	141
Long-term debt	2,094	2,094
Derivatives	376	389
Liabilities related to separate accounts	84,569	80,174
Total liabilities	145,521	141,609
Commitments and Contingencies (Note 15)
Mezzanine equity:
Redeemable noncontrolling interest	166	166
Shareholders' equity:
Preferred stock ($0.01 par value per share; $625 aggregate liquidation preference as of 2023 and 2022 respectively)	0	0
Common stock ($0.01 par value per share; 900,000,000 shares authorized; 99,302,325 and 97,789,852 shares issued as of 2023 and 2022, respectively; 98,180,167 and 97,186,970 shares outstanding as of 2023 and 2022, respectively)	1	1
Treasury stock (at cost; 1,122,158 and 602,882 shares as of 2023 and 2022, respectively)	(77)	(39)
Additional paid-in capital	6,693	6,643
Accumulated other comprehensive income (loss)	(2,545)	(3,055)
Retained earnings (deficit):
Unappropriated	(118)	(201)
Total Voya Financial, Inc. shareholders' equity	3,954	3,349
Noncontrolling interest	1,567	1,482
Total shareholders' equity	5,521	4,831
Total liabilities, mezzanine equity and shareholders' equity	151,208	146,606
Consolidated Entity, Excluding Consolidated VIE
Investments:
Fixed maturities, available-for-sale, at fair value (amortized cost of $29,534 as of 2023 and $30,202 as of 2022; net of allowance for credit losses of $12 as of 2023 and 2022)	27,018	27,044
Fixed maturities, at fair value using the fair value option	2,224	2,151
Equity securities, at fair value	308	336
Short-term investments	33	356
Mortgage loans on real estate, net	5,329	5,427
Policy loans	359	363
Limited partnerships/corporations	1,794	1,781
Derivatives	342	422
Other investments	70	68
Securities pledged (amortized cost of $1,347 as of 2023 and $1,303 as of 2022)	1,226	1,162
Total investments	38,703	39,110
Cash and cash equivalents	724	919
Other assets (net of allowance for credit losses of $1 as of 2023 and $1 as of 2022)	2,644	2,625
Liabilities:
Other liabilities	2,974	2,901
VIEs
Investments:
Limited partnerships/corporations	3,009	2,802
Cash and cash equivalents	100	88
Other assets (net of allowance for credit losses of $1 as of 2023 and $1 as of 2022)	92	21
Financing Receivable, after Allowance for Credit Loss	1,232	1,293
Liabilities:
Other liabilities	1,288	1,200
Collateralized loan obligations notes, at fair value using the fair value option	$ 1,256	$ 1,234

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Statement of Financial Position [Abstract]
Fixed maturities, amortized cost	$ 29,534	$ 30,202
Fixed maturities, allowance for credit losses	12
Mortgage loans, allowance for credit losses	17	18
Securities pledged, amortized costs	1,347	1,303
Premium receivable and reinsurance recoverable, allowance for credit losses	29	32
Other assets, allowance for credit losses	1	$ 1
Preferred stock, par value (usd per share)		$ 0.01
Preferred stock, aggregate liquidation preference	$ 625
Common stock, par value (usd per share)	$ 0.01
Common stock, shares outstanding (in shares)	900,000,000
Common stock, shares issued (in shares)	99,302,325	97,789,852
Common stock, shares outstanding (in shares)	98,180,167	97,186,970
Treasury stock, shares (in shares)	1,122,158	602,882

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Revenues:
Net investment income	$ 545	$ 630
Fee income	464	433
Premiums	685	608
Net realized capital gains (losses)	(16)	(288)
Other revenue	78	40
Income (loss) related to CIEs:
Net investment income	79	83
Total revenues	1,835	1,506
Benefits and expenses:
Policyholder benefits	510	411
Interest credited to contract owner account balances	241	233
Operating expenses	836	632
Net amortization of Deferred policy acquisition costs and Value of business acquired	59	62
Interest expense	32	40
Operating expenses related to CIEs:
Interest expense	16	6
Total benefits and expenses	1,694	1,384
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Total	141	122
Income tax expense (benefit)	12	11
Net income (loss)	129	111
Less: Net income (loss) attributable to noncontrolling interest	46	43
Net income (loss) available to Voya Financial, Inc.	83	68
Less: Preferred stock dividends	14	14
Net income (loss) available to Voya Financial, Inc.'s common shareholders	$ 69	$ 54
Net income (loss) available to Voya Financial, Inc.'s common shareholders per common share:
Basic (usd per share)	$ 0.70	$ 0.51
Diluted (usd per share)	$ 0.63	$ 0.46

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ 129	$ 111
AOCI, Liability for Future Policy Benefit, Expected Future Policy Benefit, before Tax	2	104
Other comprehensive income (loss), before tax:
Unrealized gains (losses) on securities	643	(2,593)
Other Comprehensive Income (Loss), before Tax, Total	645	(2,489)
Income tax expense (benefit) related to items of other comprehensive income (loss)	135	(522)
Other Comprehensive Income (Loss), Net of Tax, Total	510	(1,967)
Comprehensive income (loss)	639	(1,856)
Less: Comprehensive income (loss) attributable to noncontrolling interest and redeemable noncontrolling interest	46	43
Comprehensive income (loss) attributable to Voya Financial, Inc.	$ 593	$ (1,899)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($) $ in Millions	Total	Previously Reported	Total Voya Financial, Inc. Shareholders' Equity	Total Voya Financial, Inc. Shareholders' Equity Previously Reported	Common Stock	Common Stock Previously Reported	Treasury Stock	Treasury Stock Previously Reported	Additional Paid-In Capital	Additional Paid-In Capital Previously Reported	Accumulated Other Comprehensive Income (Loss)	Accumulated Other Comprehensive Income (Loss) Previously Reported	Retained Earnings (Deficit), Unappropriated	Noncontrolling Interest	Noncontrolling Interest Previously Reported
Beginning balance at Dec. 31, 2021		$ 9,668		$ 8,100		$ 1		$ (80)		$ 7,542		$ 1,807	$ (1,170)		$ 1,568
Comprehensive income (loss):
Net income (loss)	$ 111		$ 68		$ 0		$ 0		$ 0		$ 0		68	$ 43
Other comprehensive income (loss), after tax	(1,967)		(1,967)		0		0		0		(1,967)		0	0
Comprehensive income (loss)	(1,856)		(1,899)
Less: Comprehensive income (loss) attributable to noncontrolling interest and redeemable noncontrolling interest	43													43
Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Nonredeemable Noncontrolling Interest	(1,856)
Common stock issuance	2		2		0		0		2		0		0	0
Common stock acquired - Share repurchase	(500)		(500)		0		(445)		55		0		0	0
Dividends on preferred stock	(14)		(14)		0		0		(14)		0		0	0
Dividends on common stock	(21)		(21)		0		0		(21)		0		0	0
Share-based compensation	10		10		0		(40)		50		0		0	0
Contributions from (Distributions to) noncontrolling interest, net	(105)													(105)
Ending Balance at Mar. 31, 2022	7,184		5,678		1		(565)		7,504		(160)		(1,102)	1,506
Increase (Decrease) in Temporary Equity [Roll Forward]
Redeemable noncontrolling interest	166
Beginning balance at Dec. 31, 2022	4,831	$ 4,831		$ 3,349		$ 1		$ (39)		$ 6,643		$ (3,055)	(201)		$ 1,482
Comprehensive income (loss):
Net income (loss)	127		83		0		0		0		0		83	44
Net income (loss)	129
Other comprehensive income (loss), after tax	510		510		0		0		0		510		0	0
Comprehensive income (loss)	639		593
Less: Comprehensive income (loss) attributable to noncontrolling interest and redeemable noncontrolling interest	46													44
Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Nonredeemable Noncontrolling Interest	637
Dividends on preferred stock	(14)		(14)		0		0		(14)		0		0	0
Dividends on common stock	(20)		(20)		0		0		(20)		0		0	0
Share-based compensation	46		46		0		(38)		84		0		0	0
Contributions from (Distributions to) noncontrolling interest, net	41		0		0		0		0		0		0	41
Ending Balance at Mar. 31, 2023	5,521		$ 3,954		$ 1		$ (77)		$ 6,693		$ (2,545)		$ (118)	$ 1,567
Increase (Decrease) in Temporary Equity [Roll Forward]
Temporary Equity, Net Income	2
Temporary Equity, Other Changes	(2)
Temporary Equity, Comprehensive Income (Loss)	2
Redeemable noncontrolling interest	$ 166

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash Flows from Operating Activities:
Net cash provided by operating activities	$ 156	$ 362
Proceeds from the sale, maturity, disposal or redemption of:
Fixed maturities	1,979	1,897
Equity securities	28	0
Mortgage loans on real estate	175	204
Limited partnerships/corporations	32	59
Acquisition of:
Fixed maturities	(1,293)	(2,183)
Equity securities	(25)	0
Mortgage loans on real estate	(76)	(112)
Limited partnerships/corporations	(44)	(115)
Short-term investments, net	323	40
Derivatives, net	2	(4)
Sales from CIEs	205	449
Purchases within CIEs	(300)	(651)
Collateral received (delivered), net	(43)	(22)
Receipts on deposit asset contracts	72	30
Payments for business acquisitions, net of cash acquired	(534)	(2)
Net cash provided by (used in) investing activities	(29)	7
Net cash provided by (used in) investing activities	472	(403)
Cash Flows from Financing Activities:
Deposits received for investment contracts	730	1,212
Maturities and withdrawals from investment contracts	(1,594)	(1,024)
Repayments of long-term debt. including current maturities	(5)	(194)
Borrowings of CIEs	103	441
Repayments of borrowings of CIEs	(39)	(60)
Contributions from (distributions to) participants in CIEs, net	66	(202)
Proceeds from issuance of common stock, net	0	2
Common stock acquired - Share repurchase	0	(500)
Dividends paid on preferred stock	(14)	(14)
Dividends paid on common stock	(20)	(21)
Other, net	(38)	(47)
Net cash provided by (used in) financing activities	(811)	(407)
Net increase (decrease) in cash and cash equivalents, including cash in CIEs	(183)	(448)
Cash and cash equivalents, including cash in CIEs, beginning of period	1,007	1,573
Cash and cash equivalents, including cash in CIEs, end of period	824	$ 1,125
Condensed Financial Statements, Captions [Line Items]
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Total	824
Consolidated Entity, Excluding Consolidated VIE
Condensed Financial Statements, Captions [Line Items]
Cash and cash equivalents	724
VIEs
Condensed Financial Statements, Captions [Line Items]
Cash and cash equivalents	$ 100

Business, Basis of Presentation

Business, Basis of Presentation and Significant Accounting Policies	3 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
Business Description and Basis of Presentation	1. Business, Basis of Presentation and Significant Accounting Policies Business Voya Financial, Inc. and its subsidiaries (collectively, the "Company") is a financial services organization in the United States that offers a broad range of retirement services, investment management services, mutual funds, group insurance and supplemental health products. P roducts and services are provided by the Company through three segments: Wealth Solutions, Health Solutions and Investment Management . Activities not directly related to the Company's segments and certain run-off activities that are not meaningful to the Company's business strategy are included within Corporate. See the Segments Note to these Condensed Consolidated Financial Statements. On July 25, 2022, the Company completed a series of transactions pursuant to a Combination Agreement dated as of June 13, 2022 (the “AllianzGI Agreement”) with Voya Investment Management LLC (“Voya IM”) and VIM Holdings LLC ("VIM Holdings"), both indirect subsidiaries of the Company, Allianz SE (“Allianz”) and Allianz Global Investors U.S. LLC (“AllianzGI”), an indirect subsidiary of Allianz, pursuant to which the parties have combined Voya IM with assets and teams comprising specified transferred strategies managed by AllianzGI. The transaction increases the international scale and distribution of the Company’s investment products and provides diverse investment strategies that meet the needs of a larger and more global client base. Under the terms of the AllianzGI Agreement, AllianzGI transferred to VIM Holdings the rights to certain assets and liabilities related to specified investment teams and strategies and the associated assets under management (the “AllianzGI Transferred Business”). The Company transferred all of the limited liability company interests in Voya IM to VIM Holdings and in exchange, received a 76% economic stake in VIM Holdings. Pursuant to the Amended and Restated Limited Liability Company Agreement of VIM Holdings entered into at the closing date (“A&R VIM Holdings Operating Agreement”), the Company now holds, indirectly, a 76% economic stake in VIM Holdings and Allianz holds, indirectly, a 24% economic stake in VIM Holdings. In accordance with the A&R VIM Holdings Operating Agreement, the Company has full operational control of VIM Holdings, Voya IM and the transferred assets and investment teams. The AllianzGI Agreement was executed for noncash consideration and accounted for under the acquisition method of accounting. Accordingly, the purchase price was allocated to the assets acquired and liabilities assumed based upon their estimated fair values as of the date of the transaction. The 24% economic stake in VIM Holdings shares is reflected on the Condensed Consolidated Balance Sheets under Redeemable noncontrolling interests within Mezzanine equity. On November 1, 2022, Voya Investment Management Alternative Assets, LLC (“VIMAA”), one of the Company’s indirect subsidiaries, acquired all of the issued and outstanding equity interests of Czech Asset Management, L.P., a private credit asset manager dedicated to the U.S. middle market pursuant to a sales and purchase agreement (“SPA”) entered into on August 1, 2022 with Czech Management GP, LLC, and Czech Holdings, LLC. The purchase consideration for the acquisition included cash paid upon close and contingent consideration that is based on revenues that will be earned during the earnout period and capital raised in the underlying funds and is subject to conditions as defined in the SPA. The acquisition expands VIMAA's private and leveraged credit business. On January 24, 2023, the Company acquired all outstanding shares of Benefitfocus, Inc. (“Benefitfocus”), a Delaware corporation, pursuant to an agreement and plan of merger (the “Merger Agreement”) entered into on November 1, 2022. The acquisition expands the Company’s capacity to meet the growing demand for comprehensive benefits and savings solutions and increases its ability to deliver innovative solutions for employers and health plans. The total purchase consideration in the acquisition was $595, of which $583 was paid in cash ($558 paid by the Company and $25 of the cash acquired was used to fund the transaction). Net assets acquired as part of this transaction included cash of $49, goodwill of $319, intangible assets of $275, deferred tax assets of $45 and assumed lease liabilities of $91. This represents the best estimate of fair value of net assets acquired at the transaction date and will continue to be revised during the remeasurement period as further information becomes available. Intangible assets primarily include customer relationships of $190 with a useful life of 15 years, and software of $70 with a useful life of 5 years. The estimated amortization expense of the acquired intangible assets for the next five years is approximately $29 annually. The revenues, expenses, assets and liabilities of the business acquired are reported in the Health Solutions segment. Benefitfocus revenue primarily consists of software subscriptions and services, which include access to and usage of cloud-based benefits software, software implementation and support services, and distribution services. Such revenue is generally recognized over time and is recorded in Other revenue in the Condensed Consolidated Statements of Operation. Basis of Presentation The accompanying Condensed Consolidated Financial Statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States ("U.S. GAAP") and are unaudited. The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the Condensed Consolidated Financial Statements and the reported amounts of revenues and expenses during the reporting period. Those estimates are inherently subject to change and actual results could differ from those estimates, and the differences may be material to the Condensed Consolidated Financial Statements. The Condensed Consolidated Financial Statements include the accounts of Voya Financial, Inc. and its subsidiaries, as well as other voting interest entities ("VOEs") and variable interest entities ("VIEs") in which the Company has a controlling financial interest. See the Consolidated and Nonconsolidated Investment Entities Note to these Condensed Consolidated Financial Statements. Intercompany transactions and balances have been eliminated. The accompanying Condensed Consolidated Financial Statements are unaudited and reflect adjustments (including normal, recurring adjustments) necessary to present fairly the financial position, results of operations, and cash flows for the interim periods presented in conformity with U.S. GAAP. Interim results are not necessarily indicative of full year performance. Certain reclassifications have been made to prior-period amounts to conform to current-period reporting classifications. These reclassifications had no impact on Net income (loss) or Total shareholders’ equity. As a result of the modified retrospective adoption methodology for Accounting Standards Update ("ASU") 2018-12, Targeted Improvements to the Accounting for Long-Duration Contracts ("ASU 2018-12"), adjustments have been made to the December 31, 2022 audited Consolidated Financial Statements included in the Company's Annual Report on Form 10-K , filed with the SEC. Certain of these adjustments are included below in the Adoption of New Pronouncements - Long-Duration Contracts section, in accordance with the transition disclosure requirements of ASU 2018-12, and are unaudited. These interim Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and related notes included in the Company's Annual Report on Form 10-K . Significant Accounting Policies Effective January 1, 2023, the Company adopted ASU 2018-12, as amended. As a result, the Company made changes to the following significant accounting policies: Estimates and Assumptions Upon adoption of ASU 2018-12, deferred policy acquisition costs ("DAC") and value of business acquired ("VOBA") were no longer considered significant estimates by the Company, as the amortization methodology is no longer subject to a significant degree of variability and does not require a high degree of judgment. Deferred Policy Acquisition Costs and Value of Business Acquired DAC represents policy acquisition costs that have been capitalized and are subject to amortization. Capitalized costs are incremental, direct costs of contract acquisition and certain other costs related directly to successful acquisition activities. Such costs consist principally of commissions, underwriting, sales and contract issuance and processing expenses directly related to the successful acquisition of new and renewal business. Indirect or unsuccessful acquisition costs, maintenance, product development and overhead expenses are charged to expense as incurred. VOBA represents the outstanding value of in-force business acquired and is subject to amortization. The value is based on the present value of estimated net cash flows embedded in the insurance contracts at the time of the acquisition and increased for subsequent deferrable expenses on purchased policies. DAC/VOBA amortization is recorded in Net amortization of Deferred policy acquisition costs and Value of business acquired in the Condensed Consolidated Statements of Operations. Amortization Methodologies The Company amortizes DAC/VOBA related to certain traditional life insurance contracts, certain accident and health insurance contracts, and deferred annuity contracts on a constant level basis over the expected term of the related contracts. Contracts are grouped for amortization purposes by product or market type and issue year cohort using assumptions on a basis consistent with those used in estimating the associated liability or other related balance, where applicable. The principal assumption deemed critical to the DAC/VOBA amortization is the estimated contract term, which incorporates mortality and persistency, and represents management’s best estimate of future outcome. The Company periodically reviews this assumption against actual experience and, based on additional information that becomes available, updates the assumption. Changes in contract term estimates are reflected prospectively in amortization expense as of the beginning of the reporting period in which the change is made. VOBA is subject to recoverability testing; DAC is not. The Company performs testing to assess the recoverability of VOBA on an annual basis, or more frequently if circumstances indicate a potential loss recognition issue exists. If VOBA is not deemed recoverable, charges will be applied against the VOBA balance before an additional reserve is established. Future Policy Benefits Future Policy Benefits The Company establishes and carries actuarially-determined reserves that are calculated to meet its future obligations, including estimates of unpaid claims and claims that the Company believes have been incurred but have not yet been reported as of the balance sheet date. • Reserves for long-duration traditional life insurance contracts (term insurance, participating and non-participating whole life insurance and traditional group life insurance) and accident and health insurance represent the present value of future benefits to be paid to or on behalf of contract owners and related expenses, less the present value of future net premiums. • Reserves for payout contracts with life contingencies are equal to the present value of future payments. Principal assumptions used to establish liabilities for future policy benefits include interest rate, mortality, morbidity, policy lapse, contract renewal, payment of subsequent premiums or deposits by the contract owner, retirement, inflation, and benefit utilization. Other than interest rate assumptions, these assumptions are based on Company experience and periodically reviewed against industry standards. The Company reviews these assumptions at least annually and updates them if necessary. In addition to assumption updates, the Company adjusts reserves for actual experience in the period in which the experience occurs. Changes in, or deviations from, the assumptions used can significantly affect the Company's reserve levels and related results of operations. Remeasurements of the reserves as a result of assumption updates and adjustments for actual experience are recognized in Policyholder benefits in the Condensed Consolidated Statements of Operations. Interest rates used in discounting the reserves are based on an upper-medium grade (low-credit-risk) fixed-income instrument yield derived from observable market data. A 30-year forward rate is used for periods beyond the last observable market point. Reserves are remeasured quarterly to reflect changes in the discount rate, with the resulting change recorded in Accumulated other comprehensive income ("AOCI"). Locked-in interest rates used to determine interest accretion on reserves for new contracts sold after January 1, 2021 are based on the upper-medium grade (low-credit-risk) fixed-income instrument yield applicable at the time the business was issued. Locked-in interest accretion rates for contracts in-force as of the January 1, 2021 transition date for ASU 2018-12 are based on the locked-in interest rates in effect for those contracts immediately before the transition date. Interest accretion is recorded in Policyholder benefits on the Condensed Consolidated Statements of Operations. Product Guarantees and Additional Reserves The Company calculates additional reserve liabilities for certain universal life-type products and certain variable annuity guaranteed benefits and variable funding products. The Company periodically evaluates its estimates and adjusts the additional liability balance, with a related charge or credit to benefit expense, if actual experience or other evidence suggests that earlier assumptions should be revised. Changes in, or deviations from, the assumptions used can significantly affect the Company's reserve levels and related results of operations. Universal and Variable Universal Life : The Company establishes additional reserves on universal life ("UL") and variable universal life ("VUL") contracts, primarily related to secondary guarantees and paid-up guarantees, for the portion of contract assessments received in early years that will be used to compensate the Company for benefits provided in later years. These reserves are calculated by estimating the expected value of benefits payable and recognizing those benefits ratably over the accumulation period based on total expected assessments, using interest rates consistent with the underlying contracts' interest crediting rates. Included are contracts where the Company contractually guaranteed a death benefit even when there is insufficient value to cover monthly mortality and expense charges, whereas otherwise the contract would typically lapse ("no lapse guarantee"), and other provisions that would produce expected gains from the insurance benefit function followed by losses from that function in later years. Additional reserves for UL and VUL contracts are recorded in Future policy benefits on the Condensed Consolidated Balance Sheets. Stabilizer and MCG : Guaranteed credited rates give rise to an embedded derivative in the stabilizer ("Stabilizer") products and a stand-alone derivative for managed custody guarantee products ("MCG"). These derivatives are measured at estimated fair value and recorded in Contract owner account balances. Changes in estimated fair value, that are not related to attributed fees collected or payments made, are reported in Net gains (losses) in the Condensed Consolidated Statements of Operations. The estimated fair value of the Stabilizer embedded derivative and MCG stand-alone derivative is determined based on the present value of projected future claims, minus the present value of future guaranteed premiums. At inception of the contract, the Company projects a guaranteed premium to be equal to the present value of the projected future claims. The income associated with the contracts is projected using actuarial and capital market assumptions, including benefits and related contract charges, over the anticipated life of the related contracts. The cash flow estimates are projected under multiple capital market scenarios using observable risk-free rates and other best estimate assumptions. The liabilities for the Stabilizer embedded derivative and the MCG stand-alone derivative include a risk margin to capture uncertainties related to policyholder behavior assumptions. The margin represents additional compensation a market participant would require to assume these risks. The discount rate used to determine the fair value of the liabilities for the Stabilizer embedded derivative and the MCG stand-alone derivative includes an adjustment to reflect the risk that these obligations will not be fulfilled ("nonperformance risk"). Reinsurance The Company utilizes reinsurance agreements in most aspects of its insurance business to reduce its exposure to large losses. Such reinsurance permits recovery of a portion of losses from reinsurers, although it does not discharge the primary liability of the Company as direct insurer of the risks reinsured. For each of its reinsurance agreements, the Company determines whether the agreement provides indemnification against loss or liability relating to insurance risk. The Company reviews contractual features, particularly those that may limit the amount of insurance risk to which the reinsurer is subject or features that delay the timely reimbursement of claims. The assumptions used to account for both long and short-duration reinsurance agreements are consistent with those used for the underlying contracts, with the exception of the interest accretion rate on reinsurance recoverable assets associated with in-force business reinsured. Ceded Future policy benefits and Contract owner account balances are reported gross on the Condensed Consolidated Balance Sheets. Long-duration : For reinsurance of long-duration contracts that transfer significant insurance risk, the difference, if any, between the amounts paid and benefits received related to the underlying contracts is included in the expected net cost of reinsurance, which is recorded in Premiums receivable and reinsurance recoverable or Other liabilities, as appropriate, on the Condensed Consolidated Balance Sheets. Short-duration : For prospective reinsurance of short-duration contracts that meet the criteria for reinsurance accounting, amounts paid are recorded as ceded premiums and ceded unearned premiums and are reflected as a component of Premiums in the Condensed Consolidated Statements of Operations and Other assets on the Condensed Consolidated Balance Sheets, respectively. Ceded unearned premiums are amortized through premiums over the remaining contract period in proportion to the amount of protection provided. For retroactive reinsurance of short-duration contracts that meet the criteria for reinsurance accounting, amounts paid in excess of the related insurance liabilities ceded are recognized immediately as a loss. Any gains on such retroactive agreements are deferred in Other liabilities and amortized over the remaining life of the underlying contracts. Accounting for reinsurance requires use of assumptions and estimates, particularly related to the future performance of the underlying business and the potential impact of counterparty credit risks. The Company reviews assumptions used to establish assets and liabilities relating to ceded and assumed reinsurance at least annually and updates them if necessary. In addition to the assumption updates, the Company adjusts these assets or liabilities for actual experience in the period in which the experience occurs. The Company also evaluates the financial strength of potential reinsurers and continually monitors the financial condition of reinsurers. Reinsurance recoverable balances are reported net of the allowance for credit losses on the Company’s Condensed Consolidated Balance Sheets. Management estimates the credit loss allowance balance using a factor-based method of probability of default and loss given default which incorporates relevant available information, from internal and external sources, relating to past events, current conditions, and reasonable and supportable forecasts. Included in the factor-based method are the consideration of capital market factors, counterparty financial information and ratings, and reinsurance agreement-specific risk characteristics such as collateral type, collateral size, and covenant strength. The allowance for credit losses is a valuation account that is deducted from the reinsurance recoverable balance to present the net amount expected to be collected on the reinsurance recoverable. The change in the allowance for credit losses is recorded in Policyholder benefits in the Condensed Consolidated Statements of Operations. Current reinsurance recoverable balances deemed probable of recovery and payable balances under reinsurance agreements are included in Premium receivable and reinsurance recoverable and Other liabilities, respectively. Such assets and liabilities relating to reinsurance agreements with the same reinsurer are recorded net on the Condensed Consolidated Balance Sheets if a right of offset exists within the reinsurance agreement. Premiums, Fee income and Policyholder benefits are reported net of reinsurance ceded. The Company has entered into coinsurance funds withheld reinsurance arrangements that contain embedded derivatives for which carrying value is estimated based on the change in the fair value of the assets supporting the funds withheld payable under the agreements. Significant accounting policies that were unchanged from those included in the Company’s December 31, 2022 Annual Report on Form 10-K as a result of the adoption of ASU 2018-12 have not been repeated. These policies include Internal Replacements, Contract Owner Account Balances, and Separate Accounts. Adoption of New Pronouncements Long-Duration Contracts The following section provides a description of the Company's adoption of ASU 2018-12 issued by the Financial Accounting Standards Board ("FASB") and the impact of the adoption on the Company's financial statements: This standard, issued in August 2018, changes the measurement and disclosures of insurance liabilities and DAC for long-duration contracts issued by insurers. In addition to expanded disclosures, the standard’s requirements include: • Annual review and, if necessary, update of cash flow assumptions used to measure the liability for future policy benefits for nonparticipating traditional and limited payment insurance contracts, measured on a retrospective catch-up basis and recognized in the period the update is made. The rate used is required to be updated quarterly, with related changes in the liability recorded in AOCI. • Fair value measurement of contract guarantee features qualifying as Market Risk Benefits (“MRB”), with changes in fair value recognized in the Statement of Operations. Changes in the instrument-specific credit risk will be recorded in AOCI. • Amortization of DAC on a constant level basis over the expected term of the contracts, without reference to revenue or profitability. An accounting election may be made to apply the DAC requirements to VOBA. • Insurance entities may make an accounting policy election to exclude contracts from application of the requirements in ASU 2018-12 when those contracts have been derecognized because of a sale or disposal of a legal entity before the effective date of ASU 2018-12. The Company adopted ASU 2018-12 on January 1, 2023, on a modified retrospective basis for the liability for future policy benefits and DAC and on a full retrospective basis for MRBs. The January 1, 2021 transition impact increased Total shareholders’ equity. This increase was primarily driven by the removal of DAC/VOBA and Premium deficiency reserve adjustment balances, and partially offset by the impact of remeasurement of Future policy benefits and Reinsurance recoverable using the discount rate at January 1, 2021. Total shareholders’ equity was also impacted by the establishment of MRB liabilities related to guaranteed minimum benefits on certain deferred annuity contracts. The Company elected the option to exclude contracts reported as discontinued operations in 2021. Disclosures and post-transition comparative information have been restated to conform to the requirements of ASU 2018-12. The following tables provide additional information related to the transition adjustments: DAC VOBA Wealth Solutions Deferred and Individual Annuities Businesses Exited (1) Balance, December 31, 2020 $ 119 $ 1,186 $ 70 Adjustment for removal of related balances in AOCI 571 104 635 Balance, January 1, 2021 $ 690 $ 1,290 $ 705 Liability for Future Policy Benefits Health Solutions Group (2) Health Solutions Voluntary (3) Businesses Exited (1) Balance, December 31, 2020 $ 822 $ 188 $ 5,448 Adjustment for reversal of related balances in AOCI — — (386) Adjustment for loss contracts under the modified retrospective approach 7 3 3 Effect of remeasurement of liability at current discount rate 118 83 1,362 Balance, January 1, 2021 $ 947 $ 274 $ 6,427 (1) Includes long duration retail individual life and annuity business exited via reinsurance (2) Includes long duration employee-sponsored group life and health products (3) Includes long duration employee-paid whole life products The following table presents information on transition adjustments, net of tax, related to the adoption of ASU 2018-12 for retained earnings and AOCI to arrive at the opening balances as of January 1, 2021: Total Shareholders' equity December 31, 2020 $ 11,178 AOCI Reversal of AOCI adjustments 1,328 Effect of remeasurement of liability at current discount rate (1,065) Total AOCI adjustments $ 263 Retained Earnings Establishment of MRBs $ (132) Other adjustments 27 Total Retained earnings $ (105) Total adjustment for the adoption of ASU 2018-12 $ 158 Total Shareholders' equity January 1, 2021 $ 11,336 The following table provides a description of the Company’s adoption of other new ASUs issued by the FASB and the impact of adoption on the Company’s financial statements: Standard Description of Requirements Effective Date and Transition Provisions Effect on the Financial Statements or Other Significant Matters ASU 2022-02, Troubled Debt Restructurings ("TDRs") and Vintage Disclosures This standard, issued in March 2022, eliminates the accounting guidance on troubled debt restructurings for creditors, requires enhanced disclosures for creditors about loan modifications when a borrower is experiencing financial difficulty, and requires public business entities to include current-period gross write-offs in the vintage disclosure tables. January 1, 2023 on a prospective basis. Adoption of the ASU did not have an impact on the Company's financial condition, results of operations, or cash flows. Required disclosure changes have been included in the Investments (excluding Consolidated Investment Entities) Note to these Condensed Consolidated Financial Statements . ASU 2020-04, Reference Rate Reform This standard, issued in March 2020, provides temporary optional expedients and exceptions for applying U.S. GAAP principles to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments were effective as of March 12, 2020, the issuance date of the ASU. An entity may elect to apply the amendments prospectively through December 31, 2024. The Company has elected to apply the expedient provided in ASU 2020-04 for qualifying contract modifications. To date, adoption of the guidance has not had a material impact on the Company’s financial condition and results of operations. The Company will continue to evaluate the impacts of reference rate reform on contract modifications and hedging relationships as transition progresses. Future Adoption of Accounting Pronouncements The following table provides a description of future adoptions of new accounting standards that may have an impact on the Company's financial statements when adopted: Standard Description of Requirements Effective Date and Transition Provisions Effect on the Financial Statements or Other Significant Matters ASU 2022-03, Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions This standard, issued in June 2022, clarifies that contractual restrictions on equity security sales are not considered part of the security unit of account and, therefore, are not considered in measuring fair value. In addition, the restrictions cannot be recognized and measured as separate units of account. Disclosures on such restrictions are also required. The amendments are effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, and are required to be applied prospectively, with any adjustments from the adoption recognized in earnings and disclosed. The Company is currently in the process of determining the impact of adoption of the provisions of ASU 2022-03.

Investments (excluding Consolid

Investments (excluding Consolidated Investment Entities)	3 Months Ended
	Mar. 31, 2023
Investments, Debt and Equity Securities [Abstract]
Investments (excluding Consolidated Investment Entities)	50% - 60% >60% - 70% >70% - 80% >80% and above Total 2023 $ 58 $ — $ — $ — $ — $ 58 2022 246 337 64 — — 647 2021 236 246 253 — — 735 2020 150 169 14 10 — 343 2019 225 93 29 — — 347 2018 161 40 3 — — 204 2017 and prior 2,509 477 26 — — 3,012 Total $ 3,585 $ 1,362 $ 389 $ 10 $ — $ 5,346 As of December 31, 2022 Loan-to-Value Ratios Year of Origination 0% - 50% >50% - 60% >60% - 70% >70% - 80% >80% and above Total 2022 $ 250 $ 320 $ 65 $ — $ — $ 635 2021 240 272 255 10 — 777 2020 119 209 25 10 — 363 2019 227 94 29 — — 350 2018 163 41 2 — — 206 2017 and prior 2,606 482 26 — — 3,114 Total $ 3,605 $ 1,418 $ 402 $ 20 $ — $ 5,445 The following tables present commercial mortgage loans by year of origination and DSC ratio as of the dates indicated. The information is updated as of March 31, 2023 and December 31, 2022, respectively. As of March 31, 2023 Debt Service Coverage Ratios Year of Origination >1.5x >1.25x - 1.5x >1.0x - 1.25x <1.0x Total* 2023 $ 51 $ 7 $ — $ — $ 58 2022 278 96 187 86 647 2021 265 26 113 331 735 2020 242 27 5 69 343 2019 220 45 75 7 347 2018 122 26 56 — 204 2017 and prior 2,091 446 226 249 3,012 Total $ 3,269 $ 673 $ 662 $ 742 $ 5,346 *No commercial mortgage loans were secured by land or construction loans As of December 31, 2022 Debt Service Coverage Ratios Year of Origination >1.5x >1.25x - 1.5x >1.0x - 1.25x <1.0x Total* 2022 $ 331 $ 100 $ 181 $ 23 $ 635 2021 273 33 269 202 777 2020 259 11 11 82 363 2019 222 54 67 7 350 2018 128 27 51 — 206 2017 and prior 2,172 454 226 262 3,114 Total $ 3,385 $ 679 $ 805 $ 576 $ 5,445 *No commercial mortgage loans were secured by land or construction loans The following tables present the commercial mortgage loans by year of origination and U.S. region as of the dates indicated. The information is updated as of March 31, 2023 and December 31, 2022, respectively. As of March 31, 2023 U.S. Region Year of Origination Pacific South Atlantic Middle Atlantic West South Central Mountain East North Central New England West North Central East South Central Total 2023 $ 20 $ — $ 4 $ — $ — $ 31 $ 3 $ — $ — $ 58 2022 140 129 48 99 114 93 4 1 19 647 2021 98 63 131 145 112 127 9 48 2 735 2020 74 161 17 16 12 40 — 7 16 343 2019 57 105 10 76 46 5 14 13 21 347 2018 50 61 54 9 14 10 — 6 — 204 2017 and prior 767 602 748 222 210 242 49 147 25 3,012 Total $ 1,206 $ 1,121 $ 1,012 $ 567 $ 508 $ 548 $ 79 $ 222 $ 83 $ 5,346 As of December 31, 2022 U.S. Region Year of Origination Pacific South Atlantic Middle Atlantic West South Central Mountain East North Central New England West North Central East South Central Total 2022 $ 140 $ 129 $ 48 $ 98 $ 114 $ 82 $ 4 $ 1 $ 19 $ 635 2021 99 72 134 143 112 138 9 48 22 777 2020 74 170 18 16 12 39 — 7 27 363 2019 58 106 10 77 46 5 14 13 21 350 2018 50 62 55 10 14 10 — 5 — 206 2017 and prior 777 623 759 248 227 257 49 149 25 3,114 Total $ 1,198 $ 1,162 $ 1,024 $ 592 $ 525 $ 531 $ 76 $ 223 $ 114 $ 5,445 The following tables present the commercial mortgage loans by year of origination and property type as of the dates indicated. The information is updated as of March 31, 2023 and December 31, 2022, respectively. As of March 31, 2023 Property Type Year of Origination Retail Industrial Apartments Office Hotel/Motel Other Mixed Use Total 2023 $ 15 $ 3 $ 20 $ 20 $ — $ — $ — $ 58 2022 79 265 249 34 10 10 — 647 2021 37 165 381 125 — 18 9 735 2020 58 60 82 143 — — — 343 2019 45 85 164 40 13 — — 347 2018 37 83 55 12 — 17 — 204 2017 and prior 858 742 639 500 68 154 51 3,012 Total $ 1,129 $ 1,403 $ 1,590 $ 874 $ 91 $ 199 $ 60 $ 5,346 As of December 31, 2022 Property Type Year of Origination Retail Industrial Apartments Office Hotel/Motel Other Mixed Use Total 2022 $ 79 $ 255 $ 247 $ 34 $ 10 $ 10 $ — $ 635 2021 37 168 420 125 — 18 9 777 2020 58 61 93 151 — — — 363 2019 46 85 165 40 14 — — 350 2018 37 84 56 12 — 17 — 206 2017 and prior 888 757 679 513 69 156 52 3,114 Total $ 1,145 $ 1,410 $ 1,660 $ 875 $ 93 $ 201 $ 61 $ 5,445 The following table summarizes the activity in the allowance for losses for commercial mortgage loans for the periods indicated: March 31, 2023 December 31, 2022 Allowance for credit losses, beginning of period $ 18 $ 15 Credit losses on mortgage loans for which credit losses were not previously recorded — 3 Increase (decrease) on mortgage loans with allowance recorded in previous period (1) — Provision for expected credit losses 17 18 Write-offs — — Recoveries of amounts previously written-off — — Allowance for credit losses, end of period $ 17 $ 18 The following table presents past due commercial mortgage loans as of the dates indicated: March 31, 2023 December 31, 2022 Delinquency: Current $ 5,346 $ 5,445 30-59 days past due — — 60-89 days past due — — Greater than 90 days past due — — Total $ 5,346 $ 5,445 Commercial mortgage loans are placed on non-accrual status when 90 days in arrears if the Company has concerns regarding the collectability of future payments, or if a loan has matured without being paid off or extended. As of March 31, 2023, and December 31, 2022, the Company had no commercial mortgage loan in non-accrual status. There was no interest income recognized on loans in non-accrual status for the three months ended March 31, 2023 and year ended December 31, 2022. Net Investment Income The following table summarizes Net investment income for the periods indicated: Three Months Ended March 31, 2023 2022 Fixed maturities $ 458 $ 479 Equity securities 7 4 Mortgage loans on real estate 61 59 Policy loans 6 6 Short-term investments and cash equivalents 9 1 Limited partnerships and other 22 96 Gross investment income 563 645 Less: Investment expenses 18 15 Net investment income $ 545 $ 630 As of March 31, 2023, the Company had $12 of investments in fixed maturities that did not produce net investment income. As of December 31, 2022, the Company had $11 investments in fixed maturities that did not produce net investment income. Fixed maturities are moved to a non-accrual status when the investment defaults. Interest income on fixed maturities is recorded when earned using an effective yield method, giving effect to amortization of premiums and accretion of discounts. Such interest income is recorded in Net investment income in the Condensed Consolidated Statements of Operations. Net Gains (Losses) Net gains (losses) comprise the difference between the amortized cost of investments and proceeds from sale and redemption, as well as losses incurred due to the credit-related and intent-related impairment of investments. Net gains (losses) are also primarily generated from changes in fair value of embedded derivatives within products and fixed maturities, changes in fair value of fixed maturities recorded at FVO and changes in fair value including accruals on derivative instruments, except for effective cash flow hedges. Net gains (losses) also include changes in fair value of equity securities. The cost of the investments on disposal is generally determined based on first-in-first-out ("FIFO") methodology. Net gains (losses) were as follows for the periods indicated: Three Months Ended March 31, 2023 2022 Fixed maturities, available-for-sale, including securities pledged $ 1 $ (73) Fixed maturities, at fair value option 36 (305) Equity securities, at fair value (2) (8) Derivatives (54) 94 Embedded derivatives - fixed maturities 1 (4) Other derivatives, net — 5 Standalone derivatives — 1 Managed custody guarantees 3 (3) Mortgage Loans — 4 Other investments (1) 1 Net gains (losses) $ (16) $ (288) Proceeds from the sale of fixed maturities, available-for-sale and equity securities and the related gross realized gains and losses, before tax, were as follows for the periods indicated: Three Months Ended March 31, 2023 2022 Proceeds on sales $ 1,306 $ 1,249 Gross gains 20 15 Gross losses 25 32 " id="sjs-B4" xml:space="preserve">Investments (excluding Consolidated Investment Entities) Fixed Maturities Available-for-sale and fair value option ("FVO") fixed maturities were as follows as of March 31, 2023: Amortized Cost Gross Unrealized Capital Gains Gross Unrealized Capital Losses Embedded Derivatives (2) Fair Value Allowance for credit losses Fixed maturities: U.S. Treasuries $ 428 $ 15 $ 11 $ — $ 432 $ — U.S. Government agencies and authorities 54 4 1 — 57 — State, municipalities and political subdivisions 949 2 98 — 853 — U.S. corporate public securities 9,132 156 998 — 8,290 — U.S. corporate private securities 5,088 32 340 — 4,780 — Foreign corporate public securities and foreign governments (1) 3,259 38 331 — 2,957 9 Foreign corporate private securities (1) 3,151 14 171 — 2,992 2 Residential mortgage-backed securities 4,190 40 257 4 3,977 — Commercial mortgage-backed securities 4,415 1 574 — 3,842 — Other asset-backed securities 2,439 7 157 — 2,288 1 Total fixed maturities, including securities pledged 33,105 309 2,938 4 30,468 12 Less: Securities pledged 1,347 — 121 — 1,226 — Total fixed maturities $ 31,758 $ 309 $ 2,817 $ 4 $ 29,242 $ 12 (1) Primarily U.S. dollar denominated. (2) Embedded derivatives within fixed maturity securities are reported with the host investment. The changes in fair value of embedded derivatives are reported in Net gains (losses) in the Condensed Consolidated Statements of Operations. Available-for-sale and FVO fixed maturities were as follows as of December 31, 2022: Amortized Cost Gross Unrealized Capital Gains Gross Unrealized Capital Losses Embedded Derivatives (2) Fair Value Allowance for credit losses Fixed maturities: U.S. Treasuries $ 590 $ 12 $ 21 $ — $ 581 $ — U.S. Government agencies and authorities 58 3 2 — 59 — State, municipalities and political subdivisions 978 1 134 — 845 — U.S. corporate public securities 9,343 97 1,239 — 8,201 — U.S. corporate private securities 5,087 14 409 — 4,692 — Foreign corporate public securities and foreign governments (1) 3,343 18 403 — 2,949 9 Foreign corporate private securities (1) 3,254 7 225 — 3,034 2 Residential mortgage-backed securities 4,230 34 290 3 3,977 — Commercial mortgage-backed securities 4,466 2 585 — 3,883 — Other asset-backed securities 2,307 3 173 — 2,136 1 Total fixed maturities, including securities pledged 33,656 191 3,481 3 30,357 12 Less: Securities pledged 1,303 3 144 — 1,162 — Total fixed maturities $ 32,353 $ 188 $ 3,337 $ 3 $ 29,195 $ 12 (1) Primarily U.S. dollar denominated. (2) Embedded derivatives within fixed maturity securities are reported with the host investment. The changes in fair value of embedded derivatives are reported in Net gains (losses) in the Condensed Consolidated Statements of Operations. The amortized cost and fair value of fixed maturities, including securities pledged, as of March 31, 2023, are shown below by contractual maturity. Actual maturities may differ from contractual maturities as securities may be restructured, called or prepaid. Mortgage-backed securities ("MBS") and Other asset-backed securities ("ABS") are shown separately because they are not due at a single maturity date. Amortized Fair Due to mature: One year or less $ 679 $ 676 After one year through five years 4,276 4,086 After five years through ten years 4,206 4,014 After ten years 12,900 11,585 Mortgage-backed securities 8,605 7,819 Other asset-backed securities 2,439 2,288 Fixed maturities, including securities pledged $ 33,105 $ 30,468 As of March 31, 2023 and December 31, 2022, the Company did not have any investments in a single issuer, other than obligations of the U.S. Government and government agencies, with a carrying value in excess of 10% of the Company’s Total shareholders' equity. The following tables present the composition of the U.S. and foreign corporate securities within the fixed maturity portfolio by industry category as of the dates indicated: Amortized Gross Gross Fair March 31, 2023 Communications $ 1,184 $ 27 $ 101 $ 1,110 Financial 4,008 48 425 3,631 Industrial and other companies 8,136 60 748 7,448 Energy 1,987 55 127 1,915 Utilities 3,648 40 286 3,402 Transportation 1,115 5 100 1,020 Total $ 20,078 $ 235 $ 1,787 $ 18,526 December 31, 2022 Communications $ 1,156 $ 16 $ 130 $ 1,042 Financial 4,153 31 491 3,693 Industrial and other companies 8,379 26 953 7,452 Energy 1,979 39 160 1,858 Utilities 3,664 21 355 3,330 Transportation 1,165 2 128 1,039 Total $ 20,496 $ 135 $ 2,217 $ 18,414 The Company invests in various categories of collateralized mortgage obligations (CMOs), including CMOs that are not agency-backed, that are subject to different degrees of risk from changes in interest rates and defaults. The principal risks inherent in holding CMOs are prepayment and extension risks related to significant decreases and increases in interest rates resulting in the prepayment of principal from the underlying mortgages, either earlier or later than originally anticipated. As of March 31, 2023 and December 31, 2022, approximately 45.2% and 41.6%, respectively, of the Company's CMO holdings, were invested in the above mentioned types of CMOs such as interest-only or principal-only strips, that are subject to more prepayment and extension risk than traditional CMOs. Public corporate fixed maturity securities are distinguished from private corporate fixed maturity securities based upon the manner in which they are transacted. Public corporate fixed maturity securities are issued initially through market intermediaries on a registered basis or pursuant to Rule 144A under the Securities Act of 1933 (the "Securities Act") and are traded on the secondary market through brokers acting as principal. Private corporate fixed maturity securities are originally issued by borrowers directly to investors pursuant to Section 4(a)(2) of the Securities Act, and are traded in the secondary market directly with counterparties, either without the participation of a broker or in agency transactions. Repurchase Agreements As of March 31, 2023 and December 31, 2022, the Company did not have any securities pledged in dollar rolls or reverse repurchase agreements. As of March 31, 2023, the carrying value of securities pledged and obligation to repay loans related to repurchase agreement transactions were $113 and included in Securities pledged and Payables under securities loan and repurchase agreements, including collateral held on the Condensed Consolidated Balance Sheets. As of December 31, 2022, the carrying value of securities pledged and obligation to repay loans related to repurchase agreement transactions were $113. Securities pledged related to repurchase agreements are comprised of other asset-backed securities. Securities Pledged The Company engages in securities lending whereby the initial collateral is required at a rate of 102% of the market value of the loaned securities. The lending agent retains the collateral and invests it in high quality liquid assets on behalf of the Company. The market value of the loaned securities is monitored on a daily basis with additional collateral obtained or refunded as the market value of the loaned securities fluctuates. The lending agent indemnifies the Company against losses resulting from the failure of a counterparty to return securities pledged where collateral is insufficient to cover the loss. As of March 31, 2023 and December 31, 2022, the fair value of loaned securities was $976 and $907, respectively, and is included in Securities pledged on the Condensed Consolidated Balance Sheets. If cash is received as collateral, the lending agent retains the cash collateral and invests it in short-term liquid assets on behalf of the Company. As of March 31, 2023 and December 31, 2022, cash collateral retained by the lending agent and invested in short-term liquid assets on the Company's behalf was $879 and $807, respectively, and is recorded in Short-term investments under securities loan agreements, including collateral delivered on the Condensed Consolidated Balance Sheets. As of March 31, 2023 and December 31, 2022, liabilities to return collateral of $879 and $807, respectively, are included in Payables under securities loan and repurchase agreements, including collateral held on the Condensed Consolidated Balance Sheets. The Company accepts non-cash collateral in the form of securities. The securities retained as collateral by the lending agent may not be sold or re-pledged, except in the event of default, and are not reflected on the Company’s Condensed Consolidated Balance Sheets. This collateral generally consists of U.S. Treasury, U.S. Government agency securities and MBS pools. As of March 31, 2023 and December 31, 2022, the fair value of securities retained as collateral by the lending agent on the Company’s behalf was $125 and $135, respectively. The following table presents borrowings under securities lending transactions by asset class as of the dates indicated: March 31, 2023 December 31, 2022 U.S. Treasuries $ 7 $ 53 U.S. corporate public securities 700 604 Foreign corporate public securities and foreign governments 297 285 Payables under securities loan agreements $ 1,004 $ 942 The Company's securities lending activities are conducted on an overnight basis, and all securities loaned can be recalled at any time. The Company does not offset assets and liabilities associated with its securities lending program. Allowance for credit losses The following table presents a rollforward of the allowance for credit losses on available-for-sale fixed maturity securities for the periods presented: Three Months Ended March 31, 2023 Foreign corporate public securities and foreign governments Foreign corporate private securities Other asset-backed securities Total Balance as of January 1 $ 9 $ 2 $ 1 $ 12 Reductions for securities sold during the period (2) — — (2) Increase (decrease) on securities with allowance recorded in previous period 2 — — 2 Balance as of March 31 $ 9 $ 2 $ 1 $ 12 Year Ended December 31, 2022 Residential mortgage-backed securities Foreign Foreign corporate private securities Other asset-backed securities Total Balance as of January 1 $ 1 $ — $ 56 $ 1 $ 58 Credit losses on securities for which credit losses were not previously recorded — 9 — — 9 Reductions for securities sold during the period — — (57) — (57) Increase (decrease) on securities with allowance recorded in previous period (1) — 3 — 2 Balance as of December 31 $ — $ 9 $ 2 $ 1 $ 12 Unrealized Capital Losses The following table presents available-for-sale fixed maturities, including securities pledged, for which an allowance for credit losses has not been recorded by market sector and duration as of March 31, 2023: Twelve Months or Less More Than Twelve Total Fair Value Unrealized Capital Losses Number of securities Fair Value Unrealized Capital Losses Number of securities Fair Value Unrealized Capital Losses Number of securities U.S. Treasuries $ 106 $ 1 10 $ 47 $ 10 13 $ 153 $ 11 23 U.S. Government agencies and authorities — — — 3 1 1 3 1 1 State, municipalities and political subdivisions 573 44 206 209 54 82 782 98 288 U.S. corporate public securities 3,181 220 558 2,864 778 733 6,045 998 1,291 U.S. corporate private securities 2,268 113 243 1,552 227 152 3,820 340 395 Foreign corporate public securities and foreign governments 1,185 76 205 1,008 255 230 2,193 331 435 Foreign corporate private securities 1,834 75 138 793 96 68 2,627 171 206 Residential mortgage-backed 782 43 329 964 214 447 1,746 257 776 Commercial mortgage-backed 1,346 141 213 2,410 433 438 3,756 574 651 Other asset-backed 554 26 138 1,532 131 399 2,086 157 537 Total $ 11,829 $ 739 2,040 $ 11,382 $ 2,199 2,563 $ 23,211 $ 2,938 4,603 The Company concluded that an allowance for credit losses was unnecessary for these securities because the unrealized losses are interest rate related. The following table presents available-for-sale fixed maturities, including securities pledged, for which an allowance for credit losses has not been recorded by market sector and duration as of December 31, 2022: Twelve Months or Less More Than Twelve Total Fair Value Unrealized Capital Losses Number of securities Fair Value Unrealized Capital Losses Number of securities Fair Value Unrealized Capital Losses Number of securities U.S. Treasuries $ 197 $ 19 19 $ 9 $ 2 7 $ 206 $ 21 26 U.S. Government agencies and authorities 21 2 2 — — — 21 2 2 State, municipalities and political subdivisions 751 121 284 30 13 17 781 134 301 U.S. corporate public securities 5,479 792 1,054 1,137 447 347 6,616 1,239 1,401 U.S. corporate private securities 3,569 322 375 458 87 32 4,027 409 407 Foreign corporate public securities and foreign governments 2,050 260 371 391 143 97 2,441 403 468 Foreign corporate private securities 2,728 211 217 65 14 6 2,793 225 223 Residential mortgage-backed 1,538 128 536 562 162 283 2,100 290 819 Commercial mortgage-backed 2,628 390 441 1,133 195 207 3,761 585 648 Other asset-backed 1,430 104 334 578 69 191 2,008 173 525 Total $ 20,391 $ 2,349 3,633 $ 4,363 $ 1,132 1,187 $ 24,754 $ 3,481 4,820 Based on the Company's quarterly evaluation of its securities in an unrealized loss position, described below, the Company concluded that these securities were not impaired as of March 31, 2023. The Company does not intend to sell the investments and it is not more likely than not that the Company will be required to sell the investments before recovery of their amortized cost bases. Gross unrealized capital losses on fixed maturities, including securities pledged, decreased $543 from $3,481 to $2,938 for the three months ended March 31, 2023. The decrease in unrealized losses was driven by lower interest rates across the yield curve. As of March 31, 2023, $41 of the total $2,938 of gross unrealized losses were from 68 available-for-sale fixed maturity securities with an unrealized loss position of 20% or more of amortized cost for 12 months or greater. Evaluating Securities for Impairments The Company performs a regular evaluation, on a security-by-security basis, of its available-for-sale securities holdings, including fixed maturity securities, in accordance with its impairment policy in order to evaluate whether such investments are impaired. The following table identifies the Company's intent impairments included in the Condensed Consolidated Statements of Operations, excluding impairments included in Other comprehensive income (loss) by type for the periods indicated: Three Months Ended March 31, 2023 2022 Impairment No. of Impairment No. of Residential mortgage-backed — * 2 7 13 Total $ — * 2 $ 7 13 (1) Primarily U.S. dollar denominated. *Less than $1 The Company may sell securities during the period in which fair value has declined below amortized cost for fixed maturities. In certain situations, new factors, including changes in the business environment, can change the Company’s previous intent to continue holding a security. Accordingly, these factors may lead the Company to record additional intent related capital losses. Debt Restructuring Upon the adoption of ASU 2022-02 as of January 1, 2023, the Company no longer identifies certain debt modifications as troubled debt restructuring, but instead evaluates all debt modifications to determine whether a modification results in a new loan or a continuation of an existing loan. Disclosures are required for loan modifications with borrowers experiencing financial difficulty. For the three months ended March 31, 2023, the Company had no debt modifications that require such disclosure. Mortgage Loans on Real Estate The Company diversifies its commercial mortgage loan portfolio by geographic region and property type to reduce concentration risk. The Company manages risk when originating commercial mortgage loans by generally lending only up to 75% of the estimated fair value of the underlying real estate. Subsequently, the Company continuously evaluates mortgage loans based on relevant current information including a review of loan-specific performance, property characteristics and market trends. Loan performance is monitored on a loan specific basis through the review of submitted appraisals, operating statements, rent revenues and annual inspection reports, among other items. This review ensures properties are performing at a consistent and acceptable level to secure the debt. The components to evaluate debt service coverage are received and reviewed at least annually to determine the level of risk. Loan-to-value ("LTV") and debt service coverage ("DSC") ratios are measures commonly used to assess the risk and quality of mortgage loans. The LTV ratio, calculated at time of origination, is expressed as a percentage of the amount of the loan relative to the value of the underlying property. A LTV ratio in excess of 100% indicates the unpaid loan amount exceeds the underlying collateral. The DSC ratio, based upon the most recently received financial statements, is expressed as a percentage of the amount of a property’s net income to its debt service payments. A DSC ratio of less than 1.0 indicates that a property’s operations do not generate sufficient income to cover debt payments. These ratios are utilized as part of the review process described above. The following tables present commercial mortgage loans by year of origination and LTV ratio as of the dates indicated. The information is updated as of March 31, 2023 and December 31, 2022, respectively. As of March 31, 2023 Loan-to-Value Ratios Year of Origination 0% - 50% >50% - 60% >60% - 70% >70% - 80% >80% and above Total 2023 $ 58 $ — $ — $ — $ — $ 58 2022 246 337 64 — — 647 2021 236 246 253 — — 735 2020 150 169 14 10 — 343 2019 225 93 29 — — 347 2018 161 40 3 — — 204 2017 and prior 2,509 477 26 — — 3,012 Total $ 3,585 $ 1,362 $ 389 $ 10 $ — $ 5,346 As of December 31, 2022 Loan-to-Value Ratios Year of Origination 0% - 50% >50% - 60% >60% - 70% >70% - 80% >80% and above Total 2022 $ 250 $ 320 $ 65 $ — $ — $ 635 2021 240 272 255 10 — 777 2020 119 209 25 10 — 363 2019 227 94 29 — — 350 2018 163 41 2 — — 206 2017 and prior 2,606 482 26 — — 3,114 Total $ 3,605 $ 1,418 $ 402 $ 20 $ — $ 5,445 The following tables present commercial mortgage loans by year of origination and DSC ratio as of the dates indicated. The information is updated as of March 31, 2023 and December 31, 2022, respectively. As of March 31, 2023 Debt Service Coverage Ratios Year of Origination >1.5x >1.25x - 1.5x >1.0x - 1.25x <1.0x Total* 2023 $ 51 $ 7 $ — $ — $ 58 2022 278 96 187 86 647 2021 265 26 113 331 735 2020 242 27 5 69 343 2019 220 45 75 7 347 2018 122 26 56 — 204 2017 and prior 2,091 446 226 249 3,012 Total $ 3,269 $ 673 $ 662 $ 742 $ 5,346 *No commercial mortgage loans were secured by land or construction loans As of December 31, 2022 Debt Service Coverage Ratios Year of Origination >1.5x >1.25x - 1.5x >1.0x - 1.25x <1.0x Total* 2022 $ 331 $ 100 $ 181 $ 23 $ 635 2021 273 33 269 202 777 2020 259 11 11 82 363 2019 222 54 67 7 350 2018 128 27 51 — 206 2017 and prior 2,172 454 226 262 3,114 Total $ 3,385 $ 679 $ 805 $ 576 $ 5,445 *No commercial mortgage loans were secured by land or construction loans The following tables present the commercial mortgage loans by year of origination and U.S. region as of the dates indicated. The information is updated as of March 31, 2023 and December 31, 2022, respectively. As of March 31, 2023 U.S. Region Year of Origination Pacific South Atlantic Middle Atlantic West South Central Mountain East North Central New England West North Central East South Central Total 2023 $ 20 $ — $ 4 $ — $ — $ 31 $ 3 $ — $ — $ 58 2022 140 129 48 99 114 93 4 1 19 647 2021 98 63 131 145 112 127 9 48 2 735 2020 74 161 17 16 12 40 — 7 16 343 2019 57 105 10 76 46 5 14 13 21 347 2018 50 61 54 9 14 10 — 6 — 204 2017 and prior 767 602 748 222 210 242 49 147 25 3,012 Total $ 1,206 $ 1,121 $ 1,012 $ 567 $ 508 $ 548 $ 79 $ 222 $ 83 $ 5,346 As of December 31, 2022 U.S. Region Year of Origination Pacific South Atlantic Middle Atlantic West South Central Mountain East North Central New England West North Central East South Central Total 2022 $ 140 $ 129 $ 48 $ 98 $ 114 $ 82 $ 4 $ 1 $ 19 $ 635 2021 99 72 134 143 112 138 9 48 22 777 2020 74 170 18 16 12 39 — 7 27 363 2019 58 106 10 77 46 5 14 13 21 350 2018 50 62 55 10 14 10 — 5 — 206 2017 and prior 777 623 759 248 227 257 49 149 25 3,114 Total $ 1,198 $ 1,162 $ 1,024 $ 592 $ 525 $ 531 $ 76 $ 223 $ 114 $ 5,445 The following tables present the commercial mortgage loans by year of origination and property type as of the dates indicated. The information is updated as of March 31, 2023 and December 31, 2022, respectively. As of March 31, 2023 Property Type Year of Origination Retail Industrial Apartments Office Hotel/Motel Other Mixed Use Total 2023 $ 15 $ 3 $ 20 $ 20 $ — $ — $ — $ 58 2022 79 265 249 34 10 10 — 647 2021 37 165 381 125 — 18 9 735 2020 58 60 82 143 — — — 343 2019 45 85 164 40 13 — — 347 2018 37 83 55 12 — 17 — 204 2017 and prior 858 742 639 500 68 154 51 3,012 Total $ 1,129 $ 1,403 $ 1,590 $ 874 $ 91 $ 199 $ 60 $ 5,346 As of December 31, 2022 Property Type Year of Origination Retail Industrial Apartments Office Hotel/Motel Other Mixed Use Total 2022 $ 79 $ 255 $ 247 $ 34 $ 10 $ 10 $ — $ 635 2021 37 168 420 125 — 18 9 777 2020 58 61 93 151 — — — 363 2019 46 85 165 40 14 — — 350 2018 37 84 56 12 — 17 — 206 2017 and prior 888 757 679 513 69 156 52 3,114 Total $ 1,145 $ 1,410 $ 1,660 $ 875 $ 93 $ 201 $ 61 $ 5,445 The following table summarizes the activity in the allowance for losses for commercial mortgage loans for the periods indicated: March 31, 2023 December 31, 2022 Allowance for credit losses, beginning of period $ 18 $ 15 Credit losses on mortgage loans for which credit losses were not previously recorded — 3 Increase (decrease) on mortgage loans with allowance recorded in previous period (1) — Provision for expected credit losses 17 18 Write-offs — — Recoveries of amounts previously written-off — — Allowance for credit losses, end of period $ 17 $ 18 The following table presents past due commercial mortgage loans as of the dates indicated: March 31, 2023 December 31, 2022 Delinquency: Current $ 5,346 $ 5,445 30-59 days past due — — 60-89 days past due — — Greater than 90 days past due — — Total $ 5,346 $ 5,445 Commercial mortgage loans are placed on non-accrual status when 90 days in arrears if the Company has concerns regarding the collectability of future payments, or if a loan has matured without being paid off or extended. As of March 31, 2023, and December 31, 2022, the Company had no commercial mortgage loan in non-accrual status. There was no interest income recognized on loans in non-accrual status for the three months ended March 31, 2023 and year ended December 31, 2022. Net Investment Income The following table summarizes Net investment income for the periods indicated: Three Months Ended March 31, 2023 2022 Fixed maturities $ 458 $ 479 Equity securities 7 4 Mortgage loans on real estate 61 59 Policy loans 6 6 Short-term investments and cash equivalents 9 1 Limited partnerships and other 22 96 Gross investment income 563 645 Less: Investment expenses 18 15 Net investment income $ 545 $ 630 As of March 31, 2023, the Company had $12 of investments in fixed maturities that did not produce net investment income. As of December 31, 2022, the Company had $11 investments in fixed maturities that did not produce net investment income. Fixed maturities are moved to a non-accrual status when the investment defaults. Interest income on fixed maturities is recorded when earned using an effective yield method, giving effect to amortization of premiums and accretion of discounts. Such interest income is recorded in Net investment income in the Condensed Consolidated Statements of Operations. Net Gains (Losses) Net gains (losses) comprise the difference between the amortized cost of investments and proceeds from sale and redemption, as well as losses incurred due to the credit-related and intent-related impairment of investments. Net gains (losses) are also primarily generated from changes in fair value of embedded derivatives within products and fixed maturities, changes in fair value of fixed maturities recorded at FVO and changes in fair value including accruals on derivative instruments, except for effective cash flow hedges. Net gains (losses) also include changes in fair value of equity securities. The cost of the investments on disposal is generally determined based on first-in-first-out ("FIFO") methodology. Net gains (losses) were as follows for the periods indicated: Three Months Ended March 31, 2023 2022 Fixed maturities, available-for-sale, including securities pledged $ 1 $ (73) Fixed maturities, at fair value option 36 (305) Equity securities, at fair value (2) (8) Derivatives (54) 94 Embedded derivatives - fixed maturities 1 (4) Other derivatives, net — 5 Standalone derivatives — 1 Managed custody guarantees 3 (3) Mortgage Loans — 4 Other investments (1) 1 Net gains (losses) $ (16) $ (288) Proceeds from the sale of fixed maturities, available-for-sale and equity securities and the related gross realized gains and losses, before tax, were as follows for the periods indicated: Three Months Ended March 31, 2023 2022 Proceeds on sales $ 1,306 $ 1,249 Gross gains 20 15 Gross losses 25 32

Derivative Financial Instrument

Derivative Financial Instruments	3 Months Ended
	Mar. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments	Derivative Financial Instruments The Company primarily enters into the following types of derivatives: Interest rate swaps: Interest rate swaps are used by the Company primarily to reduce market risks from changes in interest rates and to alter interest rate exposure arising from mismatches between assets and/or liabilities. Interest rate swaps are also used to hedge the interest rate risk associated with the value of assets it owns or in an anticipation of acquiring them. Using interest rate swaps, the Company agrees with another party to exchange, at specified intervals, the difference between fixed rate and floating rate interest payments, calculated by reference to an agreed upon notional principal amount. These transactions are entered into pursuant to master agreements that provide for a single net payment to be made to/from the counterparty at each due date. The Company utilizes these contracts in qualifying hedging relationships as well as non-qualifying hedging relationships. Foreign exchange swaps: The Company uses foreign exchange or currency swaps to reduce the risk of change in the value, yield or cash flows associated with certain foreign denominated invested assets. Foreign exchange swaps represent contracts that require the exchange of foreign currency cash flows against U.S. dollar cash flows at regular periods, typically quarterly or semi-annually. The Company utilizes these contracts in qualifying hedging relationships as well as non-qualifying hedging relationships. Total return swaps: The Company uses total return swaps as a hedge of interest related risks within various Legacy Annuity and Retirement products. Total return swaps are also used as a hedge of other corporate liabilities. Using total return swaps, the Company agrees with another party to exchange, at specified intervals, the difference between the economic performance of assets or a market index and a fixed or variable funding multiplied by reference to an agreed upon notional amount. No cash is exchanged at the onset of the contracts. Cash is paid and received over the life of the contract based upon the terms of the swaps. The Company utilized these contracts in non-qualifying hedging relationships. Futures: Futures contracts are used to hedge against a decrease in certain equity indices. Such decreases may correlate to a decrease in variable annuity account values which would increase the possibility of the Company incurring an expense for guaranteed benefits in excess of account values. The Company also uses interest rate futures contracts to hedge its exposure to market risks due to changes in interest rates. The Company enters into exchange traded futures with regulated futures commissions that are members of the exchange. The Company also posts initial and variation margins, with the exchange, on a daily basis. The Company utilizes exchange-traded futures in non-qualifying hedging relationships. The Company may also use futures contracts as a hedge against an increase in certain equity indices. Embedded derivatives: The Company also invests in certain fixed maturity instruments and has issued certain products that contain embedded derivatives for which market value is at least partially determined by, among other things, levels of or changes in domestic and/or foreign interest rates (short-term or long-term), exchange rates, prepayment rates, equity rates or credit ratings/spreads. In addition, the Company has entered into coinsurance with funds withheld arrangements, which contain embedded derivatives. The notional amounts and fair values of derivatives were as follows as of the dates indicated: March 31, 2023 December 31, 2022 Notional Asset Liability Notional Asset Liability Derivatives: Qualifying for hedge accounting (1) Fair value hedges: Foreign exchange contracts $ 88 $ — $ — $ 81 $ — $ 6 Cash flow hedges: Interest rate contracts 22 — — 22 — — Foreign exchange contracts 745 59 2 718 71 2 Derivatives: Non-qualifying for hedge accounting (1) Interest rate contracts 16,564 276 367 18,304 341 376 Foreign exchange contracts 185 3 1 160 9 2 Equity contracts 268 4 2 248 1 1 Credit contracts 188 — 4 174 — 2 Embedded derivatives and Managed custody guarantees: Within fixed maturity investments (2) N/A 4 — N/A 3 — Within reinsurance agreements (4) N/A 72 49 N/A 95 46 Managed custody guarantees (3) N/A — 3 N/A — 6 Total $ 418 $ 428 $ 520 $ 441 (1) Open derivative contracts are reported as Derivatives assets or liabilities on the Condensed Consolidated Balance Sheets at fair value. (2) Included in Fixed maturities, available-for-sale, at fair value on the Condensed Consolidated Balance Sheets. (3) Included in Contract owner account balances on the Condensed Consolidated Balance Sheets. (4) Included in Other liabilities, other assets and Premium receivable and reinsurance recoverable on the Condensed Consolidated Balance Sheets. N/A - Not applicable The Company utilizes derivative contracts mainly to hedge exposure to variability in cash flows, interest rate risk, credit risk, foreign exchange risk and equity market risk. The majority of derivatives used by the Company are designated as product hedges, which hedge the exposure arising from insurance liabilities or guarantees embedded in the contracts the Company offers through various product lines. The Company also uses derivatives contracts to hedge its exposure to various risks associated with the investment portfolio. The Company also uses credit default swaps coupled with other investments in order to produce the investment characteristics of otherwise permissible investments. Based on the notional amounts, a substantial portion of the Company’s derivative positions was not designated or did not qualify for hedge accounting as part of a hedging relationship as outlined in ASC Topic 815 as of March 31, 2023 and December 31, 2022. Although the Company has not elected to net its derivative exposures, the notional amounts and fair values of Over-The-Counter ("OTC") and cleared derivatives excluding exchange traded contracts are presented in the tables below as of the dates indicated: March 31, 2023 Notional Amount Asset Fair Value Liability Fair Value Credit contracts $ 188 $ — $ 4 Equity contracts 220 4 1 Foreign exchange contracts 1,018 62 3 Interest rate contracts 13,458 276 365 342 373 Counterparty netting (1) (241) (241) Cash collateral netting (1) (92) (126) Securities collateral netting (1) (6) (2) Net receivables/payables $ 3 $ 4 (1) Represents the netting of receivable balances with payable balances, net of collateral, for the same counterparty under eligible netting agreements. December 31, 2022 Notional Amount Asset Fair Value Liability Fair Value Credit contracts $ 174 $ — $ 2 Equity contracts 201 1 1 Foreign exchange contracts 959 80 10 Interest rate contracts 13,328 339 376 420 389 Counterparty netting (1) (295) (295) Cash collateral netting (1) (64) (88) Securities collateral netting (1) (6) (1) Net receivables/payables $ 55 $ 5 (1) Represents the netting of receivable balances with payable balances, net of collateral, for the same counterparty under eligible netting agreements. Collateral Under the terms of the OTC Derivative International Swaps and Derivatives Association, Inc. ("ISDA") agreements, the Company may receive from, or deliver to, counterparties collateral to assure that terms of the ISDA agreements will be met with regard to the Credit Support Annex ("CSA"). The terms of the CSA call for the Company to pay interest on any cash received equal to the Federal Funds rate. To the extent cash collateral is received and delivered, it is included in Payables under securities loan and repurchase agreements, including collateral held and Short-term investments under securities loan agreements, including collateral delivered, respectively, on the Condensed Consolidated Balance Sheets and is reinvested in short-term investments. Collateral held is used in accordance with the CSA to satisfy any obligations. Investment grade bonds owned by the Company are the source of noncash collateral posted, which is reported in Securities pledged on the Condensed Consolidated Balance Sheets. As of March 31, 2023, the Company held $96 and pledged $126 of net cash collateral related to OTC derivative contracts and cleared derivative contracts, respectively. As of December 31, 2022, the Company held $56 and pledged $79 of net cash collateral related to OTC derivative contracts and cleared derivative contracts, respectively. In addition, as of March 31, 2023, the Company delivered $137 of securities and held $7 of securities as collateral. As of December 31, 2022, the Company delivered $142 of securities and held $7 of securities as collateral. The location and effect of derivatives qualifying for hedge accounting on the Condensed Consolidated Statements of Operations and Condensed Consolidated Statements of Comprehensive Income are as follows for the periods indicated: Three Months Ended March 31, 2023 2022 Interest Rate Contracts Foreign Exchange Contracts Interest Rate Contracts Foreign Exchange Contracts Derivatives: Qualifying for hedge accounting Location of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income into Income Net investment income Net investment income and Net gains/(losses) Net investment income Net investment income and Net gains/(losses) Amount of Gain or (Loss) Recognized in Other Comprehensive Income $ — $ (12) $ (1) $ 7 Amount of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income — 3 — 3 The location and amount of gain (loss) recognized in the Condensed Consolidated Statements of Operations for derivatives qualifying for hedge accounting are as follows for the periods indicated: Three Months Ended March 31, 2023 2022 Net investment income Net gains/(losses) Net investment income Net gains/(losses) Total amounts of line items presented in the statement of operations in which the effects of fair value or cash flow hedges are recorded $ 545 $ (16) $ 630 $ (288) Derivatives: Qualifying for hedge accounting Fair value hedges: Foreign exchange contracts: Hedged items — 2 — (2) Derivatives designated as hedging instruments (1) — (1) — 2 Cash flow hedges: Foreign exchange contracts: Gain (loss) reclassified from accumulated other comprehensive income into income 3 — 3 — (1) For the three months ended March 31, 2023, $1 of the change in derivative instruments designated and qualifying as fair value hedges was excluded from the assessment of hedge effectiveness and recognized currently in earning. For the three months ended March 31, 2022, an immaterial portion of the change in derivative instruments designated and qualifying as fair value hedges was excluded from the assessment of hedge effectiveness and recognized currently in earning. The location and effect of derivatives not designated as hedging instruments on the Condensed Consolidated Statements of Operations are as follows for the periods indicated: Location of Gain or (Loss) on Derivative Three Months Ended March 31, 2023 2022 Derivatives: Non-qualifying for hedge accounting Interest rate contracts Net gains (losses) $ (56) $ 100 Foreign exchange contracts Net gains (losses) 1 (1) Equity contracts Net gains (losses) 3 (8) Credit contracts Net gains (losses) (1) — Embedded derivatives and Managed custody guarantees: Within fixed maturity investments Net gains (losses) 1 (4) Within reinsurance agreements (1) Policyholder benefits (26) 92 Managed custody guarantees Net gains (losses) 3 (3) Total $ (75) $ 176 (1) For the three months ended March 31, 2023, the amount excludes immaterial gains (losses) from standalone derivatives that were recognized in Net gains (losses). For the three months ended March 31, 2022, the amount excluded gains (losses) of $1, respectively, from standalone derivatives recognized in Net gains (losses).

Fair Value Measurements (exclud

Fair Value Measurements (excluding Consolidated Investment Entities)	3 Months Ended
	Mar. 31, 2023
Fair Value Disclosures [Abstract]
Fair Value Measurements (excluding Consolidated Investment Entities)	Fair Value Measurements (excluding Consolidated Investment Entities) Fair Value Measurement The following table presents the Company's hierarchy for its assets and liabilities measured at fair value on a recurring basis as of March 31, 2023: Level 1 Level 2 Level 3 Total Assets: Fixed maturities, including securities pledged: U.S. Treasuries $ 373 $ 59 $ — $ 432 U.S. Government agencies and authorities — 56 1 57 State, municipalities and political subdivisions — 853 — 853 U.S. corporate public securities — 8,269 21 8,290 U.S. corporate private securities — 2,980 1,800 4,780 Foreign corporate public securities and foreign governments (1) — 2,957 — 2,957 Foreign corporate private securities (1) — 2,551 441 2,992 Residential mortgage-backed securities — 3,921 56 3,977 Commercial mortgage-backed securities — 3,842 — 3,842 Other asset-backed securities — 2,211 77 2,288 Total fixed maturities, including securities pledged 373 27,699 2,396 30,468 Equity securities 116 — 192 308 Derivatives: Interest rate contracts 3 273 — 276 Foreign exchange contracts — 62 — 62 Equity contracts — 4 — 4 Embedded derivative on reinsurance — 72 — 72 Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements 1,982 21 — 2,003 Assets held in separate accounts 78,617 5,603 349 84,569 Total assets $ 81,091 $ 33,734 $ 2,937 $ 117,762 Percentage of Level to total 69 % 29 % 2 % 100 % Liabilities: Contingent consideration $ — $ — $ 112 $ 112 Stabilizer and MCGs — — 3 3 Derivatives: Interest rate contracts 1 366 — 367 Foreign exchange contracts — 3 — 3 Equity contracts 1 1 — 2 Credit contracts — 4 — 4 Embedded derivative on reinsurance — (9) (2) 58 49 Total liabilities $ 2 $ 365 $ 173 $ 540 (1) Primarily U.S. dollar denominated. (2) The Company classifies the embedded derivative within liabilities given the underlying nature of the balance and the right-of-offset. The following table presents the Company's hierarchy for its assets and liabilities measured at fair value on a recurring basis as of December 31, 2022: Level 1 Level 2 Level 3 Total Assets: Fixed maturities, including securities pledged: U.S. Treasuries $ 433 $ 148 $ — $ 581 U.S. Government agencies and authorities — 58 1 59 State, municipalities and political subdivisions — 845 — 845 U.S. corporate public securities — 8,181 20 8,201 U.S. corporate private securities — 2,891 1,801 4,692 Foreign corporate public securities and foreign governments (1) — 2,946 3 2,949 Foreign corporate private securities (1) — 2,602 432 3,034 Residential mortgage-backed securities — 3,949 28 3,977 Commercial mortgage-backed securities — 3,883 — 3,883 Other asset-backed securities — 2,072 64 2,136 Total fixed maturities, including securities pledged 433 27,575 2,349 30,357 Equity securities 140 — 196 336 Derivatives: Interest rate contracts 2 339 — 341 Foreign exchange contracts — 80 — 80 Equity contracts — 1 — 1 Embedded derivative on reinsurance — 95 — 95 Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements 2,430 24 — 2,454 Assets held in separate accounts 74,600 5,227 347 80,174 Total assets $ 77,605 $ 33,341 $ 2,892 $ 113,838 Percentage of Level to total 68 % 29 % 3 % 100 % Liabilities: Contingent consideration $ — $ — $ 112 $ 112 Stabilizer and MCGs — — 6 6 Derivatives: Interest rate contracts 3 373 — 376 Foreign exchange contracts — 10 — 10 Equity contracts — 1 — 1 Credit contracts — 2 — 2 Embedded derivative on reinsurance — (12) (2) 58 46 Total liabilities $ 3 $ 374 $ 176 $ 553 (1) Primarily U.S. dollar denominated. (2) The Company classifies the embedded derivative within liabilities given the underlying nature of the balance and the right-of-offset. Valuation of Financial Assets and Liabilities at Fair Value Certain assets and liabilities are measured at estimated fair value on the Company's Consolidated Balance Sheets. The Company defines fair value as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The exit price and the transaction (or entry) price will be the same at initial recognition in many circumstances. However, in certain cases, the transaction price may not represent fair value. The fair value of a liability is based on the amount that would be paid to transfer a liability to a third-party with an equal credit standing. Fair value is required to be a market-based measurement that is determined based on a hypothetical transaction at the measurement date, from a market participant’s perspective. The Company considers three broad valuation approaches when a quoted price is unavailable: (i) the market approach, (ii) the income approach and (iii) the cost approach. The Company determines the most appropriate valuation technique to use, given the instrument being measured and the availability of sufficient inputs. The Company prioritizes the inputs to fair valuation approaches and allows for the use of unobservable inputs to the extent that observable inputs are not available. The Company utilizes a number of valuation methodologies to determine the fair values of its financial assets and liabilities in conformity with the concepts of exit price and the fair value hierarchy as prescribed in ASC Topic 820. Valuations are obtained from third-party commercial pricing services, brokers and industry-standard, vendor-provided software that models the value based on market observable inputs. The valuations obtained from third-party commercial pricing services are non-binding. The Company reviews the assumptions and inputs used by third-party commercial pricing services for each reporting period in order to determine an appropriate fair value hierarchy level. The documentation and analysis obtained from third-party commercial pricing services are reviewed by the Company, including in-depth validation procedures confirming the observability of inputs. The valuations are reviewed and validated monthly through the internal valuation committee price variance review, comparisons to internal pricing models, back testing to recent trades or monitoring of trading volumes. When available, the fair value of the Company's financial assets and liabilities are based on quoted prices of identical assets in active markets and therefore, reflected in Level 1. The valuation approaches and key inputs for each category of assets or liabilities that are classified within Level 2 and Level 3 of the fair value hierarchy are presented below. For fixed maturities classified as Level 2 assets, fair values are determined using a matrix-based market approach, based on prices obtained from third-party commercial pricing services and the Company’s matrix and analytics-based pricing models, which in each case incorporate a variety of market observable information as valuation inputs. The market observable inputs used for these fair value measurements, by fixed maturity asset class, are as follows: U.S. Treasuries: Fair value is determined using third-party commercial pricing services, with the primary inputs being stripped interest and principal U.S. Treasury yield curves that represent a U.S. Treasury zero-coupon curve. U.S. government agencies and authorities, State, municipalities and political subdivisions: Fair value is determined using third-party commercial pricing services, with the primary inputs being U.S. Treasury yield curves, trades of comparable securities, credit spreads off benchmark yields and issuer ratings. U.S. corporate public securities, Foreign corporate public securities and foreign governments: Fair value is determined using third-party commercial pricing services, with the primary inputs being benchmark yields, trades of comparable securities, issuer ratings, bids and credit spreads off benchmark yields. U.S. corporate private securities and Foreign corporate private securities: Fair values are determined using a matrix and analytics-based pricing model. The model incorporates the current level of risk-free interest rates, current corporate credit spreads, credit quality of the issuer and cash flow characteristics of the security. The model also considers a liquidity spread, the value of any collateral, the capital structure of the issuer, the presence of guarantees, and prices and quotes for comparably rated publicly traded securities. RMBS, CMBS and ABS: Fair value is determined using third-party commercial pricing services, with the primary inputs being credit spreads off benchmark yields, prepayment speed assumptions, current and forecasted loss severity, debt service coverage ratios, collateral type, payment priority within tranche and the vintage of the loans underlying the security. Generally, the Company does not obtain more than one vendor price from pricing services per instrument. The Company uses a hierarchy process in which prices are obtained from a primary vendor and, if that vendor is unable to provide the price, the next vendor in the hierarchy is contacted until a price is obtained or it is determined that a price cannot be obtained from a commercial pricing service. When a price cannot be obtained from a commercial pricing service, independent broker quotes are solicited. Securities priced using independent broker quotes are classified as Level 3. Fair values of privately placed bonds are determined primarily using a matrix-based pricing model and are generally classified as Level 2 assets. The model considers the current level of risk-free interest rates, current corporate spreads, the credit quality of the issuer and cash flow characteristics of the security. Also considered are factors such as the net worth of the borrower, the value of collateral, the capital structure of the borrower, the presence of guarantees and the Company’s evaluation of the borrower’s ability to compete in its relevant market. Using this data, the model generates estimated market values, which the Company considers reflective of the fair value of each privately placed bond. Equity securities: Level 2 and Level 3 equity securities, typically private equities or equity securities not traded on an exchange, are valued by other sources such as analytics or brokers. Derivatives: Derivatives are carried at fair value, which is determined using the Company’s derivative accounting system in conjunction with observable key financial data from third-party sources, such as yield curves, exchange rates, S&P 500 Index prices, London Interbank Offered Rates ("LIBOR"), Overnight Index Swap ("OIS") rates, and Secured Overnight Financing Rate ("SOFR"). The Company uses SOFR discounting for valuations of interest rate derivatives; however, certain legacy positions may continue to be discounted on OIS. The Company uses OIS for valuations of collateralized interest rate derivatives, which are obtained from third-party sources. For those derivatives that are unable to be valued by the accounting system, the Company typically utilizes values established by third-party brokers. Counterparty credit risk is considered and incorporated in the Company’s valuation process through counterparty credit rating requirements and monitoring of overall exposure. It is the Company’s policy to transact only with investment grade counterparties with a credit rating of A- or better. The Company’s nonperformance risk is also considered and incorporated in the Company’s valuation process. The Company also has certain credit default swaps and options that are priced by third party vendors or by using models that primarily use market observable inputs, but contain inputs that are not observable to market participants, which have been classified as Level 3. The remaining derivative instruments are valued based on market observable inputs and are classified as Level 2. Contingent consideration: The fair value of the contingent consideration liability associated with the Company’s acquisitions uses unobservable inputs and as such are reported as Level 3. Unobservable inputs include projected revenues, duration of earnouts and other metrics as well as discount rate. Changes in the fair value of the contingent consideration are recorded in Operating expenses in the Company’s Condensed Consolidated Statements of Operations. The Company records reserves for Stabilizer and MCG contracts containing guaranteed credited rates. The guarantee is treated as an embedded derivative or a stand-alone derivative (depending on the underlying product) and is required to be reported at fair value. The estimated fair value is determined based on the present value of projected future claims, minus the present value of future guaranteed premiums. At inception of the contract, the Company projects a guaranteed premium to be equal to the present value of the projected future claims. The income associated with the contracts is projected using relevant actuarial and capital market assumptions, including benefits and related contract charges, over the anticipated life of the related contracts. The cash flow estimates are projected under multiple capital market scenarios using observable risk-free rates and other best estimate assumptions. These derivatives are classified as Level 3 liabilities. The discount rate used to determine the fair value of the Company's Stabilizer embedded derivative liabilities and the stand-alone derivative for MCG includes an adjustment to reflect the risk that these obligations will not be fulfilled ("nonperformance risk"). The nonperformance risk adjustment incorporates a blend of observable, similarly rated peer holding company credit spreads, adjusted to reflect the credit quality of the individual insurance subsidiary that issued the guarantee, as well as an adjustment to reflect the non-default spreads and the priority and recovery rates of policyholder claims. Embedded derivatives on reinsurance: The carrying value of embedded derivatives is estimated based upon the change in the fair value of the assets supporting the funds withheld payable under reinsurance agreements. The fair value of the embedded derivative is based on market observable inputs and is classified as Level 2. The remaining derivative instruments are classified as Level 3 and are estimated using the income approach. The fair value is calculated by estimating future cash flows for a certain discrete projection period, estimating the terminal value, if appropriate, and discounting these amounts to present value at a rate of return that considers the relative risk of the cash flows and the time value of money. Level 3 Financial Instruments The fair values of certain assets and liabilities are determined using prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement (i.e., Level 3 as defined by ASC Topic 820), including but not limited to liquidity spreads for investments within markets deemed not currently active. These valuations, whether derived internally or obtained from a third-party, use critical assumptions that are not widely available to estimate market participant expectations in valuing the asset or liability. In addition, the Company has determined, for certain financial instruments, an active market is such a significant input to determine fair value that the presence of an inactive market may lead to classification in Level 3. In light of the methodologies employed to obtain the fair values of financial assets and liabilities classified as Level 3, additional information is presented below. The following tables summarize the change in fair value of the Company's Level 3 assets and liabilities and transfers in and out of Level 3 for the periods indicated: Three Months Ended March 31, 2023 Fair Value as of January 1 Realized/Unrealized Purchases Issuances Sales Settlements Transfers Transfers Fair Value as of March 31 Change In (3) Change In Unrealized Gains (Losses) Included in OCI (3) Net OCI Fixed maturities, including securities pledged: U.S. Government agencies and authorities $ 1 $ — $ — $ — $ — $ — $ — $ — $ — $ 1 $ — $ — U.S. corporate public securities 20 — — 1 — — — — — 21 — — U.S. corporate private securities 1,801 1 34 40 — — (76) — — 1,800 1 34 Foreign corporate public securities and foreign governments (1) 3 — — — — — — — (3) — — — Foreign corporate private securities (1) 432 1 4 57 — — (53) — — 441 1 4 Residential mortgage-backed securities 28 — — 28 — — — — — 56 — — Other asset-backed securities 64 — 1 34 — — (1) — (21) 77 — 1 Total fixed maturities, including securities pledged 2,349 2 39 160 — — (130) — (24) 2,396 2 39 Equity securities, at fair value 196 (4) — — — — — — — 192 (3) — Contingent consideration (112) — — — — — — — — (112) — — Stabilizer and MCGs (2) (6) 4 — — (1) — — — — (3) — — Embedded derivatives on reinsurance (58) — — — — — — — — (58) — — Assets held in separate accounts (4) 347 4 — — — (2) — — — 349 — — (1) Primarily U.S. dollar denominated. (2) All gains and losses on Level 3 liabilities are classified as realized gains (losses) for the purpose of this disclosure because it is impracticable to track realized and unrealized gains (losses) separately on a contract by contract basis. These amounts are included in Net gains (losses) in the Condensed Consolidated Statements of Operations. (3) For financial instruments still held as of March 31 amounts are included in Net investment income and Net gains (losses) in the Condensed Consolidated Statements of Operations or Unrealized gains (losses) on securities in the Condensed Consolidated Statements of Comprehensive Income. (4) The investment income and realized gains (losses) and change in unrealized gains (losses) included in net income for separate account assets are offset by an equal amount for separate account liabilities, which results in a net zero impact on Net income (loss) for the Company. Three Months Ended March 31, 2022 Fair Value as of January 1 Realized/Unrealized Purchases Issuances Sales Settlements Transfers Transfers Fair Value as of March 31 Change In (3) Change In Unrealized Gains (Losses) Included in OCI (3) Net OCI Fixed maturities, including securities pledged: U.S. corporate public securities $ 16 $ — $ (2) $ 21 $ — $ — $ — $ 36 $ — $ 71 $ — $ (2) U.S. corporate private securities 1,910 (1) (145) 111 — — (61) 121 (10) 1,925 (1) (145) Foreign corporate public securities and foreign governments (1) — — — 11 — — — — — 11 — — Foreign corporate private securities (1) 353 (18) (24) 50 — — (13) 148 — 496 — (24) Residential mortgage-backed securities 43 (9) — 13 — — — — (2) 45 (9) — Other asset-backed securities 44 — (2) 18 — (10) (1) — — 49 — (2) Total fixed maturities, including securities pledged 2,366 (28) (173) 224 — (10) (75) 305 (12) 2,597 (10) (173) Equity securities, at fair value 203 (10) — — — — — 10 — 203 (10) — Contingent consideration (11) — — — — — — — — (11) — — Stabilizer and MCGs (2) (20) 6 — — (1) — — — — (15) — — Embedded derivatives on (87) 1 — — — — — — — (86) — — Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements — — — 8 — — — — — 8 — — Assets held in separate accounts (4) 316 (14) — 65 — (1) — 6 (38) 334 — — For the three months ended March 31, 2023 and 2022, the transfers in and out of Level 3 for fixed maturities were due to the variation in inputs relied upon for valuation each quarter. Securities that are primarily valued using independent broker quotes when prices are not available from one of the commercial pricing services are reflected as transfers into Level 3. When securities are valued using more widely available information, the securities are transferred out of Level 3 and into Level 1 or 2, as appropriate. Significant Unobservable Inputs The Company's Level 3 fair value measurements of its fixed maturities, equity securities and equity and credit derivative contracts are primarily based on broker quotes for which the quantitative detail of the unobservable inputs is neither provided nor reasonably corroborated, thus negating the ability to perform a sensitivity analysis. The Company performs a review of broker quotes by performing a monthly price variance comparison and back tests broker quotes to recent trade prices. Other Financial Instruments The following disclosures are made in accordance with the requirements of ASC Topic 825 which requires disclosure of fair value information about financial instruments, whether or not recognized at fair value on the Condensed Consolidated Balance Sheets. ASC Topic 825 excludes certain financial instruments, including insurance contracts and all nonfinancial instruments from its disclosure requirements. Accordingly, the aggregate fair value amounts presented do not represent the underlying value of the Company. The carrying values and estimated fair values of the Company's financial instruments as of the dates indicated: March 31, 2023 December 31, 2022 Carrying Fair Carrying Fair Assets: Fixed maturities, including securities pledged $ 30,468 $ 30,468 $ 30,357 $ 30,357 Equity securities 308 308 336 336 Mortgage loans on real estate 5,346 5,078 5,445 5,149 Policy loans 359 359 363 363 Cash, cash equivalents, short-term investments and short-term investments under securities loan agreements 2,003 2,003 2,454 2,454 Derivatives 342 342 422 422 Embedded derivatives on reinsurance 72 72 95 95 Other investments 70 70 68 68 Assets held in separate accounts 84,569 84,569 80,174 80,174 Liabilities: Investment contract liabilities: Funding agreements without fixed maturities and deferred annuities (1) $ 34,958 $ 36,635 $ 35,707 $ 36,385 Funding agreements with fixed maturities 1,360 1,358 1,285 1,281 Supplementary contracts, immediate annuities and other 701 640 727 636 Stabilizer and MCGs 3 3 6 6 Derivatives 376 376 389 389 Embedded derivative on reinsurance 49 49 46 46 Short-term debt 143 144 141 142 Long-term debt 2,094 1,935 2,094 1,935 (1) Certain amounts included in Funding agreements without fixed maturities and deferred annuities are also reflected within the Stabilizer and MCGs section of the table above. The following table presents the classifications of financial instruments which are not carried at fair value on the Condensed Consolidated Balance Sheets: Financial Instrument Classification Mortgage loans on real estate Level 3 Policy loans Level 2 Other investments Level 2 Funding agreements without fixed maturities and deferred annuities Level 3 Funding agreements with fixed maturities Level 2 Supplementary contracts and immediate annuities Level 3 Short-term debt and Long-term debt Level 2

Deferred Policy Acquisition Cos

Deferred Policy Acquisition Costs and Value of Business Acquired	3 Months Ended
	Mar. 31, 2023
Deferred Policy Acquisition Costs and Present Value of Future Insurance Profits, Net [Abstract]
Deferred Policy Acquisition Costs and Value of Business Acquired	Deferred Policy Acquisition Costs and Value of Business Acquired The following tables present a rollforward of DAC and VOBA for the periods indicated: DAC VOBA Wealth Solutions Deferred and Individual Annuities Businesses exited Balance as of January 1, 2022 $ 691 $ 1,158 $ 473 Deferrals of commissions and expenses 59 — 5 Amortization expense (59) (115) (39) Balance as of December 31, 2022 $ 691 $ 1,043 $ 439 Deferrals of commissions and expenses 15 — 1 Amortization expense (14) (27) (10) Balance as of March 31, 2023 $ 692 $ 1,016 $ 430 The following table shows a reconciliation of DAC and VOBA balances to the Condensed Consolidated Balance Sheets for the periods indicated: March 31, 2023 December 31, 2022 DAC: Wealth Solutions Deferred and Individual Annuities $ 692 $ 691 Businesses exited 1,016 1,043 Other 195 190 VOBA 430 439 Total $ 2,333 $ 2,363

Financial Services, Insurance,

Financial Services, Insurance, ASU 2018-12 Transition	3 Months Ended
	Mar. 31, 2023
Reserves for Future Policy Benefits and Contract Owner Balances [Abstract]
Liability for Future Policy Benefits and Unpaid Claims Disclosure	Reserves for Future Policy Benefits and Contract Owner Account Balances The balances and changes in the liability for future policy benefits for Health Solutions Group, Health Solutions Voluntary and Businesses Exited are presented in the tables below for the periods indicated: Health Solutions Group Health Solutions Voluntary Businesses Exited March 31, 2023 December 31, 2022 March 31, 2023 December 31, 2022 March 31, 2023 December 31, 2022 Present Value of Expected Net Premiums: Balance at January 1 $ 77 $ 93 $ 97 $ 105 $ 4,244 $ 5,634 Beginning balance at original discount rate 84 85 100 92 4,128 4,226 Effect of change in cash flow assumptions — (7) — — — (69) Effect of actual variances from expected experience 6 23 5 20 (10) 86 Adjusted balance at January 1 90 101 105 112 4,118 4,243 Interest accrual 1 2 1 4 57 230 Net premiums collected (1) (6) (19) (4) (16) (82) (345) Ending balance at original discount rate 85 84 102 100 4,093 4,128 Effects of changes in discount rate assumptions (5) (7) (1) (3) 244 116 Balance at end of period $ 80 $ 77 $ 101 $ 97 $ 4,337 $ 4,244 Present Value of Expected Future Policy Benefits: Balance at January 1 $ 881 $ 1,048 $ 285 $ 359 $ 8,639 $ 11,444 Beginning balance at original discount rate 913 952 294 290 8,644 9,079 Effect of change in cash flow assumptions 1 (43) — (2) — (77) Effect of actual variances from expected experience 1 (27) 5 11 (9) (52) Adjusted balance at January 1 915 882 299 299 8,635 8,950 Issuances 35 139 — — 4 13 Interest accrual 6 25 4 14 110 458 Benefit payments (32) (133) (7) (19) (209) (777) Ending balance at original discount rate 924 913 296 294 8,540 8,644 Effects of changes in discount rate assumptions (23) (32) 1 (9) 227 (5) Balance at end of period $ 901 $ 881 $ 297 $ 285 $ 8,767 $ 8,639 Net liability for future policy benefits $ 821 $ 804 $ 196 $ 188 $ 4,430 $ 4,395 Less: Reinsurance recoverable 295 283 — — 4,447 4,411 Net liability for future policy benefits, after reinsurance recoverable $ 526 $ 521 $ 196 $ 188 $ (17) $ (16) (1) Net Premiums collected represent the portion of gross premiums collected from policyholders that is used to fund expected benefit payments. The reconciliation of the net liability for future policy benefits to the liability for future policy benefits in the Condensed Consolidated Balance Sheets is presented below: March 31, 2023 December 31, 2022 Health Solutions Group $ 821 $ 804 Health Solutions Voluntary 196 188 Businesses Exited - Future policy benefits 4,430 4,395 Businesses Exited – Additional liability 2,096 2,107 Other 2,241 2,225 Total $ 9,784 $ 9,719 The amount of undiscounted expected gross premiums and future benefit payments is presented in the table below: March 31, 2023 December 31, 2022 Undiscounted Discounted Undiscounted Discounted Health Solutions Group Expected future benefit payments $ 1,152 $ 924 $ 1,141 $ 913 Expected future gross premiums 287 231 286 231 Health Solutions Voluntary Expected future benefit payments 591 296 588 294 Expected future gross premiums 312 206 307 205 The following table presents a rollforward of the additional reserve liability for Businesses exited for the periods indicated: Businesses exited March 31, 2023 December 31, 2022 Balance at beginning of period $ 2,107 $ 1,715 Effect of change in cash flow assumptions — 540 Effect of actual variances from expected experience (50) 15 Adjusted balance at January 1 2,057 2,270 Interest accrual 21 80 Excess Benefits (108) (427) Assessments 126 184 Balance at end of period 2,096 2,107 Less: Reinsurance recoverable 2,044 2,054 Net additional liability, after reinsurance recoverable $ 52 $ 53 The following table presents the weighted average duration of the liability for future policy benefits and the weighted average interest rates for the periods indicated: Health Solutions Group Health Solutions Voluntary Businesses Exited March 31, 2023 December 31, 2022 March 31, 2023 December 31, 2022 March 31, 2023 December 31, 2022 Weighted average duration (in years) (1) 7 7 14 14 8 8 Interest accretion rate 4.0 % 4.1 % 5.3 % 5.3 % 5.0 % 5.0 % Current discount rate 4.9 % 5.2 % 5.0 % 5.4 % 5.1 % 5.7 % (1) Weighted average duration (in years) for Businesses Exited includes additional liability. The weighted average interest rates for the additional liability related to businesses exited were 4.1% and 4.3% for the periods ended March 31, 2023 and December 31,2022, respectively. The following table presents a rollforward of Contract owner account balances for the periods indicated: Wealth Solutions Deferred Group and Individual Annuity Businesses Exited March 31, 2023 December 31, 2022 March 31, 2023 December 31, 2022 Balance at January 1 $ 33,622 $ 33,044 $ 5,146 $ 5,532 Deposits 615 2,962 76 310 Fee income (2) (8) (94) (384) Surrenders and withdrawals (1,506) (4,280) (120) (281) Benefit payments (43) (157) (39) (144) Net transfers from (to) separate accounts 93 1,174 — — Interest credited 219 874 36 150 Other 2 13 — (37) Ending Balance $ 33,000 $ 33,622 $ 5,005 $ 5,146 Weighted-average crediting rate 2.7 % 2.6 % 2.5 % 2.5 % Net amount at risk (1) $ 159 $ 199 $ 847 $ 900 Cash surrender value $ 32,513 $ 33,125 $ 1,730 $ 1,824 (1) For those guarantees of benefits that are payable in the event of death, the net amount at risk is generally defined as the current guaranteed minimum death benefit in excess of the current account balance at the balance sheet date and is calculated at a contract level. When a contract has both a living benefit and a death benefit, the Company calculates NAR at a contract level and aggregates the higher of the two values together. The following table shows a reconciliation of the Contract owner account balances to the Condensed Consolidated Balance Sheets for the periods indicated: March 31, 2023 December 31, 2022 Wealth Solutions Deferred group and individual annuity $ 33,000 $ 33,622 Businesses exited 5,005 5,146 Other 3,704 3,687 Total $ 41,709 $ 42,455 The following table summarizes detail on the differences between the interest rate being credited to contract holders as of March 31, 2023, and the respective guaranteed minimum interest rates ("GMIRs"): Account Value (1) Excess of crediting rate over GMIR At GMIR Up to .50% Above GMIR 0.51% - 1.00% 1.01% - 1.50% Above GMIR 1.51% - 2.00% Above GMIR More than 2.00% Above GMIR Total Guaranteed minimum interest rate Up to 1.00% $ 234 $ 7,296 $ 2,899 $ 1,146 $ 1,487 $ 38 $ 13,100 1.01% - 2.00% 619 141 42 2 3 7 814 2.01% - 3.00% 12,269 78 50 110 — 3 12,510 3.01% - 4.00% 9,459 153 — — — — 9,612 4.01% and Above 1,626 86 — — — — 1,712 Renewable beyond 12 months (MYGA) (2) 412 — — — 3 — 415 Total discretionary rate setting products $ 24,619 $ 7,754 $ 2,991 $ 1,258 $ 1,493 $ 48 $ 38,163 (1) Includes only the account values for investment spread products with GMIRs and discretionary crediting rates, net of policy loans. Excludes Stabilizer products, which are fee based. (2) Represents multi year guaranteed annuity ("MYGA") contracts with renewal dates after March 31, 2023 on which we are required to credit interest above the contractual GMIR for at least the next twelve months. The following table summarizes detail on the differences between the interest rate being credited to contract holders as of December 31, 2022 and the respective GMIRs: Account Value (1) Excess of crediting rate over GMIR At GMIR Up to .50% Above GMIR 0.51% - 1.00% 1.01% - 1.50% Above GMIR 1.51% - 2.00% Above GMIR More than 2.00% Above GMIR Total Guaranteed minimum interest rate Up to 1.00% $ 5,848 $ 2,967 $ 1,907 $ 1,112 $ 1,462 $ 102 $ 13,398 1.01% - 2.00% 707 52 35 2 2 7 805 2.01% - 3.00% 12,677 56 46 110 — 3 12,892 3.01% - 4.00% 9,448 153 — — — — 9,601 4.01% and Above 1,643 87 — — — — 1,730 Renewable beyond 12 months (MYGA) (2) 402 — — — 3 — 405 Total discretionary rate setting products $ 30,725 $ 3,315 $ 1,988 $ 1,224 $ 1,467 $ 112 $ 38,831 (1) Includes only the account values for investment spread products with GMIRs and discretionary crediting rates, net of policy loans. Excludes Stabilizer products, which are fee based.

Reinsurance

Reinsurance	3 Months Ended
	Mar. 31, 2023
Insurance [Abstract]
Reinsurance	ReinsuranceThe Company reinsures its business through a diversified group of reinsurers. However, the Company remains liable to the extent its reinsurers do not meet their obligations under the reinsurance agreements. The Company monitors trends in arbitration and any litigation outcomes with its reinsurers. Collectability of reinsurance balances are evaluated by monitoring ratings and evaluating the financial strength of its reinsurers. Large reinsurance recoverable balances with offshore or other non-accredited reinsurers are secured through various forms of collateral, including secured trusts, funds withheld accounts and irrevocable letters of credit ("LOC"). Information regarding the effect of reinsurance on the Condensed Consolidated Balance Sheets is as follows as of the periods indicated: March 31, 2023 Direct Assumed Ceded Total, Assets Premiums receivable $ 190 $ 12 $ (237) $ (35) Reinsurance recoverable, net of allowance for credit losses — — 12,473 12,473 Total $ 190 $ 12 $ 12,236 $ 12,438 Liabilities Future policy benefits and contract owner account balances $ 50,470 $ 1,023 $ — $ 51,493 Liability for funds withheld under reinsurance agreements 111 — — 111 Total $ 50,581 $ 1,023 $ — $ 51,604 December 31, 2022 Direct Assumed Ceded Total, Assets Premiums receivable $ 172 $ 11 $ (212) $ (29) Reinsurance recoverable, net of allowance for credit losses — — 12,455 12,455 Total $ 172 $ 11 $ 12,243 $ 12,426 Liabilities Future policy benefits and contract owner account balances $ 51,137 $ 1,037 $ — $ 52,174 Liability for funds withheld under reinsurance agreements 104 — — 104 Total $ 51,241 $ 1,037 $ — $ 52,278 Information regarding the effect of reinsurance on the Condensed Consolidated Statements of Operations is as follows for the periods indicated: Three Months Ended March 31, 2023 2022 Premiums: Direct premiums $ 908 $ 808 Reinsurance assumed 10 9 Reinsurance ceded (233) (209) Net premiums $ 685 $ 608 Fee income: Gross fee income $ 562 $ 532 Reinsurance assumed 4 5 Reinsurance ceded (102) (104) Net fee income $ 464 $ 433 Interest credited and other benefits to contract owners / policyholders: Direct interest credited and other benefits to contract owners / policyholders $ 1,108 $ 976 Reinsurance assumed 19 8 Reinsurance ceded (376) (340) Net interest credited and other benefits to contract owners / policyholders $ 751 $ 644 If the Company determines that a reinsurance agreement does not expose the reinsurer to a reasonable possibility of a significant loss from insurance risk, the Company records the agreement using the deposit method of accounting. As of March 31, 2023 and December 31, 2022, the Company had a deposit asset of $1.4 billion and $1.5 billion, respectively, which is reported in Other assets on the Condensed Consolidated Balance Sheets.

Share-based Incentive Compensat

Share-based Incentive Compensation Plans	3 Months Ended
	Mar. 31, 2023
Share-Based Payment Arrangement [Abstract]
Share-based Incentive Compensation Plans	Share-based Incentive Compensation Plans The Company offers equity-based compensation awards to its employees and non-employee directors under various employee and non-employee incentive plans (together, the "Omnibus Plans"). As of March 31, 2023, common stock reserved and available for issuance under the Omnibus Plans was 9,000,476 shares. Compensation Cost The following table summarizes share-based compensation expense, which includes expenses related to awards granted under the Omnibus Plans for the periods indicated: Three Months Ended March 31, 2023 2022 Restricted Stock Unit (RSU) awards $ 37 $ 22 Performance Stock Unit (PSU) awards 26 24 Total share-based compensation expense 63 46 Income tax benefit 15 15 After-tax share-based compensation expense $ 48 $ 31 Awards Outstanding The following table summarizes RSU and PSU awards activity under the Omnibus Plans for the periods indicated: RSU Awards PSU Awards (awards in millions) Number of Awards Weighted Average Grant Date Fair Value Number of Awards Weighted Average Grant Date Fair Value Outstanding as of January 1, 2023 1.5 $ 60.91 2.1 $ 55.68 Adjustment for PSU performance factor — — (0.1) 61.50 Granted 1.5 70.42 0.8 76.59 Vested (0.7) 62.53 (0.5) 63.08 Forfeited — * 66.36 — * 63.67 Outstanding as of March 31, 2023 2.3 $ 66.55 2.3 $ 61.03 *Less than 0.1 The following table summarizes the number of options under the Omnibus Plans for the periods indicated: Stock Options (awards in millions) Number of Awards Weighted Average Exercise Price Outstanding as of January 1, 2023 1.6 $ 43.05 Granted — — Exercised (0.3) 38.21 Forfeited — — Outstanding as of March 31, 2023 1.3 $ 44.25 Vested, exercisable, as of March 31, 2023 1.3 $ 44.25

Shareholders' Equity

Shareholders' Equity	3 Months Ended
	Mar. 31, 2023
Equity [Abstract]
Shareholder's Equity	Shareholders' Equity Common Shares The following table presents the rollforward of common shares used in calculating the weighted average shares utilized in the basic earnings per common share calculation for the periods indicated: Common Shares (shares in millions) Issued Held in Treasury Outstanding Balance, January 1, 2022 109.0 1.2 107.8 Common shares issued 0.1 — 0.1 Common shares acquired - share repurchase — 11.7 (11.7) Share-based compensation 1.7 0.7 1.0 Treasury Stock retirement (13.0) (13.0) — Balance, December 31, 2022 97.8 0.6 97.2 Common shares issued — * — — Share-based compensation 1.5 0.5 1.0 Balance, March 31, 2023 99.3 1.1 98.2 *less than 0.1 Dividends declared per share of Common Stock were as follows for the periods indicated: Three Months Ended March 31, 2023 2022 Dividends declared per share of Common Stock $ 0.200 $ 0.200 Share Repurchase Program From time to time, the Company's Board of Directors authorizes the Company to repurchase shares of its common stock and warrants to purchase shares of its common stock. These authorizations permit stock and warrant repurchases up to a prescribed dollar amount and generally may be accomplished through various means, including, without limitation, open market transactions, privately negotiated transactions, forward, derivative, or accelerated repurchase, or automatic repurchase transactions, including 10b5-1 plans, or tender offers. Share and warrant repurchase authorizations typically expire if unused by a prescribed date. On April 28, 2022, the Board of Directors provided its most recent share repurchase authorization, increasing the aggregate amount of the Company's common stock authorized for repurchase by $500. On April 27, 2023, the share repurchase authorization, which had an original expiration of June 30, 2023, was extended by the Board of Directors through September 30, 2023 and does not obligate the Company to purchase any shares. The authorization for the share repurchase program may be terminated, increased or decreased by the Board of Directors at any time. During the three months ended March 31, 2023, there were no repurchases of the Company's common stock. Warrants On May 7, 2013, the Company issued to ING Group warrants to purchase up to 26,050,846 shares of the Company's common stock equal in the aggregate to 9.99% of the issued and outstanding shares of common stock at that date. The exercise price of the warrants at the time of issuance was $48.75 per share of common stock, subject to adjustments, including for stock dividends, cash dividends in excess of $0.01 per share a quarter, subdivisions, combinations, reclassifications and non-cash distributions. The warrants also provide for, upon the occurrence of certain change of control events affecting the Company, an increase in the number of shares to which a warrant holder will be entitled upon payment of the aggregate exercise price of the warrant. The warrants became exercisable to ING Group and its affiliates on January 1, 2017 and to all other holders starting on the first anniversary of the completion of the IPO (May 7, 2014). The warrants expire on the tenth anniversary of the completion of the IPO (May 7, 2023). The warrants are net share settled, which means that no cash will be payable by a warrant holder in respect of the exercise price of a warrant upon exercise, and are classified as permanent equity. They have been recorded at their fair value determined on the issuance date of May 7, 2013 in the amount of $94 as an addition and reduction to Additional-paid-in-capital. Warrant holders are not entitled to receive dividends. On March 12, 2018, ING Group sold its remaining interests in the warrants and no longer owns any warrants. On February 22, 2023, the Company entered into an amendment of the warrant agreement to permit warrant holders to elect a calculation period of either 30 or 45 trading days as an alternative to the 10-trading day calculation period provided in the warrant agreement. On March 29, 2023, the Company paid a quarterly dividend of $0.20 per share on its common stock. As a consequence, the exercise price of the warrants to purchase shares of common stock was adjusted to $46.82 per share of common stock and the number of shares of common stock for which each warrant is exercisable has been adjusted to 1.041295182. All of the warrants will be settled on May 10, 2023, in accordance with their terms. Preferred Stock As of March 31, 2023 and December 31, 2022, there were 100,000,000 shares of preferred stock authorized. Preferred stock issued and outstanding are as follows: March 31, 2023 December 31, 2022 Series Issued Outstanding Issued Outstanding 6.125% Non-cumulative Preferred Stock, Series A 325,000 325,000 325,000 325,000 5.35% Non-cumulative Preferred Stock, Series B 300,000 300,000 300,000 300,000 Total 625,000 625,000 625,000 625,000 The declaration of dividends on preferred stock per share and in the aggregate were as follows for the periods indicated: Series A Series B Three Months Ended March 31, Per Share Aggregate Per Share Aggregate 2023 $ 30.625 $ 10 $ 13.375 $ 4 2022 30.625 10 13.375 4 As of March 31, 2023, there were no preferred stock dividends in arrears.

Earnings per Common Share

Earnings per Common Share	3 Months Ended
	Mar. 31, 2023
Earnings Per Share [Abstract]
Earnings per Common Share	Earnings per Common Share The following table presents a reconciliation of Net income (loss) and shares used in calculating basic and diluted net income (loss) per common share for the periods indicated: Three Months Ended March 31, (in millions, except for per share data) 2023 2022 Earnings Net income (loss) available to common shareholders: Net income (loss) $ 129 $ 111 Less: Preferred stock dividends 14 14 Less: Net income (loss) attributable to noncontrolling interest and redeemable noncontrolling interest 46 43 Net income (loss) available to common shareholders $ 69 $ 54 Weighted average common shares outstanding Basic 97.7 106.1 Dilutive Effects: Warrants 8.9 8.2 RSU awards 1.2 1.0 PSU awards 1.2 1.0 Stock Options 0.6 0.7 Diluted 109.6 117.0 Net income (loss) available to Voya Financial, Inc.'s common shareholders per common share (1) : Basic $ 0.70 $ 0.51 Diluted $ 0.63 $ 0.46 (1) Basic and diluted earnings per share are calculated using unrounded, actual amounts. Therefore, the components of earnings per share may not sum to its corresponding total.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Income (Loss)	3 Months Ended
	Mar. 31, 2023
Equity [Abstract]
Accumulated Other Comprehensive Income (Loss)	Accumulated Other Comprehensive Income (Loss) Shareholders' equity included the following components of AOCI as of the dates indicated: March 31, 2023 2022 Fixed maturities, net of impairment $ (2,635) $ 602 Derivatives (1) 109 80 Change in discount rate (855) (1,044) Deferred income tax asset (liability) 833 199 Total (2,548) (163) Pension and other postretirement benefits liability, net of tax 3 3 AOCI $ (2,545) $ (160) (1) Gains and losses reported in Accumulated Other Comprehensive Income (AOCI) from hedge transactions that resulted in the acquisition of an identified asset are reclassified into earnings in the same period or periods during which the asset acquired affects earnings. As of March 31, 2023, the portion of the AOCI that is expected to be reclassified into earnings within the next 12 months is $17. Changes in AOCI, including the reclassification adjustments recognized in the Condensed Consolidated Statements of Operations, were as follows for the periods indicated: Three Months Ended March 31, 2023 Before-Tax Amount Income Tax (Benefit) After-Tax Amount Available-for-sale securities: Fixed maturities $ 661 $ (139) $ 522 Adjustments for amounts recognized in Net gains (losses) in the Condensed Consolidated Statements of Operations (1) — (1) Change in unrealized gains (losses) on available-for-sale securities 660 (139) 521 Derivatives: Derivatives (12) (1) 3 (9) Adjustments related to effective cash flow hedges for amounts recognized in Net investment income in the Condensed Consolidated Statements of Operations (5) 1 (4) Change in unrealized gains (losses) on derivatives (17) 4 (13) Change in current discount rate 2 — 2 Change in Accumulated other comprehensive income (loss) $ 645 $ (135) $ 510 (1) See the Derivative Financial Instruments Note to these Condensed Consolidated Financial Statements for additional information. Three Months Ended March 31, 2022 Before-Tax Amount Income Tax (Benefit) After-Tax Amount Available-for-sale securities: Fixed maturities $ (2,663) $ 559 $ (2,104) Adjustments for amounts recognized in Net gains (losses) in the Condensed Consolidated Statements of Operations 70 (15) 55 Change in unrealized gains (losses) on available-for-sale securities (2,593) 544 (2,049) Derivatives: Derivatives 5 (1) (1) 4 Adjustments related to effective cash flow hedges for amounts recognized in Net investment income in the Condensed Consolidated Statements of Operations (5) 1 (4) Change in unrealized gains (losses) on derivatives — — — Change in current discount rate 104 (22) 82 Change in Accumulated other comprehensive income (loss) $ (2,489) $ 522 $ (1,967) (1) See the Derivative Financial Instruments Note to these Condensed Consolidated Financial Statements for additional information.

Income Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2023
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The Company uses the estimated annual effective tax rate method in computing its interim tax provision. Certain items, including changes in the realizability of deferred tax assets and changes in liabilities for uncertain tax positions, are excluded from the estimated annual effective tax rate and the actual tax expense or benefit is reported in the period the related item is incurred. The Company's effective tax rate for the three months ended March 31, 2023 and March 31, 2022 was 8.5% and 9.0%, respectively. The effective tax rate differed from the statutory rate of 21% primarily due to noncontrolling interest, the effect of the dividends received deduction and tax credits. In August 2022, President Biden signed into law the Inflation Reduction Act of 2022, which imposes a 15% alternative minimum tax (“CAMT”) on the adjusted financial statement income of large corporations. The CAMT is effective in taxable years beginning after December 31, 2022. The Internal Revenue Service has only issued limited guidance on the CAMT, and uncertainty remains regarding the application of and potential adjustments to the CAMT. If the CAMT applies, the Company will be required to pay tax at the 15% CAMT rate despite our U.S. Federal net operating loss carryforwards. Valuation allowances are provided when it is considered more likely than not that some portion or all of the deferred tax assets ("DTAs") will not be realized. The Company reviews all available positive and negative evidence to determine if a valuation allowance is recorded, including historical and projected pre-tax book income, tax planning strategies and reversals of temporary differences. As of March 31, 2023, the Company had year-to-date gains on securities of $645 in Other comprehensive income, which reduced the related DTA. Additionally, operating income remained positive for the period and was largely consistent with the 2022 year-end valuation allowance analysis. After evaluating the positive and negative evidence, the Company did not change its judgement regarding the realization of DTAs. For more information related to the valuation allowance, refer to the Income Taxes Note to the Consolidated Financial Statements included in Part II, Item 8. of the Annual Report on F orm 10-K . Tax Regulatory Matters For the tax years 2021 through 2023, the Company participated in the Internal Revenue Service ("IRS") Compliance Assurance Process ("CAP"), which is a continuous audit program provided by the IRS. For the 2023 tax year, the Company was in the Compliance Maintenance Bridge ("Bridge") phase of CAP. In the Bridge phase, the IRS did not conduct any review or provide any letters of assurance for that tax year.

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Leases During the three months ended March 31, 2023 and 2022 the Company recorded an impairment of $2 and $3 respectively, on its right-of-use asset associated with leased office space, which is included in Operating expenses in the Condensed Consolidated Statements of Operations. Commitments Through the normal course of investment operations, the Company commits to either purchase or sell securities, mortgage loans, or money market instruments, at a specified future date and at a specified price or yield. The inability of counterparties to honor these commitments may result in either a higher or lower replacement cost. Also, there is likely to be a change in the value of the securities underlying the commitments. As of March 31, 2023, the Company had off-balance sheet commitments to acquire mortgage loans of $79 and purchase limited partnerships and private placement investments of $1,000, of which $355 related to consolidated investment entities. Restricted Assets The Company is required to maintain assets on deposit with various regulatory authorities to support its insurance operations. The Company may also post collateral in connection with certain securities lending, repurchase agreements, funding agreements, credit facilities and derivative transactions. The components of the fair value of the restricted assets were as follows as of the dates indicated: March 31, 2023 December 31, 2022 Fixed maturity collateral pledged to FHLB (1) $ 1,811 $ 1,791 FHLB restricted stock (2) 69 67 Other fixed maturities-state deposits 40 38 Cash and cash equivalents 29 27 Securities pledged (3) 1,226 1,162 Total restricted assets $ 3,175 $ 3,085 (1) Included in Fixed maturities, available for sale, at fair value on the Condensed Consolidated Balance Sheets. (2) Included in Other investments on the Condensed Consolidated Balance Sheets. (3) Includes the fair value of loaned securities of $976 and $907 as of March 31, 2023 and December 31, 2022, respectively. In addition, as of March 31, 2023 and December 31, 2022, the Company delivered securities as collateral of $137 and $142 and repurchase agreements of $113 and $113, respectively. Loaned securities and securities delivered as collateral are included in Securities pledged on the Condensed Consolidated Balance Sheets. Federal Home Loan Bank Funding Agreements The Company is a member of the FHLB of Des Moines and the FHLB of Boston and is required to pledge collateral to back funding agreements issued to the FHLB. As of March 31, 2023 and December 31, 2022, the Company had $1,360 and $1,279, respectively, in non-putable funding agreements, which are included in Contract owner account balances on the Condensed Consolidated Balance Sheets. As of March 31, 2023 and December 31, 2022, assets with a market value of approximately $1,811 and $1,791, respectively, collateralized the FHLB funding agreements. Assets pledged to the FHLB are included in Fixed maturities, available-for-sale, at fair value on the Condensed Consolidated Balance Sheets. Litigation, Regulatory Matters and Contingencies Litigation, regulatory and other loss contingencies arise in connection with the Company's activities as a diversified financial services firm. The Company is a defendant in a number of litigation matters, such as negligence, breach of contract, fraud, violations of a regulation or statute, breach of fiduciary duty, failure to supervise, elder abuse and other torts, arising from the conduct of its business, both in the ordinary course and otherwise. In some of these matters, claimants seek to recover very large or indeterminate amounts, including compensatory, punitive, treble and exemplary damages. The variability in pleading requirements and past experience demonstrate that the monetary and other relief that may be requested in a lawsuit or claim often bears little relevance to the merits or potential value of a claim. As with other financial services companies, the Company periodically receives informal and formal requests for information from various state and federal governmental agencies and self-regulatory organizations in connection with inquiries and investigations of the products and practices of the Company or the financial services industry. It is the practice of the Company to cooperate fully in these matters. While it is possible that an adverse outcome in certain cases could have a material adverse effect upon the Company's financial position, based on information currently known, management believes that neither the outcome of pending litigation and regulatory matters nor potential liabilities associated with other loss contingencies, are likely to have such an effect. However, given the large and indeterminate amounts sought in certain litigation and the inherent unpredictability of all such matters, it is possible that an adverse outcome in certain of the Company's litigation or regulatory matters, or liabilities arising from other loss contingencies, could, from time to time, have a material adverse effect upon the Company's results of operations or cash flows in a particular quarterly or annual period. For some matters, the Company is able to estimate a possible range of loss. For such matters in which a loss is probable, an accrual has been made. For matters where the Company, however, believes a loss is reasonably possible, but not probable, no accrual is required. For matters for which an accrual has been made, but there remains a reasonably possible range of loss in excess of the amounts accrued or for matters where no accrual is required, the Company develops an estimate of the unaccrued amounts of the reasonably possible range of losses. As of March 31, 2023, the Company estimates the aggregate range of reasonably possible losses, in excess of any amounts accrued for these matters as of such date, to be up to approximately $25. For other matters, the Company is currently not able to estimate the reasonably possible loss or range of loss. The Company is often unable to estimate the possible loss or range of loss until developments in such matters have provided sufficient information to support an assessment of the range of possible loss, such as quantification of a damage demand from plaintiffs, discovery from plaintiffs and other parties, investigation of factual allegations, rulings by a court on motions or appeals, analysis by experts and the progress of settlement discussions. On a quarterly and annual basis, the Company reviews relevant information with respect to litigation and regulatory contingencies and updates the Company's accruals, disclosures and reasonably possible losses or ranges of loss based on such reviews. Litigation includes Henkel of America v. ReliaStar Life Insurance Company, et al. (USDC District of Connecticut, No. 1:18-cv-00965)(filed June 8, 2018). Plaintiff alleges that ReliaStar breached the terms of a stop loss policy it issued to Plaintiff by refusing to reimburse Plaintiff for more than $47 in claims incurred by participants in prior years and submitted for coverage under the stop loss policy. Plaintiff alleges a breach of contract claim or, in the alternative, that the stop loss policy be declared to cover the submitted claims, and also asserts that ReliaStar engaged in unfair trade practices and unfair insurance practices in violation of state statutes, and did so willfully and intentionally to warrant an award of punitive damages under state law. On February 7, 2023, the district court issued its ruling on various motions for partial judgment in which the court denied in part and granted in part the various motions except for Express Scripts’ motion, which the court denied in whole. The Company denies the allegations, which it believes are without merit, and intends to defend the case vigorously. Litigation also includes Ravarino, et al. v. Voya Financial, Inc., et al. (USDC District of Connecticut, No. 3:21-cv-01658)(filed December 14, 2021). In this putative class action, the plaintiffs allege that the named defendants breached their fiduciary duties of prudence and loyalty in the administration of the Voya 401(k) Savings Plan. The plaintiffs claim that the named defendants did not exercise proper prudence in their management of allegedly poorly performing investment options, including proprietary funds, and passed excessive investment-management and other administrative fees for proprietary and non-proprietary funds onto plan participants. The plaintiffs also allege that the defendants engaged in self-dealing through the inclusion of the Voya Stable Value Option into the plan offerings and by setting the “crediting rate” for participants’ investment in the Stable Value Fund artificially low in relation to Voya’s general account investment returns in order to maximize the spread and Voya’s profits at the participants’ expense. The complaint seeks disgorgement of unjust profits as well as costs incurred. The Company denies the allegations, which it believes are without merit, and intends to defend the case vigorously. Finally, industry wide, life insurers continue to be exposed to class action litigation related to the cost of insurance rates and periodic deductions from cash value. Common allegations include that insurance companies have breached the terms of their universal life insurance policies by establishing or increasing the cost of insurance rates using cost factors not permitted by the contract, thereby unjustly enriching themselves. This litigation is generally known as cost of insurance litigation. Cost of insurance litigation for the Company includes Advance Trust & Life Escrow Services, LTA v. ReliaStar Life Insurance Company (USDC District of Minnesota, No. 1:18-cv-02863)(filed October 5, 2018), a putative class action in which Plaintiff alleges that the Company’s universal life insurance policies only permitted the Company to rely upon the policyholders’ expected future mortality experience to establish the cost of insurance, and that as projected mortality experience improved, the policy language required the Company to decrease the cost of insurance. Plaintiff alleges that the Company did not decrease the cost of insurance as required, thereby breaching its contract with the policyholders, and seeks class certification. On March 29, 2022, the district court granted the Plaintiff’s motion for class certification and denied the Company’s motion for summary judgment. The Company denies the allegations in the complaint, believes the complaint to be without merit, and will defend the lawsuit vigorously. Contingencies related to Performance-based Capital Allocations on Private Equity Funds Certain performance-based capital allocations related to sponsored private equity funds ("carried interest") are not final until the conclusion of an investment term specified in the relevant asset management contract. As a result, such carried interest, if accrued or paid to the Company during such term, is subject to later adjustment based on subsequent fund performance. If the fund’s cumulative investment return falls below specified investment return hurdles, some or all of the previously accrued carried interest is reversed to the extent that the Company is no longer entitled to the performance-based capital allocation. Should the fund’s cumulative investment return subsequently increase above specified investment return hurdles in future periods, previous reversals could be fully or partially recovered. As of March 31, 2023, approximately $126 of previously accrued carried interest would be subject to full or partial reversal in future periods if cumulative fund performance hurdles are not maintained throughout the remaining life of the affected funds.

Consolidated and Nonconsolidate

Consolidated and Nonconsolidated Investment Entities	3 Months Ended
	Mar. 31, 2023
Consolidated Investment Entities [Abstract]
Consolidated and Nonconsolidated Investment Entities	Consolidated and Nonconsolidated Investment Entities The Company holds variable interests in certain investment entities in the form of debt or equity investments, as well as the right to receive management fees, performance fees, and carried interest. The Company consolidates certain entities under the VIE guidance when it is determined that the Company is the primary beneficiary. Alternatively, certain entities are consolidated under the VOE guidance when control is obtained through voting rights. Refer to the Condensed Consolidated Balance Sheets for the assets and liabilities of the Company's consolidated investment entities. The Company has no right to the benefits from, nor does it bear the risks associated with consolidated investment entities beyond the Company’s direct equity and debt investments in and management fees generated from these entities. Such direct investments amounted to approximately $322 and $288 as of March 31, 2023 and December 31, 2022, respectively. If the Company were to liquidate, the assets held by consolidated investment entities would not be available to the general creditors of the Company as a result of the liquidation. Consolidated VIEs and VOEs Collateral Loan Obligations Entities ("CLOs") The Company is involved in the design, creation, and the ongoing management of CLOs. These entities are created for the purpose of acquiring diversified portfolios of senior secured floating rate leveraged loans, and securitizing these assets by issuing multiple tranches of collateralized debt; thereby providing investors with a broad array of risk and return profiles. Also known as collateralized financing entities under Topic 810, CLOs are variable interest entities by definition. In return for providing collateral management services, the Company earns investment management fees and contingent performance fees. In addition to earning fee income, the Company often invests in the subordinated debt of entities formed to be the issuers of CLO offerings during their warehouse periods. The Company’s investments in these CLOs are repaid when the CLOs’ warehouse periods are closed and the CLO offerings are issued. The Company performs ongoing monitoring of the consolidation assessment for CLOs during and after their warehouse periods to determine if Voya remains the primary beneficiary of the CLOs. The fee income earned and investments held are included in the Company's ongoing consolidation assessment for each CLO. The Company was the primary beneficiary of 8 and 7 CLOs as of March 31, 2023 and December 31, 2022, respectively. Limited Partnerships ("LPs") The Company invests in and manages various limited partnerships, including private equity funds and hedge funds. The LPs generally have a ten-year life and a specified period during which investors can subscribe for limited partnership interests. Once the investors are admitted as limited partners, the investors are required to contribute capital when called by the general partners. The purpose of the LPs is to obtain subscriptions from limited partners and maximize the return to their partners by assembling a diversified portfolio of investments in private equity funds and other securities or assets with similar risk and return characteristics primarily through secondary market purchases. The majority of the investors in the LPs are unrelated parties to the Company. In return for subscriptions, each partner receives an equity interest in the LPs in proportion to its respective investment. These entities have been evaluated by the Company and are determined to be VIEs due to the equity holders, as a group, lacking the characteristics of a controlling financial interest. In return for serving as the general partner of and providing investment management services to these entities, the Company earns management fees and carried interest in the normal course of business. Additionally, the Company often holds an investment in each limited partnership it manages, generally in the form of general partner and limited partner interests. The fee income, carried interest, and investments held are included in the Company’s ongoing consolidation analysis for each limited partnership. The Company consolidated 10 funds, which were structured as partnerships, as of March 31, 2023 and December 31, 2022. The noncontrolling interest related to partnerships increased from $1,482 at December 31, 2022 to $1,567 at March 31, 2023. Changes in market value, contributions, and distributions related to these investments in the funds directly impact the noncontrolling interest component of Shareholders' equity on the Company's Condensed Consolidated Balance Sheets. The change in noncontrolling interest was primarily driven by an increase in net contributions and favorable market appreciation in limited partnership and equity security investments. The Company records the noncontrolling interest using a lag methodology relying on the most recent financial information available. Fair Value Measurement Upon consolidation, the Company elected to apply the FVO for financial assets and financial liabilities held by CLOs and continued to measure these assets (primarily corporate loans) and liabilities (debt obligations issued by CLOs) at fair value in subsequent periods. The Company has elected the FVO to more closely align its accounting with the economics of its transactions and allows the Company to more effectively align changes in the fair value of CLO assets with a commensurate change in the fair value of CLO liabilities. Investments held by consolidated private equity funds are measured and reported at fair value in the Company's Condensed Consolidated Financial Statements. Changes in the fair value of consolidated investment entities are recorded as a separate line item within Income (loss) related to consolidated investment entities in the Company's Condensed Consolidated Statements of Operations. The methodology for measuring the fair value of financial assets and liabilities of consolidated investment entities, and the classification of these measurements in the fair value hierarchy is consistent with the methodology and classification applied by the Company to its investment portfolio, as discussed within the Fair Value Measurements (excluding Consolidated Investment Entities) Note to these Condensed Consolidated Financial Statements. As discussed in more detail below, the Company utilizes valuations obtained from third-party commercial pricing services, brokers and investment sponsors or third-party administrators that supply NAV (or its equivalent) per share used as a practical expedient. The valuations obtained from brokers and third-party commercial pricing services are non-binding. These valuations are reviewed on a monthly or quarterly basis depending on the entity and its underlying investments. Procedures include, but are not limited to, a review of underlying fund investor reports, review of top and worst performing funds requiring further scrutiny, review of variance from prior periods and review of variance from benchmarks, where applicable. In addition, the Company considers both macro and fund specific events that may impact the latest NAV supplied and determines if further adjustments of value should be made. Such changes, if any, are subject to senior management review. When a price cannot be obtained from a commercial pricing service, independent broker quotes are solicited. Securities priced using independent broker quotes are classified as Level 3. Broker quotes and prices obtained from pricing services are reviewed and validated through an internal valuation committee price variance review, comparisons to internal pricing models, back testing to recent trades or monitoring of trading volumes. Cash and Cash Equivalents The carrying amounts for cash reflect the assets’ fair values. The fair value for cash equivalents is determined based on quoted market prices. These assets are classified as Level 1. CLOs Corporate loans : Corporate loan investments, which comprise the majority of consolidated CLO portfolio collateral, are senior secured corporate loans maturing at various dates between 2023 and 2030, paying interest at LIBOR, SOFR, EURIBOR or PRIME plus a spread of up to 10.0%. As of March 31, 2023 and December 31, 2022, the unpaid principal balance exceeded the fair value of the corporate loans by approximately $59 and $85, respectively. Less than 1.0% of the collateral loans were in default as of March 31, 2023 and December 31, 2022. The fair values for corporate loans are determined using independent commercial pricing services. Fair value measurement based on pricing services may be classified in Level 2 or Level 3 depending on the type, complexity, observability and liquidity of the asset being measured. The inputs used by independent commercial pricing services, such as benchmark yields and credit risk adjustments, are those that are derived principally from or corroborated by observable market data. Hence, the fair value measurement of corporate loans priced by independent pricing service providers is classified within Level 2 of the fair value hierarchy. In addition, there are assets held with CLO portfolios that represent senior level debt of other third party CLOs. These CLO investments are classified within Level 3 of the fair value hierarchy. See description of fair value process for CLO notes below. CLO notes : The CLO notes are backed by diversified loan portfolios consisting primarily of senior secured floating rate leveraged loans. Repayment risk is segmented into tranches with credit ratings of these tranches reflecting both the credit quality of underlying collateral as well as how much protection a given tranche is afforded by tranches that are subordinate to it. The most subordinated tranche bears the first loss and receives the residual payments, if any. The interest rates are generally variable rates based on LIBOR, SOFR or EURIBOR plus a pre-defined spread, which varies from 1.0% for the more senior tranches to 8.8% for the more subordinated tranches. CLO notes mature in 2026 and 2034, and have a weighted average maturity of 12 years as of March 31, 2023. The investors in this debt are not affiliated with the Company and have no recourse to the general credit of the Company for this debt. The fair values of the CLO notes are measured based on the fair value of the CLO's corporate loans, as the Company uses the measurement alternative available under ASU 2014-13 and determined that the inputs for measuring financial assets are more observable. The CLO notes are classified within Level 2 of the fair value hierarchy, consistent with the classification of the majority of the CLO financial assets. The Company reviews the detailed prices including comparisons to prior periods for reasonableness. The Company utilizes a formal pricing challenge process to request a review of any price during which time the vendor examines its assumptions and relevant market inputs to determine if a price change is warranted. The following narrative indicates the sensitivity of inputs: • Default Rate: An increase (decrease) in the expected default rate would likely increase (decrease) the discount margin (increase risk premium) used to value the CLO investments and CLO notes and, as a result, would potentially decrease the value of the CLO investments and CLO notes. • Recovery Rate: A decrease (increase) in the expected recovery of defaulted assets would potentially decrease (increase) the valuation of CLO investments and CLO notes. • Prepayment Rate: A decrease (increase) in the expected rate of collateral prepayments would potentially decrease (increase) the valuation of CLO investments and CLO notes as the expected weighted average life ("WAL") would increase (decrease). • Discount Margin (spread over LIBOR/SOFR): An increase (decrease) in the discount margin used to value the CLO investments and CLO notes would decrease (increase) the value of the CLO investments and CLO notes. Private Equity Funds As prescribed in ASC Topic 820, the unit of account for these investments is the interest in the investee fund. The Company owns an undivided interest in the fund portfolio and does not have the ability to dispose of individual assets and liabilities in the fund portfolio. Rather, the Company would be required to redeem or dispose of its entire interest in the investee fund. There is no current active market for interests in underlying private equity funds. Valuation is generally based on the valuations provided by the fund's general partner or investment manager. The valuations typically reflect the fair value of the Company's capital account balance of each fund investment, including unrealized capital gains (losses), as reported in the financial statements of the respective investee fund as of the respective year end or the latest available date. In circumstances where fair values are not provided, the Company seeks to determine the fair value of fund investments based upon other information provided by the fund's general partner or investment manager or from other sources. The fair value of securities received in-kind from fund investments is determined based on the restrictions around the securities. • Unrestricted, publicly traded securities are valued at the closing public market price on the reporting date; • Restricted, publicly traded securities may be valued at a discount from the closing public market price on the reporting date, depending on the circumstances; and • Privately held securities are valued by the directors/general partner of the investee fund, based on a variety of factors, including the price of recent transactions in the company's securities and the company's earnings, revenue and book value. In the case of direct investments or co-investments in private equity companies, the Company initially recognizes investments at cost and subsequently adjusts investments to fair value. On a quarterly basis, the Company reviews the general partner or lead investor's valuation of the investee company, taking into account other available information, such as indications of a market value through subsequent issues of capital or transactions between third parties, performance of the investee company during the period and public, comparable companies' analysis, where appropriate. Investments in these funds typically may not be fully redeemed at net asset value ("NAV") within 90 days because of inherent restriction on near term redemptions. As of March 31, 2023 and December 31, 2022, certain private equity funds maintained term loans and revolving lines of credit of $1,360 and $1,366, respectively. The term loans mature in four The following table summarizes the fair value hierarchy levels of consolidated investment entities as of March 31, 2023: Level 1 Level 2 Level 3 NAV Total Assets VIEs Cash and cash equivalents $ 100 $ — $ — $ — $ 100 Corporate loans — 1,232 — — 1,232 Limited partnerships/corporations — — — 3,009 3,009 Total assets $ 100 $ 1,232 $ — $ 3,009 $ 4,341 Liabilities VIEs CLO notes $ — $ 1,256 $ — $ — $ 1,256 Total liabilities $ — $ 1,256 $ — $ — $ 1,256 The following table summarizes the fair value hierarchy levels of consolidated investment entities as of December 31, 2022: Level 1 Level 2 Level 3 NAV Total Assets VIEs Cash and cash equivalents $ 88 $ — $ — $ — $ 88 Corporate loans — 1,293 — — 1,293 Limited partnerships/corporations — — — 2,802 2,802 Total assets $ 88 $ 1,293 $ — $ 2,802 $ 4,183 Liabilities VIEs CLO notes $ — $ 1,234 $ — $ — $ 1,234 Total liabilities $ — $ 1,234 $ — $ — $ 1,234 Transfers of investments out of Level 3 and into Level 2 or Level 1, if any, are recorded as of the beginning of the period in which the transfer occurred. For the three months ended March 31, 2023 and 2022, there were no transfers in or out of Level 3 or transfers between Level 1 and Level 2. Deconsolidation of Certain Investment Entities Certain investment entities that have historically been consolidated in the financial statements may require deconsolidation as of the reporting period because: (a) such funds have been liquidated or dissolved; or (b) the Company is no longer deemed to be the primary beneficiary of the VIEs/VOEs as it no longer has a controlling financial interest. The change in CLO’s consolidation status due to the close of the warehouse and the launch of the CLO do not meet the criteria described above as this transaction represents normal business operations of the entity. Refer to the CLO life cycle described above. During the three months ended March 31, 2023 and 2022, the Company had no deconsolidations. Nonconsolidated VIEs The Company also holds variable interest in certain CLOs and LPs that are not consolidated as it has been determined that the Company is not the primary beneficiary. CLOs As of March 31, 2023 and December 31, 2022, the Company held $398 and $364 ownership interests, respectively, in unconsolidated CLOs, which also represents the Company's maximum exposure to loss. LPs As of March 31, 2023 and December 31, 2022, the Company held $1,794 and $1,781 ownership interests, respectively, in unconsolidated limited partnerships, which also represents the Company's maximum exposure to loss. Securitizations The Company invests in various tranches of securitization entities, including RMBS, CMBS and ABS. Through its investments, the Company is not obligated to provide any financial or other support to these entities. Each of the RMBS, CMBS and ABS entities are thinly capitalized by design and considered VIEs. The Company's involvement with these entities is limited to that of a passive investor. The Company has no unilateral right to appoint or remove the servicer, special servicer or investment manager, which are generally viewed to have the power to direct the activities that most significantly impact the securitization entities' economic performance, in any of these entities, nor does the Company function in any of these roles. The Company, through its investments or other arrangements, does not have the obligation to absorb losses or the right to receive benefits from the entity that could potentially be significant to the entity. Therefore, the Company is not the primary beneficiary and does not consolidate any of the RMBS, CMBS and ABS entities in which it holds investments. These investments are accounted for as investments available-for-sale as described in the Fair Value Measurements (excluding Consolidated Investment Entities) Note to these Condensed Consolidated Financial Statements and unrealized capital gains (losses) on these securities are recorded directly in AOCI, except for certain RMBS which are accounted for under the FVO whose change in fair value is reflected in Net gains (losses) in the Condensed Consolidated Statements of Operations. The Company’s maximum exposure to loss on these structured investments is limited to the amount of its investment. Refer to the Investments (excluding Consolidated Investment Entities) Note to these Condensed Consolidated Financial Statements for details regarding the carrying amounts and classifications of these assets.

Goodwill and Other Intangible A

Goodwill and Other Intangible Assets	3 Months Ended
	Mar. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Other Intangible Assets	Goodwill and Other Intangible Assets Goodwill The changes in the carrying amount of goodwill reported in the Company's operating segments were as follows: Wealth Solutions Health Solutions Investment Management Consolidated Balance as of January 1, 2022 $ 17 $ 24 $ 31 $ 72 Additions from business combinations — — 255 255 Balance as of December 31, 2022 $ 17 $ 24 $ 286 $ 327 Additions from business combinations — 319 — 319 Balance as of March 31, 2023 $ 17 $ 343 $ 286 $ 646 Other Intangible Assets The following table presents other intangible assets as of the dates indicated: Weighted March 31, 2023 December 31, 2022 Gross Accumulated Net Gross Accumulated Net Indefinite-life intangibles: Right to manage client assets N/A $ 345 $ — $ 345 $ 345 $ — $ 345 Management contract rights N/A 5 — 5 5 — 5 Total indefinite-life intangibles $ 350 $ — $ 350 $ 350 $ — $ 350 Finite-life intangibles: Management contract rights 19 years $ 741 $ 557 $ 184 $ 741 $ 554 $ 187 Customer relationship lists 17 years 324 114 210 135 111 24 Trademarks 8 years 15 — 15 — — — Computer software 4 years 457 311 146 502 432 70 Total intangible assets $ 1,887 $ 982 $ 905 $ 1,728 $ 1,097 $ 631 Amortization expense related to intangible assets were $20 and $11 for the three months ended March 31, 2023 and 2022, respectively.

Segments

Segments	3 Months Ended
	Mar. 31, 2023
Segment Reporting [Abstract]
Segments	Segments The Wealth Solutions segment provides tax-deferred, employer-sponsored retirement savings plans and administrative services to corporate, education, healthcare, other non-profit and government entities, and stable value products to institutional clients where the Company may or may not be providing defined contribution products and services, as well as individual retirement accounts ("IRAs"), other retail financial products and comprehensive financial services to individual customers. The Health Solutions segment provides stop loss, group life, voluntary employee-paid and disability products to mid-sized and large businesses as well as benefit administration software solutions to employers and health plans. The Investment Management segment provides investment products and retirement solutions across a broad range of geographies, market sectors, investment styles and capitalization spectrums. Products and services are offered to institutional clients, including public, corporate and union retirement plans, endowments and foundations and insurance companies, as well as individual investors and general accounts of the Company's insurance subsidiaries and are distributed through the Company's direct sales force, consultant channel and intermediary partners (such as banks, broker-dealers and independent financial advisers). The Company includes in Corporate the following corporate and business activities: • corporate operations, corporate level assets and financial obligations; financing and interest expenses; dividend payments made to preferred shareholders; stranded costs and other items not allocated or directly related to the Company's segments, including items such as expenses related to organizational restructurings, certain expenses and liabilities of employee benefit plans, certain adjustments to short-term and long-term incentive accruals and intercompany eliminations; • investment income on assets backing surplus in excess of amounts held at the segment level. Measurement Effective with the first quarter of 2023, the Company excludes from Adjusted operating earnings before income taxes the amortization of acquisition-related intangible assets. In addition, the Company excludes the expected return on plan assets net of interest costs associated with our qualified defined benefit pension plan, which are influenced by economic and market conditions and not indicative of normal operations. Adjusted operating earnings before income taxes in Corporate still includes the service costs related to the Company's qualified defined benefit pension plan and service and interest costs related to non-qualified defined benefit pension plans. Historical periods have been recast to conform with this change. Adjusted operating earnings before income taxes is a measure used by management to evaluate segment performance. The Company believes that Adjusted operating earnings before income taxes provides a meaningful measure of its business and segment performances and enhances the understanding of the Company’s financial results by focusing on the operating performance and trends of the underlying business segments and excluding items that tend to be highly variable from period to period based on capital market conditions and/or other factors. The Company uses the same accounting policies and procedures to measure segment Adjusted operating earnings before income taxes as it does for the directly comparable U.S. GAAP measure Income (loss) before income taxes. Adjusted operating earnings before income taxes does not replace Income (loss) before income taxes as the U.S. GAAP measure of the Company’s consolidated results of operations. Therefore, the Company believes that it is useful to evaluate both Income (loss) before income taxes and Adjusted operating earnings before income taxes when reviewing the Company’s financial and operating performance. Each segment’s Adjusted operating earnings before income taxes is calculated by adjusting Income (loss) before income taxes for the following items: • Net investment gains (losses), which are significantly influenced by economic and market conditions, including interest rates and credit spreads, and are not indicative of normal operations. Net investment gains (losses) include gains (losses) on the sale of securities, impairments, changes in the fair value of investments using the FVO unrelated to the implied loan-backed security income recognition for certain mortgage-backed obligations, and changes in the fair value of derivative instruments, excluding gains (losses) associated with swap settlements and accrued interest. It also includes changes in the fair value of derivatives related to managed custody guarantees, net of related reserve increases (decreases), less the estimated cost of these benefits, changes in nonperformance spread, and changes in market risk benefits; • Income (loss) related to businesses exited or to be exited through reinsurance or divestment, which includes gains and (losses) associated with transactions to exit blocks of business (including net investment gains (losses) on securities sold and expenses directly related to these transactions), and residual run-off activity (including an insignificant number of Individual Life, and non-Wealth Solution annuities policies that were not part of the divested businesses). Excluding this activity, which also includes amortization of intangible assets related to businesses exited or to be exited, better reveals trends in the Company's core business and more closely aligns Adjusted operating earnings before income taxes with how the Company manages its segments; • Income (loss) attributable to noncontrolling interests, which represents the interest of shareholders, other than those of the Company, in the gains and (losses) of consolidated entities, such as Allianz's stake in the results of VIM Holdings LLC (referred to as redeemable noncontrolling interest or Allianz noncontrolling interest) or the attribution of results from consolidated VIEs or VOEs to which the Company is not economically entitled; • Dividend payments made to preferred shareholders are included as reductions to reflect the Adjusted operating earnings before income taxes that are available to common shareholders; • Other adjustments may include the following items: • Income (loss) related to early extinguishment of debt, which includes losses incurred as a result of transactions where the Company repurchases outstanding principal amounts of debt. These losses are excluded from Adjusted operating earnings before income taxes since the outcome of decisions to restructure debt are not indicative of normal operations; • Impairment of goodwill, value of management contract rights and value of customer relationships acquired, which includes losses as a result of impairment analysis; these represent losses related to infrequent events and do not reflect normal, cash-settled expenses; • Amortization of value of management contract rights, value of customer relationships acquired, and other acquisition-related intangible assets as well as contingent consideration fair value adjustments incurred in connection with certain acquisitions which are not indicative of current Operating expense fundamentals; • Expected return on plan assets net of interest costs associated with the Company's qualified defined benefit pension plan and immediate recognition of net actuarial gains (losses) related to all of the Company's pension and other postretirement benefit obligations and gains (losses) from plan amendments and curtailments, which includes actuarial gains and (losses) as a result of differences between actual and expected experience on pension plan assets or projected benefit obligation during a given period. These amounts do not reflect cash-settled expenses, and are not indicative of current Operating expense fundamentals; and • Other items not indicative of normal operations or performance of the Company's segments or related to events such as capital or organizational restructurings undertaken to achieve long-term economic benefits, including certain costs related to debt and equity offerings, acquisition / merger integration expenses, severance and other third-party expenses associated with such activities, and expenses attributable to vacant real estate. These items vary widely in timing, scope and frequency between periods as well as between companies to which the Company is compared. Accordingly, the Company adjusts for these items as management believes that these items distort the ability to make a meaningful evaluation of the current and future performance of the Company's segments. The summary below reconciles Adjusted operating earnings before income taxes for the segments to Income (loss) before income taxes for the periods indicated: Three Months Ended March 31, 2023 2022 Adjusted operating earnings before income taxes by segment: Wealth Solutions $ 132 $ 228 Health Solutions 94 21 Investment Management 42 39 Corporate (69) (68) Total including Allianz noncontrolling interest 200 221 Less: Earning (loss) attributable to Allianz noncontrolling interest 8 — Total $ 192 $ 221 Adjustments: Net investment gains (losses) (9) (112) Income (loss) related to businesses exited or to be exited through reinsurance or divestment (33) (36) Income (loss) attributable to noncontrolling interests 46 43 Dividend payments made to preferred shareholders 14 14 Other adjustments (70) (8) Total adjustments to income (loss) before income taxes (51) (99) Income (loss) before income taxes $ 141 $ 122 Adjusted operating revenues is a measure of the Company's segment revenues. Each segment's Operating revenues are calculated by adjusting Total revenues to exclude the following items: • Net investment gains (losses), which are significantly influenced by economic and market conditions, including interest rates and credit spreads, and are not indicative of normal operations. Net investment gains (losses) include gains (losses) on the sale of securities, impairments, changes in the fair value of investments using the FVO unrelated to the implied loan-backed security income recognition for certain mortgage-backed obligations, and changes in the fair value of derivative instruments, excluding gains (losses) associated with swap settlements and accrued interest. It also includes changes in the fair value of derivatives related to managed custody guarantees, net of related reserve increases (decreases), less the estimated cost of these benefits, and changes in nonperformance spread; • Revenues related to businesses exited or to be exited through reinsurance or divestment, which includes revenues associated with transactions to exit blocks of business (including net investment gains (losses) on securities sold related to these transactions), and residual run-off activity (including an insignificant number of Individual Life, and non-Wealth Solution annuities policies that were not part of the divested businesses). Excluding this activity better reveals trends in the Company's core business and more closely aligns Adjusted operating revenues with how the Company manages its segments; • Revenues attributable to noncontrolling interests, which represents the interests of shareholders, other than the Company, in consolidated entities. Revenues attributable to noncontrolling interests represent such shareholders' interests in the gains and losses of those entities, or the attribution of results from consolidated VIEs or VOEs to which the Company is not economically entitled; and • Other adjustments primarily reflect fee income earned by the Company's broker-dealers for sales of non-proprietary products, which are reflected net of commission expense in the Company's segments’ operating revenues, other items where the income is passed on to third parties and the elimination of intercompany investment expenses included in Adjusted operating revenues. The summary below reconciles Adjusted operating revenues for the segments to Total revenues for the periods indicated: Three Months Ended March 31, 2023 2022 Adjusted operating revenues by segment: Wealth Solutions $ 684 $ 756 Health Solutions 774 647 Investment Management 229 178 Corporate 11 22 Total $ 1,697 $ 1,603 Adjustments: Net investment gains (losses) (14) (120) Revenues related to businesses exited or to be exited through reinsurance or divestment 30 (54) Revenues attributable to noncontrolling interests 60 48 Other adjustments 60 28 Total adjustments to revenues 137 (97) Total revenues $ 1,835 $ 1,506 Other Segment Information The Investment Management segment revenues include the following intersegment revenues, primarily consisting of asset-based management and administration fees for the periods indicated: Three Months Ended March 31, 2023 2022 Investment Management intersegment revenues $ 22 $ 22 The summary below presents Total assets for the Company’s segments as of the dates indicated: March 31, 2023 December 31, 2022 Wealth Solutions $ 115,777 $ 111,701 Health Solutions 3,335 2,668 Investment Management 1,635 1,611 Corporate 26,333 26,712 Total assets, before consolidation (1) 147,080 142,692 Consolidation of investment entities 4,128 3,914 Total assets $ 151,208 $ 146,606 (1) Total assets, before consolidation includes the Company's direct investments in CIEs prior to consolidation, which are accounted for using the equity method or fair value option.

Business, Basis of Presentati_2

Business, Basis of Presentation and Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
Adoption of New Pronouncements	The following table provides a description of future adoptions of new accounting standards that may have an impact on the Company's financial statements when adopted: Standard Description of Requirements Effective Date and Transition Provisions Effect on the Financial Statements or Other Significant Matters ASU 2022-03, Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions This standard, issued in June 2022, clarifies that contractual restrictions on equity security sales are not considered part of the security unit of account and, therefore, are not considered in measuring fair value. In addition, the restrictions cannot be recognized and measured as separate units of account. Disclosures on such restrictions are also required. The amendments are effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, and are required to be applied prospectively, with any adjustments from the adoption recognized in earnings and disclosed. The Company is currently in the process of determining the impact of adoption of the provisions of ASU 2022-03.
Derivatives	The Company primarily enters into the following types of derivatives: Interest rate swaps: Interest rate swaps are used by the Company primarily to reduce market risks from changes in interest rates and to alter interest rate exposure arising from mismatches between assets and/or liabilities. Interest rate swaps are also used to hedge the interest rate risk associated with the value of assets it owns or in an anticipation of acquiring them. Using interest rate swaps, the Company agrees with another party to exchange, at specified intervals, the difference between fixed rate and floating rate interest payments, calculated by reference to an agreed upon notional principal amount. These transactions are entered into pursuant to master agreements that provide for a single net payment to be made to/from the counterparty at each due date. The Company utilizes these contracts in qualifying hedging relationships as well as non-qualifying hedging relationships. Foreign exchange swaps: The Company uses foreign exchange or currency swaps to reduce the risk of change in the value, yield or cash flows associated with certain foreign denominated invested assets. Foreign exchange swaps represent contracts that require the exchange of foreign currency cash flows against U.S. dollar cash flows at regular periods, typically quarterly or semi-annually. The Company utilizes these contracts in qualifying hedging relationships as well as non-qualifying hedging relationships. Total return swaps: The Company uses total return swaps as a hedge of interest related risks within various Legacy Annuity and Retirement products. Total return swaps are also used as a hedge of other corporate liabilities. Using total return swaps, the Company agrees with another party to exchange, at specified intervals, the difference between the economic performance of assets or a market index and a fixed or variable funding multiplied by reference to an agreed upon notional amount. No cash is exchanged at the onset of the contracts. Cash is paid and received over the life of the contract based upon the terms of the swaps. The Company utilized these contracts in non-qualifying hedging relationships. Futures: Futures contracts are used to hedge against a decrease in certain equity indices. Such decreases may correlate to a decrease in variable annuity account values which would increase the possibility of the Company incurring an expense for guaranteed benefits in excess of account values. The Company also uses interest rate futures contracts to hedge its exposure to market risks due to changes in interest rates. The Company enters into exchange traded futures with regulated futures commissions that are members of the exchange. The Company also posts initial and variation margins, with the exchange, on a daily basis. The Company utilizes exchange-traded futures in non-qualifying hedging relationships. The Company may also use futures contracts as a hedge against an increase in certain equity indices.
Income Tax	The Company uses the estimated annual effective tax rate method in computing its interim tax provision. Certain items, including changes in the realizability of deferred tax assets and changes in liabilities for uncertain tax positions, are excluded from the estimated annual effective tax rate and the actual tax expense or benefit is reported in the period the related item is incurred.

Business, Basis of Presentati_3

Business, Basis of Presentation and Significant Accounting Policies (Tables)	3 Months Ended
	Mar. 31, 2023
Accounting Policies [Abstract]
Adoption of New Accounting Pronouncements and Future Adoption of Accounting Pronouncements	Adoption of New Pronouncements Long-Duration Contracts The following section provides a description of the Company's adoption of ASU 2018-12 issued by the Financial Accounting Standards Board ("FASB") and the impact of the adoption on the Company's financial statements: This standard, issued in August 2018, changes the measurement and disclosures of insurance liabilities and DAC for long-duration contracts issued by insurers. In addition to expanded disclosures, the standard’s requirements include: • Annual review and, if necessary, update of cash flow assumptions used to measure the liability for future policy benefits for nonparticipating traditional and limited payment insurance contracts, measured on a retrospective catch-up basis and recognized in the period the update is made. The rate used is required to be updated quarterly, with related changes in the liability recorded in AOCI. • Fair value measurement of contract guarantee features qualifying as Market Risk Benefits (“MRB”), with changes in fair value recognized in the Statement of Operations. Changes in the instrument-specific credit risk will be recorded in AOCI. • Amortization of DAC on a constant level basis over the expected term of the contracts, without reference to revenue or profitability. An accounting election may be made to apply the DAC requirements to VOBA. • Insurance entities may make an accounting policy election to exclude contracts from application of the requirements in ASU 2018-12 when those contracts have been derecognized because of a sale or disposal of a legal entity before the effective date of ASU 2018-12. The Company adopted ASU 2018-12 on January 1, 2023, on a modified retrospective basis for the liability for future policy benefits and DAC and on a full retrospective basis for MRBs. The January 1, 2021 transition impact increased Total shareholders’ equity. This increase was primarily driven by the removal of DAC/VOBA and Premium deficiency reserve adjustment balances, and partially offset by the impact of remeasurement of Future policy benefits and Reinsurance recoverable using the discount rate at January 1, 2021. Total shareholders’ equity was also impacted by the establishment of MRB liabilities related to guaranteed minimum benefits on certain deferred annuity contracts. The Company elected the option to exclude contracts reported as discontinued operations in 2021. Disclosures and post-transition comparative information have been restated to conform to the requirements of ASU 2018-12. The following tables provide additional information related to the transition adjustments: DAC VOBA Wealth Solutions Deferred and Individual Annuities Businesses Exited (1) Balance, December 31, 2020 $ 119 $ 1,186 $ 70 Adjustment for removal of related balances in AOCI 571 104 635 Balance, January 1, 2021 $ 690 $ 1,290 $ 705 Liability for Future Policy Benefits Health Solutions Group (2) Health Solutions Voluntary (3) Businesses Exited (1) Balance, December 31, 2020 $ 822 $ 188 $ 5,448 Adjustment for reversal of related balances in AOCI — — (386) Adjustment for loss contracts under the modified retrospective approach 7 3 3 Effect of remeasurement of liability at current discount rate 118 83 1,362 Balance, January 1, 2021 $ 947 $ 274 $ 6,427 (1) Includes long duration retail individual life and annuity business exited via reinsurance (2) Includes long duration employee-sponsored group life and health products (3) Includes long duration employee-paid whole life products The following table presents information on transition adjustments, net of tax, related to the adoption of ASU 2018-12 for retained earnings and AOCI to arrive at the opening balances as of January 1, 2021: Total Shareholders' equity December 31, 2020 $ 11,178 AOCI Reversal of AOCI adjustments 1,328 Effect of remeasurement of liability at current discount rate (1,065) Total AOCI adjustments $ 263 Retained Earnings Establishment of MRBs $ (132) Other adjustments 27 Total Retained earnings $ (105) Total adjustment for the adoption of ASU 2018-12 $ 158 Total Shareholders' equity January 1, 2021 $ 11,336 The following table provides a description of the Company’s adoption of other new ASUs issued by the FASB and the impact of adoption on the Company’s financial statements: Standard Description of Requirements Effective Date and Transition Provisions Effect on the Financial Statements or Other Significant Matters ASU 2022-02, Troubled Debt Restructurings ("TDRs") and Vintage Disclosures This standard, issued in March 2022, eliminates the accounting guidance on troubled debt restructurings for creditors, requires enhanced disclosures for creditors about loan modifications when a borrower is experiencing financial difficulty, and requires public business entities to include current-period gross write-offs in the vintage disclosure tables. January 1, 2023 on a prospective basis. Adoption of the ASU did not have an impact on the Company's financial condition, results of operations, or cash flows. Required disclosure changes have been included in the Investments (excluding Consolidated Investment Entities) Note to these Condensed Consolidated Financial Statements . ASU 2020-04, Reference Rate Reform This standard, issued in March 2020, provides temporary optional expedients and exceptions for applying U.S. GAAP principles to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments were effective as of March 12, 2020, the issuance date of the ASU. An entity may elect to apply the amendments prospectively through December 31, 2024. The Company has elected to apply the expedient provided in ASU 2020-04 for qualifying contract modifications. To date, adoption of the guidance has not had a material impact on the Company’s financial condition and results of operations. The Company will continue to evaluate the impacts of reference rate reform on contract modifications and hedging relationships as transition progresses. Future Adoption of Accounting Pronouncements The following table provides a description of future adoptions of new accounting standards that may have an impact on the Company's financial statements when adopted: Standard Description of Requirements Effective Date and Transition Provisions Effect on the Financial Statements or Other Significant Matters ASU 2022-03, Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions This standard, issued in June 2022, clarifies that contractual restrictions on equity security sales are not considered part of the security unit of account and, therefore, are not considered in measuring fair value. In addition, the restrictions cannot be recognized and measured as separate units of account. Disclosures on such restrictions are also required. The amendments are effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, and are required to be applied prospectively, with any adjustments from the adoption recognized in earnings and disclosed. The Company is currently in the process of determining the impact of adoption of the provisions of ASU 2022-03.

Investments (excluding Consol_2

Investments (excluding Consolidated Investment Entities) (Tables)	3 Months Ended
	Mar. 31, 2023
Investments, Debt and Equity Securities [Abstract]
Marketable Securities	Available-for-sale and fair value option ("FVO") fixed maturities were as follows as of March 31, 2023: Amortized Cost Gross Unrealized Capital Gains Gross Unrealized Capital Losses Embedded Derivatives (2) Fair Value Allowance for credit losses Fixed maturities: U.S. Treasuries $ 428 $ 15 $ 11 $ — $ 432 $ — U.S. Government agencies and authorities 54 4 1 — 57 — State, municipalities and political subdivisions 949 2 98 — 853 — U.S. corporate public securities 9,132 156 998 — 8,290 — U.S. corporate private securities 5,088 32 340 — 4,780 — Foreign corporate public securities and foreign governments (1) 3,259 38 331 — 2,957 9 Foreign corporate private securities (1) 3,151 14 171 — 2,992 2 Residential mortgage-backed securities 4,190 40 257 4 3,977 — Commercial mortgage-backed securities 4,415 1 574 — 3,842 — Other asset-backed securities 2,439 7 157 — 2,288 1 Total fixed maturities, including securities pledged 33,105 309 2,938 4 30,468 12 Less: Securities pledged 1,347 — 121 — 1,226 — Total fixed maturities $ 31,758 $ 309 $ 2,817 $ 4 $ 29,242 $ 12 (1) Primarily U.S. dollar denominated. (2) Embedded derivatives within fixed maturity securities are reported with the host investment. The changes in fair value of embedded derivatives are reported in Net gains (losses) in the Condensed Consolidated Statements of Operations. Available-for-sale and FVO fixed maturities were as follows as of December 31, 2022: Amortized Cost Gross Unrealized Capital Gains Gross Unrealized Capital Losses Embedded Derivatives (2) Fair Value Allowance for credit losses Fixed maturities: U.S. Treasuries $ 590 $ 12 $ 21 $ — $ 581 $ — U.S. Government agencies and authorities 58 3 2 — 59 — State, municipalities and political subdivisions 978 1 134 — 845 — U.S. corporate public securities 9,343 97 1,239 — 8,201 — U.S. corporate private securities 5,087 14 409 — 4,692 — Foreign corporate public securities and foreign governments (1) 3,343 18 403 — 2,949 9 Foreign corporate private securities (1) 3,254 7 225 — 3,034 2 Residential mortgage-backed securities 4,230 34 290 3 3,977 — Commercial mortgage-backed securities 4,466 2 585 — 3,883 — Other asset-backed securities 2,307 3 173 — 2,136 1 Total fixed maturities, including securities pledged 33,656 191 3,481 3 30,357 12 Less: Securities pledged 1,303 3 144 — 1,162 — Total fixed maturities $ 32,353 $ 188 $ 3,337 $ 3 $ 29,195 $ 12 (1) Primarily U.S. dollar denominated. (2) Embedded derivatives within fixed maturity securities are reported with the host investment. The changes in fair value of embedded derivatives are reported in Net gains (losses) in the Condensed Consolidated Statements of Operations.
Investments Classified by Contractual Maturity Date	The amortized cost and fair value of fixed maturities, including securities pledged, as of March 31, 2023, are shown below by contractual maturity. Actual maturities may differ from contractual maturities as securities may be restructured, called or prepaid. Mortgage-backed securities ("MBS") and Other asset-backed securities ("ABS") are shown separately because they are not due at a single maturity date. Amortized Fair Due to mature: One year or less $ 679 $ 676 After one year through five years 4,276 4,086 After five years through ten years 4,206 4,014 After ten years 12,900 11,585 Mortgage-backed securities 8,605 7,819 Other asset-backed securities 2,439 2,288 Fixed maturities, including securities pledged $ 33,105 $ 30,468
U.S. and Foreign Corporate Securities by Industry	The following tables present the composition of the U.S. and foreign corporate securities within the fixed maturity portfolio by industry category as of the dates indicated: Amortized Gross Gross Fair March 31, 2023 Communications $ 1,184 $ 27 $ 101 $ 1,110 Financial 4,008 48 425 3,631 Industrial and other companies 8,136 60 748 7,448 Energy 1,987 55 127 1,915 Utilities 3,648 40 286 3,402 Transportation 1,115 5 100 1,020 Total $ 20,078 $ 235 $ 1,787 $ 18,526 December 31, 2022 Communications $ 1,156 $ 16 $ 130 $ 1,042 Financial 4,153 31 491 3,693 Industrial and other companies 8,379 26 953 7,452 Energy 1,979 39 160 1,858 Utilities 3,664 21 355 3,330 Transportation 1,165 2 128 1,039 Total $ 20,496 $ 135 $ 2,217 $ 18,414
Schedule of Securities Borrowed Under Securities Lending Transactions	The following table presents borrowings under securities lending transactions by asset class as of the dates indicated: March 31, 2023 December 31, 2022 U.S. Treasuries $ 7 $ 53 U.S. corporate public securities 700 604 Foreign corporate public securities and foreign governments 297 285 Payables under securities loan agreements $ 1,004 $ 942
Financing Receivable, Allowance for Credit Loss	The following table presents a rollforward of the allowance for credit losses on available-for-sale fixed maturity securities for the periods presented: Three Months Ended March 31, 2023 Foreign corporate public securities and foreign governments Foreign corporate private securities Other asset-backed securities Total Balance as of January 1 $ 9 $ 2 $ 1 $ 12 Reductions for securities sold during the period (2) — — (2) Increase (decrease) on securities with allowance recorded in previous period 2 — — 2 Balance as of March 31 $ 9 $ 2 $ 1 $ 12
Schedule of Unrealized Loss on Investments	The following table presents available-for-sale fixed maturities, including securities pledged, for which an allowance for credit losses has not been recorded by market sector and duration as of March 31, 2023: Twelve Months or Less More Than Twelve Total Fair Value Unrealized Capital Losses Number of securities Fair Value Unrealized Capital Losses Number of securities Fair Value Unrealized Capital Losses Number of securities U.S. Treasuries $ 106 $ 1 10 $ 47 $ 10 13 $ 153 $ 11 23 U.S. Government agencies and authorities — — — 3 1 1 3 1 1 State, municipalities and political subdivisions 573 44 206 209 54 82 782 98 288 U.S. corporate public securities 3,181 220 558 2,864 778 733 6,045 998 1,291 U.S. corporate private securities 2,268 113 243 1,552 227 152 3,820 340 395 Foreign corporate public securities and foreign governments 1,185 76 205 1,008 255 230 2,193 331 435 Foreign corporate private securities 1,834 75 138 793 96 68 2,627 171 206 Residential mortgage-backed 782 43 329 964 214 447 1,746 257 776 Commercial mortgage-backed 1,346 141 213 2,410 433 438 3,756 574 651 Other asset-backed 554 26 138 1,532 131 399 2,086 157 537 Total $ 11,829 $ 739 2,040 $ 11,382 $ 2,199 2,563 $ 23,211 $ 2,938 4,603 The Company concluded that an allowance for credit losses was unnecessary for these securities because the unrealized losses are interest rate related. The following table presents available-for-sale fixed maturities, including securities pledged, for which an allowance for credit losses has not been recorded by market sector and duration as of December 31, 2022: Twelve Months or Less More Than Twelve Total Fair Value Unrealized Capital Losses Number of securities Fair Value Unrealized Capital Losses Number of securities Fair Value Unrealized Capital Losses Number of securities U.S. Treasuries $ 197 $ 19 19 $ 9 $ 2 7 $ 206 $ 21 26 U.S. Government agencies and authorities 21 2 2 — — — 21 2 2 State, municipalities and political subdivisions 751 121 284 30 13 17 781 134 301 U.S. corporate public securities 5,479 792 1,054 1,137 447 347 6,616 1,239 1,401 U.S. corporate private securities 3,569 322 375 458 87 32 4,027 409 407 Foreign corporate public securities and foreign governments 2,050 260 371 391 143 97 2,441 403 468 Foreign corporate private securities 2,728 211 217 65 14 6 2,793 225 223 Residential mortgage-backed 1,538 128 536 562 162 283 2,100 290 819 Commercial mortgage-backed 2,628 390 441 1,133 195 207 3,761 585 648 Other asset-backed 1,430 104 334 578 69 191 2,008 173 525 Total $ 20,391 $ 2,349 3,633 $ 4,363 $ 1,132 1,187 $ 24,754 $ 3,481 4,820
Other than Temporary Impairment, Credit Losses Recognized in Earnings	The following table identifies the Company's intent impairments included in the Condensed Consolidated Statements of Operations, excluding impairments included in Other comprehensive income (loss) by type for the periods indicated: Three Months Ended March 31, 2023 2022 Impairment No. of Impairment No. of Residential mortgage-backed — * 2 7 13 Total $ — * 2 $ 7 13 (1) Primarily U.S. dollar denominated. *Less than $1
Mortgage Loans by Loan to Value Ratio	The following tables present commercial mortgage loans by year of origination and LTV ratio as of the dates indicated. The information is updated as of March 31, 2023 and December 31, 2022, respectively. As of March 31, 2023 Loan-to-Value Ratios Year of Origination 0% - 50% >50% - 60% >60% - 70% >70% - 80% >80% and above Total 2023 $ 58 $ — $ — $ — $ — $ 58 2022 246 337 64 — — 647 2021 236 246 253 — — 735 2020 150 169 14 10 — 343 2019 225 93 29 — — 347 2018 161 40 3 — — 204 2017 and prior 2,509 477 26 — — 3,012 Total $ 3,585 $ 1,362 $ 389 $ 10 $ — $ 5,346 As of December 31, 2022 Loan-to-Value Ratios Year of Origination 0% - 50% >50% - 60% >60% - 70% >70% - 80% >80% and above Total 2022 $ 250 $ 320 $ 65 $ — $ — $ 635 2021 240 272 255 10 — 777 2020 119 209 25 10 — 363 2019 227 94 29 — — 350 2018 163 41 2 — — 206 2017 and prior 2,606 482 26 — — 3,114 Total $ 3,605 $ 1,418 $ 402 $ 20 $ — $ 5,445
Mortgage Loans by Debt Service Coverage Ratio	The following tables present commercial mortgage loans by year of origination and DSC ratio as of the dates indicated. The information is updated as of March 31, 2023 and December 31, 2022, respectively. As of March 31, 2023 Debt Service Coverage Ratios Year of Origination >1.5x >1.25x - 1.5x >1.0x - 1.25x <1.0x Total* 2023 $ 51 $ 7 $ — $ — $ 58 2022 278 96 187 86 647 2021 265 26 113 331 735 2020 242 27 5 69 343 2019 220 45 75 7 347 2018 122 26 56 — 204 2017 and prior 2,091 446 226 249 3,012 Total $ 3,269 $ 673 $ 662 $ 742 $ 5,346 *No commercial mortgage loans were secured by land or construction loans As of December 31, 2022 Debt Service Coverage Ratios Year of Origination >1.5x >1.25x - 1.5x >1.0x - 1.25x <1.0x Total* 2022 $ 331 $ 100 $ 181 $ 23 $ 635 2021 273 33 269 202 777 2020 259 11 11 82 363 2019 222 54 67 7 350 2018 128 27 51 — 206 2017 and prior 2,172 454 226 262 3,114 Total $ 3,385 $ 679 $ 805 $ 576 $ 5,445
Mortgage Loans by Geographic Location of Collateral	The following tables present the commercial mortgage loans by year of origination and U.S. region as of the dates indicated. The information is updated as of March 31, 2023 and December 31, 2022, respectively. As of March 31, 2023 U.S. Region Year of Origination Pacific South Atlantic Middle Atlantic West South Central Mountain East North Central New England West North Central East South Central Total 2023 $ 20 $ — $ 4 $ — $ — $ 31 $ 3 $ — $ — $ 58 2022 140 129 48 99 114 93 4 1 19 647 2021 98 63 131 145 112 127 9 48 2 735 2020 74 161 17 16 12 40 — 7 16 343 2019 57 105 10 76 46 5 14 13 21 347 2018 50 61 54 9 14 10 — 6 — 204 2017 and prior 767 602 748 222 210 242 49 147 25 3,012 Total $ 1,206 $ 1,121 $ 1,012 $ 567 $ 508 $ 548 $ 79 $ 222 $ 83 $ 5,346 As of December 31, 2022 U.S. Region Year of Origination Pacific South Atlantic Middle Atlantic West South Central Mountain East North Central New England West North Central East South Central Total 2022 $ 140 $ 129 $ 48 $ 98 $ 114 $ 82 $ 4 $ 1 $ 19 $ 635 2021 99 72 134 143 112 138 9 48 22 777 2020 74 170 18 16 12 39 — 7 27 363 2019 58 106 10 77 46 5 14 13 21 350 2018 50 62 55 10 14 10 — 5 — 206 2017 and prior 777 623 759 248 227 257 49 149 25 3,114 Total $ 1,198 $ 1,162 $ 1,024 $ 592 $ 525 $ 531 $ 76 $ 223 $ 114 $ 5,445
Mortgage Loans by Property Type of Collateral	The following tables present the commercial mortgage loans by year of origination and property type as of the dates indicated. The information is updated as of March 31, 2023 and December 31, 2022, respectively. As of March 31, 2023 Property Type Year of Origination Retail Industrial Apartments Office Hotel/Motel Other Mixed Use Total 2023 $ 15 $ 3 $ 20 $ 20 $ — $ — $ — $ 58 2022 79 265 249 34 10 10 — 647 2021 37 165 381 125 — 18 9 735 2020 58 60 82 143 — — — 343 2019 45 85 164 40 13 — — 347 2018 37 83 55 12 — 17 — 204 2017 and prior 858 742 639 500 68 154 51 3,012 Total $ 1,129 $ 1,403 $ 1,590 $ 874 $ 91 $ 199 $ 60 $ 5,346 As of December 31, 2022 Property Type Year of Origination Retail Industrial Apartments Office Hotel/Motel Other Mixed Use Total 2022 $ 79 $ 255 $ 247 $ 34 $ 10 $ 10 $ — $ 635 2021 37 168 420 125 — 18 9 777 2020 58 61 93 151 — — — 363 2019 46 85 165 40 14 — — 350 2018 37 84 56 12 — 17 — 206 2017 and prior 888 757 679 513 69 156 52 3,114 Total $ 1,145 $ 1,410 $ 1,660 $ 875 $ 93 $ 201 $ 61 $ 5,445
Allowance for Credit Losses on Financing Receivables	The following table summarizes the activity in the allowance for losses for commercial mortgage loans for the periods indicated: March 31, 2023 December 31, 2022 Allowance for credit losses, beginning of period $ 18 $ 15 Credit losses on mortgage loans for which credit losses were not previously recorded — 3 Increase (decrease) on mortgage loans with allowance recorded in previous period (1) — Provision for expected credit losses 17 18 Write-offs — — Recoveries of amounts previously written-off — — Allowance for credit losses, end of period $ 17 $ 18
Financing Receivable, Past Due	The following table presents past due commercial mortgage loans as of the dates indicated: March 31, 2023 December 31, 2022 Delinquency: Current $ 5,346 $ 5,445 30-59 days past due — — 60-89 days past due — — Greater than 90 days past due — — Total $ 5,346 $ 5,445
Net Investment Income	The following table summarizes Net investment income for the periods indicated: Three Months Ended March 31, 2023 2022 Fixed maturities $ 458 $ 479 Equity securities 7 4 Mortgage loans on real estate 61 59 Policy loans 6 6 Short-term investments and cash equivalents 9 1 Limited partnerships and other 22 96 Gross investment income 563 645 Less: Investment expenses 18 15 Net investment income $ 545 $ 630
Realized Gain (Loss) on Investments	Net gains (losses) were as follows for the periods indicated: Three Months Ended March 31, 2023 2022 Fixed maturities, available-for-sale, including securities pledged $ 1 $ (73) Fixed maturities, at fair value option 36 (305) Equity securities, at fair value (2) (8) Derivatives (54) 94 Embedded derivatives - fixed maturities 1 (4) Other derivatives, net — 5 Standalone derivatives — 1 Managed custody guarantees 3 (3) Mortgage Loans — 4 Other investments (1) 1 Net gains (losses) $ (16) $ (288)
Gain (Loss) on Investments	Proceeds from the sale of fixed maturities, available-for-sale and equity securities and the related gross realized gains and losses, before tax, were as follows for the periods indicated: Three Months Ended March 31, 2023 2022 Proceeds on sales $ 1,306 $ 1,249 Gross gains 20 15 Gross losses 25 32

Derivative Financial Instrume_2

Derivative Financial Instruments (Tables)	3 Months Ended
	Mar. 31, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Notional Amounts of Outstanding Derivative Positions	The notional amounts and fair values of derivatives were as follows as of the dates indicated: March 31, 2023 December 31, 2022 Notional Asset Liability Notional Asset Liability Derivatives: Qualifying for hedge accounting (1) Fair value hedges: Foreign exchange contracts $ 88 $ — $ — $ 81 $ — $ 6 Cash flow hedges: Interest rate contracts 22 — — 22 — — Foreign exchange contracts 745 59 2 718 71 2 Derivatives: Non-qualifying for hedge accounting (1) Interest rate contracts 16,564 276 367 18,304 341 376 Foreign exchange contracts 185 3 1 160 9 2 Equity contracts 268 4 2 248 1 1 Credit contracts 188 — 4 174 — 2 Embedded derivatives and Managed custody guarantees: Within fixed maturity investments (2) N/A 4 — N/A 3 — Within reinsurance agreements (4) N/A 72 49 N/A 95 46 Managed custody guarantees (3) N/A — 3 N/A — 6 Total $ 418 $ 428 $ 520 $ 441 (1) Open derivative contracts are reported as Derivatives assets or liabilities on the Condensed Consolidated Balance Sheets at fair value. (2) Included in Fixed maturities, available-for-sale, at fair value on the Condensed Consolidated Balance Sheets. (3) Included in Contract owner account balances on the Condensed Consolidated Balance Sheets. (4) Included in Other liabilities, other assets and Premium receivable and reinsurance recoverable on the Condensed Consolidated Balance Sheets. N/A - Not applicable
Offsetting Assets and Liabilities	Although the Company has not elected to net its derivative exposures, the notional amounts and fair values of Over-The-Counter ("OTC") and cleared derivatives excluding exchange traded contracts are presented in the tables below as of the dates indicated: March 31, 2023 Notional Amount Asset Fair Value Liability Fair Value Credit contracts $ 188 $ — $ 4 Equity contracts 220 4 1 Foreign exchange contracts 1,018 62 3 Interest rate contracts 13,458 276 365 342 373 Counterparty netting (1) (241) (241) Cash collateral netting (1) (92) (126) Securities collateral netting (1) (6) (2) Net receivables/payables $ 3 $ 4 (1) Represents the netting of receivable balances with payable balances, net of collateral, for the same counterparty under eligible netting agreements. December 31, 2022 Notional Amount Asset Fair Value Liability Fair Value Credit contracts $ 174 $ — $ 2 Equity contracts 201 1 1 Foreign exchange contracts 959 80 10 Interest rate contracts 13,328 339 376 420 389 Counterparty netting (1) (295) (295) Cash collateral netting (1) (64) (88) Securities collateral netting (1) (6) (1) Net receivables/payables $ 55 $ 5 (1) Represents the netting of receivable balances with payable balances, net of collateral, for the same counterparty under eligible netting agreements.
Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance	The location and effect of derivatives qualifying for hedge accounting on the Condensed Consolidated Statements of Operations and Condensed Consolidated Statements of Comprehensive Income are as follows for the periods indicated: Three Months Ended March 31, 2023 2022 Interest Rate Contracts Foreign Exchange Contracts Interest Rate Contracts Foreign Exchange Contracts Derivatives: Qualifying for hedge accounting Location of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income into Income Net investment income Net investment income and Net gains/(losses) Net investment income Net investment income and Net gains/(losses) Amount of Gain or (Loss) Recognized in Other Comprehensive Income $ — $ (12) $ (1) $ 7 Amount of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income — 3 — 3 The location and amount of gain (loss) recognized in the Condensed Consolidated Statements of Operations for derivatives qualifying for hedge accounting are as follows for the periods indicated: Three Months Ended March 31, 2023 2022 Net investment income Net gains/(losses) Net investment income Net gains/(losses) Total amounts of line items presented in the statement of operations in which the effects of fair value or cash flow hedges are recorded $ 545 $ (16) $ 630 $ (288) Derivatives: Qualifying for hedge accounting Fair value hedges: Foreign exchange contracts: Hedged items — 2 — (2) Derivatives designated as hedging instruments (1) — (1) — 2 Cash flow hedges: Foreign exchange contracts: Gain (loss) reclassified from accumulated other comprehensive income into income 3 — 3 — (1) For the three months ended March 31, 2023, $1 of the change in derivative instruments designated and qualifying as fair value hedges was excluded from the assessment of hedge effectiveness and recognized currently in earning. For the three months ended March 31, 2022, an immaterial portion of the change in derivative instruments designated and qualifying as fair value hedges was excluded from the assessment of hedge effectiveness and recognized currently in earning. The location and effect of derivatives not designated as hedging instruments on the Condensed Consolidated Statements of Operations are as follows for the periods indicated: Location of Gain or (Loss) on Derivative Three Months Ended March 31, 2023 2022 Derivatives: Non-qualifying for hedge accounting Interest rate contracts Net gains (losses) $ (56) $ 100 Foreign exchange contracts Net gains (losses) 1 (1) Equity contracts Net gains (losses) 3 (8) Credit contracts Net gains (losses) (1) — Embedded derivatives and Managed custody guarantees: Within fixed maturity investments Net gains (losses) 1 (4) Within reinsurance agreements (1) Policyholder benefits (26) 92 Managed custody guarantees Net gains (losses) 3 (3) Total $ (75) $ 176 (1) For the three months ended March 31, 2023, the amount excludes immaterial gains (losses) from standalone derivatives that were recognized in Net gains (losses). For the three months ended March 31, 2022, the amount excluded gains (losses) of $1, respectively, from standalone derivatives recognized in Net gains (losses).

Fair Value Measurements (excl_2

Fair Value Measurements (excluding Consolidated Investment Entities) (Tables)	3 Months Ended
	Mar. 31, 2023
Fair Value Disclosures [Abstract]
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis	The following table presents the Company's hierarchy for its assets and liabilities measured at fair value on a recurring basis as of March 31, 2023: Level 1 Level 2 Level 3 Total Assets: Fixed maturities, including securities pledged: U.S. Treasuries $ 373 $ 59 $ — $ 432 U.S. Government agencies and authorities — 56 1 57 State, municipalities and political subdivisions — 853 — 853 U.S. corporate public securities — 8,269 21 8,290 U.S. corporate private securities — 2,980 1,800 4,780 Foreign corporate public securities and foreign governments (1) — 2,957 — 2,957 Foreign corporate private securities (1) — 2,551 441 2,992 Residential mortgage-backed securities — 3,921 56 3,977 Commercial mortgage-backed securities — 3,842 — 3,842 Other asset-backed securities — 2,211 77 2,288 Total fixed maturities, including securities pledged 373 27,699 2,396 30,468 Equity securities 116 — 192 308 Derivatives: Interest rate contracts 3 273 — 276 Foreign exchange contracts — 62 — 62 Equity contracts — 4 — 4 Embedded derivative on reinsurance — 72 — 72 Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements 1,982 21 — 2,003 Assets held in separate accounts 78,617 5,603 349 84,569 Total assets $ 81,091 $ 33,734 $ 2,937 $ 117,762 Percentage of Level to total 69 % 29 % 2 % 100 % Liabilities: Contingent consideration $ — $ — $ 112 $ 112 Stabilizer and MCGs — — 3 3 Derivatives: Interest rate contracts 1 366 — 367 Foreign exchange contracts — 3 — 3 Equity contracts 1 1 — 2 Credit contracts — 4 — 4 Embedded derivative on reinsurance — (9) (2) 58 49 Total liabilities $ 2 $ 365 $ 173 $ 540 (1) Primarily U.S. dollar denominated. (2) The Company classifies the embedded derivative within liabilities given the underlying nature of the balance and the right-of-offset. The following table presents the Company's hierarchy for its assets and liabilities measured at fair value on a recurring basis as of December 31, 2022: Level 1 Level 2 Level 3 Total Assets: Fixed maturities, including securities pledged: U.S. Treasuries $ 433 $ 148 $ — $ 581 U.S. Government agencies and authorities — 58 1 59 State, municipalities and political subdivisions — 845 — 845 U.S. corporate public securities — 8,181 20 8,201 U.S. corporate private securities — 2,891 1,801 4,692 Foreign corporate public securities and foreign governments (1) — 2,946 3 2,949 Foreign corporate private securities (1) — 2,602 432 3,034 Residential mortgage-backed securities — 3,949 28 3,977 Commercial mortgage-backed securities — 3,883 — 3,883 Other asset-backed securities — 2,072 64 2,136 Total fixed maturities, including securities pledged 433 27,575 2,349 30,357 Equity securities 140 — 196 336 Derivatives: Interest rate contracts 2 339 — 341 Foreign exchange contracts — 80 — 80 Equity contracts — 1 — 1 Embedded derivative on reinsurance — 95 — 95 Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements 2,430 24 — 2,454 Assets held in separate accounts 74,600 5,227 347 80,174 Total assets $ 77,605 $ 33,341 $ 2,892 $ 113,838 Percentage of Level to total 68 % 29 % 3 % 100 % Liabilities: Contingent consideration $ — $ — $ 112 $ 112 Stabilizer and MCGs — — 6 6 Derivatives: Interest rate contracts 3 373 — 376 Foreign exchange contracts — 10 — 10 Equity contracts — 1 — 1 Credit contracts — 2 — 2 Embedded derivative on reinsurance — (12) (2) 58 46 Total liabilities $ 3 $ 374 $ 176 $ 553 (1) Primarily U.S. dollar denominated. (2) The Company classifies the embedded derivative within liabilities given the underlying nature of the balance and the right-of-offset.
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation	The following tables summarize the change in fair value of the Company's Level 3 assets and liabilities and transfers in and out of Level 3 for the periods indicated: Three Months Ended March 31, 2023 Fair Value as of January 1 Realized/Unrealized Purchases Issuances Sales Settlements Transfers Transfers Fair Value as of March 31 Change In (3) Change In Unrealized Gains (Losses) Included in OCI (3) Net OCI Fixed maturities, including securities pledged: U.S. Government agencies and authorities $ 1 $ — $ — $ — $ — $ — $ — $ — $ — $ 1 $ — $ — U.S. corporate public securities 20 — — 1 — — — — — 21 — — U.S. corporate private securities 1,801 1 34 40 — — (76) — — 1,800 1 34 Foreign corporate public securities and foreign governments (1) 3 — — — — — — — (3) — — — Foreign corporate private securities (1) 432 1 4 57 — — (53) — — 441 1 4 Residential mortgage-backed securities 28 — — 28 — — — — — 56 — — Other asset-backed securities 64 — 1 34 — — (1) — (21) 77 — 1 Total fixed maturities, including securities pledged 2,349 2 39 160 — — (130) — (24) 2,396 2 39 Equity securities, at fair value 196 (4) — — — — — — — 192 (3) — Contingent consideration (112) — — — — — — — — (112) — — Stabilizer and MCGs (2) (6) 4 — — (1) — — — — (3) — — Embedded derivatives on reinsurance (58) — — — — — — — — (58) — — Assets held in separate accounts (4) 347 4 — — — (2) — — — 349 — — (1) Primarily U.S. dollar denominated. (2) All gains and losses on Level 3 liabilities are classified as realized gains (losses) for the purpose of this disclosure because it is impracticable to track realized and unrealized gains (losses) separately on a contract by contract basis. These amounts are included in Net gains (losses) in the Condensed Consolidated Statements of Operations. (3) For financial instruments still held as of March 31 amounts are included in Net investment income and Net gains (losses) in the Condensed Consolidated Statements of Operations or Unrealized gains (losses) on securities in the Condensed Consolidated Statements of Comprehensive Income. (4) The investment income and realized gains (losses) and change in unrealized gains (losses) included in net income for separate account assets are offset by an equal amount for separate account liabilities, which results in a net zero impact on Net income (loss) for the Company. Three Months Ended March 31, 2022 Fair Value as of January 1 Realized/Unrealized Purchases Issuances Sales Settlements Transfers Transfers Fair Value as of March 31 Change In (3) Change In Unrealized Gains (Losses) Included in OCI (3) Net OCI Fixed maturities, including securities pledged: U.S. corporate public securities $ 16 $ — $ (2) $ 21 $ — $ — $ — $ 36 $ — $ 71 $ — $ (2) U.S. corporate private securities 1,910 (1) (145) 111 — — (61) 121 (10) 1,925 (1) (145) Foreign corporate public securities and foreign governments (1) — — — 11 — — — — — 11 — — Foreign corporate private securities (1) 353 (18) (24) 50 — — (13) 148 — 496 — (24) Residential mortgage-backed securities 43 (9) — 13 — — — — (2) 45 (9) — Other asset-backed securities 44 — (2) 18 — (10) (1) — — 49 — (2) Total fixed maturities, including securities pledged 2,366 (28) (173) 224 — (10) (75) 305 (12) 2,597 (10) (173) Equity securities, at fair value 203 (10) — — — — — 10 — 203 (10) — Contingent consideration (11) — — — — — — — — (11) — — Stabilizer and MCGs (2) (20) 6 — — (1) — — — — (15) — — Embedded derivatives on (87) 1 — — — — — — — (86) — — Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements — — — 8 — — — — — 8 — — Assets held in separate accounts (4) 316 (14) — 65 — (1) — 6 (38) 334 — — (1) Primarily U.S. dollar denominated. (2) All gains and losses on Level 3 liabilities are classified as realized gains (losses) for the purpose of this disclosure because it is impracticable to track realized and unrealized gains (losses) separately on a contract by contract basis. These amounts are included in Net gains (losses) in the Condensed Consolidated Statements of Operations. (3) For financial instruments still held as of March 31, amounts are included in Net investment income and Net gains (losses) in the Condensed Consolidated Statements of Operations or Unrealized gains (losses) on securities in the Condensed Consolidated Statements of Comprehensive Income.
Fair Value, by Balance Sheet Grouping	The carrying values and estimated fair values of the Company's financial instruments as of the dates indicated: March 31, 2023 December 31, 2022 Carrying Fair Carrying Fair Assets: Fixed maturities, including securities pledged $ 30,468 $ 30,468 $ 30,357 $ 30,357 Equity securities 308 308 336 336 Mortgage loans on real estate 5,346 5,078 5,445 5,149 Policy loans 359 359 363 363 Cash, cash equivalents, short-term investments and short-term investments under securities loan agreements 2,003 2,003 2,454 2,454 Derivatives 342 342 422 422 Embedded derivatives on reinsurance 72 72 95 95 Other investments 70 70 68 68 Assets held in separate accounts 84,569 84,569 80,174 80,174 Liabilities: Investment contract liabilities: Funding agreements without fixed maturities and deferred annuities (1) $ 34,958 $ 36,635 $ 35,707 $ 36,385 Funding agreements with fixed maturities 1,360 1,358 1,285 1,281 Supplementary contracts, immediate annuities and other 701 640 727 636 Stabilizer and MCGs 3 3 6 6 Derivatives 376 376 389 389 Embedded derivative on reinsurance 49 49 46 46 Short-term debt 143 144 141 142 Long-term debt 2,094 1,935 2,094 1,935 (1) Certain amounts included in Funding agreements without fixed maturities and deferred annuities are also reflected within the Stabilizer and MCGs section of the table above. The following table summarizes the fair value hierarchy levels of consolidated investment entities as of March 31, 2023: Level 1 Level 2 Level 3 NAV Total Assets VIEs Cash and cash equivalents $ 100 $ — $ — $ — $ 100 Corporate loans — 1,232 — — 1,232 Limited partnerships/corporations — — — 3,009 3,009 Total assets $ 100 $ 1,232 $ — $ 3,009 $ 4,341 Liabilities VIEs CLO notes $ — $ 1,256 $ — $ — $ 1,256 Total liabilities $ — $ 1,256 $ — $ — $ 1,256 The following table summarizes the fair value hierarchy levels of consolidated investment entities as of December 31, 2022: Level 1 Level 2 Level 3 NAV Total Assets VIEs Cash and cash equivalents $ 88 $ — $ — $ — $ 88 Corporate loans — 1,293 — — 1,293 Limited partnerships/corporations — — — 2,802 2,802 Total assets $ 88 $ 1,293 $ — $ 2,802 $ 4,183 Liabilities VIEs CLO notes $ — $ 1,234 $ — $ — $ 1,234 Total liabilities $ — $ 1,234 $ — $ — $ 1,234
Financial Instruments Not Carried at Fair Value	The following table presents the classifications of financial instruments which are not carried at fair value on the Condensed Consolidated Balance Sheets: Financial Instrument Classification Mortgage loans on real estate Level 3 Policy loans Level 2 Other investments Level 2 Funding agreements without fixed maturities and deferred annuities Level 3 Funding agreements with fixed maturities Level 2 Supplementary contracts and immediate annuities Level 3 Short-term debt and Long-term debt Level 2

Deferred Policy Acquisition C_2

Deferred Policy Acquisition Costs and Value of Business Acquired (Tables)	3 Months Ended
	Mar. 31, 2023
Deferred Policy Acquisition Costs and Present Value of Future Insurance Profits, Net [Abstract]
Deferred Policy Acquisition Costs and Value of Business Acquired	The following tables present a rollforward of DAC and VOBA for the periods indicated: DAC VOBA Wealth Solutions Deferred and Individual Annuities Businesses exited Balance as of January 1, 2022 $ 691 $ 1,158 $ 473 Deferrals of commissions and expenses 59 — 5 Amortization expense (59) (115) (39) Balance as of December 31, 2022 $ 691 $ 1,043 $ 439 Deferrals of commissions and expenses 15 — 1 Amortization expense (14) (27) (10) Balance as of March 31, 2023 $ 692 $ 1,016 $ 430 The following table shows a reconciliation of DAC and VOBA balances to the Condensed Consolidated Balance Sheets for the periods indicated: March 31, 2023 December 31, 2022 DAC: Wealth Solutions Deferred and Individual Annuities $ 692 $ 691 Businesses exited 1,016 1,043 Other 195 190 VOBA 430 439 Total $ 2,333 $ 2,363

Reinsurance (Tables)

Reinsurance (Tables)	3 Months Ended
	Mar. 31, 2023
Insurance [Abstract]
Effects of Reinsurance	Information regarding the effect of reinsurance on the Condensed Consolidated Balance Sheets is as follows as of the periods indicated: March 31, 2023 Direct Assumed Ceded Total, Assets Premiums receivable $ 190 $ 12 $ (237) $ (35) Reinsurance recoverable, net of allowance for credit losses — — 12,473 12,473 Total $ 190 $ 12 $ 12,236 $ 12,438 Liabilities Future policy benefits and contract owner account balances $ 50,470 $ 1,023 $ — $ 51,493 Liability for funds withheld under reinsurance agreements 111 — — 111 Total $ 50,581 $ 1,023 $ — $ 51,604 December 31, 2022 Direct Assumed Ceded Total, Assets Premiums receivable $ 172 $ 11 $ (212) $ (29) Reinsurance recoverable, net of allowance for credit losses — — 12,455 12,455 Total $ 172 $ 11 $ 12,243 $ 12,426 Liabilities Future policy benefits and contract owner account balances $ 51,137 $ 1,037 $ — $ 52,174 Liability for funds withheld under reinsurance agreements 104 — — 104 Total $ 51,241 $ 1,037 $ — $ 52,278 Information regarding the effect of reinsurance on the Condensed Consolidated Statements of Operations is as follows for the periods indicated: Three Months Ended March 31, 2023 2022 Premiums: Direct premiums $ 908 $ 808 Reinsurance assumed 10 9 Reinsurance ceded (233) (209) Net premiums $ 685 $ 608 Fee income: Gross fee income $ 562 $ 532 Reinsurance assumed 4 5 Reinsurance ceded (102) (104) Net fee income $ 464 $ 433 Interest credited and other benefits to contract owners / policyholders: Direct interest credited and other benefits to contract owners / policyholders $ 1,108 $ 976 Reinsurance assumed 19 8 Reinsurance ceded (376) (340) Net interest credited and other benefits to contract owners / policyholders $ 751 $ 644

Share-based Incentive Compens_2

Share-based Incentive Compensation Plans (Tables)	3 Months Ended
	Mar. 31, 2023
Share-Based Payment Arrangement [Abstract]
Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan	The following table summarizes share-based compensation expense, which includes expenses related to awards granted under the Omnibus Plans for the periods indicated: Three Months Ended March 31, 2023 2022 Restricted Stock Unit (RSU) awards $ 37 $ 22 Performance Stock Unit (PSU) awards 26 24 Total share-based compensation expense 63 46 Income tax benefit 15 15 After-tax share-based compensation expense $ 48 $ 31
Schedule of Share-based Compensation, Activity	The following table summarizes RSU and PSU awards activity under the Omnibus Plans for the periods indicated: RSU Awards PSU Awards (awards in millions) Number of Awards Weighted Average Grant Date Fair Value Number of Awards Weighted Average Grant Date Fair Value Outstanding as of January 1, 2023 1.5 $ 60.91 2.1 $ 55.68 Adjustment for PSU performance factor — — (0.1) 61.50 Granted 1.5 70.42 0.8 76.59 Vested (0.7) 62.53 (0.5) 63.08 Forfeited — * 66.36 — * 63.67 Outstanding as of March 31, 2023 2.3 $ 66.55 2.3 $ 61.03 *Less than 0.1
Schedule of Share-based Compensation, Stock Options, Activity	The following table summarizes the number of options under the Omnibus Plans for the periods indicated: Stock Options (awards in millions) Number of Awards Weighted Average Exercise Price Outstanding as of January 1, 2023 1.6 $ 43.05 Granted — — Exercised (0.3) 38.21 Forfeited — — Outstanding as of March 31, 2023 1.3 $ 44.25 Vested, exercisable, as of March 31, 2023 1.3 $ 44.25

Shareholders' Equity (Tables)

Shareholders' Equity (Tables)	3 Months Ended
	Mar. 31, 2023
Equity [Abstract]
Schedule of Common Stock Outstanding Roll Forward	The following table presents the rollforward of common shares used in calculating the weighted average shares utilized in the basic earnings per common share calculation for the periods indicated: Common Shares (shares in millions) Issued Held in Treasury Outstanding Balance, January 1, 2022 109.0 1.2 107.8 Common shares issued 0.1 — 0.1 Common shares acquired - share repurchase — 11.7 (11.7) Share-based compensation 1.7 0.7 1.0 Treasury Stock retirement (13.0) (13.0) — Balance, December 31, 2022 97.8 0.6 97.2 Common shares issued — * — — Share-based compensation 1.5 0.5 1.0 Balance, March 31, 2023 99.3 1.1 98.2
Schedule of Dividends Declared	Dividends declared per share of Common Stock were as follows for the periods indicated: Three Months Ended March 31, 2023 2022 Dividends declared per share of Common Stock $ 0.200 $ 0.200 The declaration of dividends on preferred stock per share and in the aggregate were as follows for the periods indicated: Series A Series B Three Months Ended March 31, Per Share Aggregate Per Share Aggregate 2023 $ 30.625 $ 10 $ 13.375 $ 4 2022 30.625 10 13.375 4
Schedule of Share Repurchase Agreements
Schedule of Preferred Stock Issued and Outstanding	As of March 31, 2023 and December 31, 2022, there were 100,000,000 shares of preferred stock authorized. Preferred stock issued and outstanding are as follows: March 31, 2023 December 31, 2022 Series Issued Outstanding Issued Outstanding 6.125% Non-cumulative Preferred Stock, Series A 325,000 325,000 325,000 325,000 5.35% Non-cumulative Preferred Stock, Series B 300,000 300,000 300,000 300,000 Total 625,000 625,000 625,000 625,000

Earnings per Common Share (Tabl

Earnings per Common Share (Tables)	3 Months Ended
	Mar. 31, 2023
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	The following table presents a reconciliation of Net income (loss) and shares used in calculating basic and diluted net income (loss) per common share for the periods indicated: Three Months Ended March 31, (in millions, except for per share data) 2023 2022 Earnings Net income (loss) available to common shareholders: Net income (loss) $ 129 $ 111 Less: Preferred stock dividends 14 14 Less: Net income (loss) attributable to noncontrolling interest and redeemable noncontrolling interest 46 43 Net income (loss) available to common shareholders $ 69 $ 54 Weighted average common shares outstanding Basic 97.7 106.1 Dilutive Effects: Warrants 8.9 8.2 RSU awards 1.2 1.0 PSU awards 1.2 1.0 Stock Options 0.6 0.7 Diluted 109.6 117.0 Net income (loss) available to Voya Financial, Inc.'s common shareholders per common share (1) : Basic $ 0.70 $ 0.51 Diluted $ 0.63 $ 0.46 (1) Basic and diluted earnings per share are calculated using unrounded, actual amounts. Therefore, the components of earnings per share may not sum to its corresponding total.

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Income (Loss) (Tables)	3 Months Ended
	Mar. 31, 2023
Equity [Abstract]
Schedule of Accumulated Other Comprehensive Income	Shareholders' equity included the following components of AOCI as of the dates indicated: March 31, 2023 2022 Fixed maturities, net of impairment $ (2,635) $ 602 Derivatives (1) 109 80 Change in discount rate (855) (1,044) Deferred income tax asset (liability) 833 199 Total (2,548) (163) Pension and other postretirement benefits liability, net of tax 3 3 AOCI $ (2,545) $ (160)
Schedule of Amounts Recognized in Other Comprehensive Income (Loss)	Changes in AOCI, including the reclassification adjustments recognized in the Condensed Consolidated Statements of Operations, were as follows for the periods indicated: Three Months Ended March 31, 2023 Before-Tax Amount Income Tax (Benefit) After-Tax Amount Available-for-sale securities: Fixed maturities $ 661 $ (139) $ 522 Adjustments for amounts recognized in Net gains (losses) in the Condensed Consolidated Statements of Operations (1) — (1) Change in unrealized gains (losses) on available-for-sale securities 660 (139) 521 Derivatives: Derivatives (12) (1) 3 (9) Adjustments related to effective cash flow hedges for amounts recognized in Net investment income in the Condensed Consolidated Statements of Operations (5) 1 (4) Change in unrealized gains (losses) on derivatives (17) 4 (13) Change in current discount rate 2 — 2 Change in Accumulated other comprehensive income (loss) $ 645 $ (135) $ 510 (1) See the Derivative Financial Instruments Note to these Condensed Consolidated Financial Statements for additional information. Three Months Ended March 31, 2022 Before-Tax Amount Income Tax (Benefit) After-Tax Amount Available-for-sale securities: Fixed maturities $ (2,663) $ 559 $ (2,104) Adjustments for amounts recognized in Net gains (losses) in the Condensed Consolidated Statements of Operations 70 (15) 55 Change in unrealized gains (losses) on available-for-sale securities (2,593) 544 (2,049) Derivatives: Derivatives 5 (1) (1) 4 Adjustments related to effective cash flow hedges for amounts recognized in Net investment income in the Condensed Consolidated Statements of Operations (5) 1 (4) Change in unrealized gains (losses) on derivatives — — — Change in current discount rate 104 (22) 82 Change in Accumulated other comprehensive income (loss) $ (2,489) $ 522 $ (1,967) (1) See the Derivative Financial Instruments Note to these Condensed Consolidated Financial Statements for additional information.

Financing Agreements (Tables)

Financing Agreements (Tables)	3 Months Ended
	Mar. 31, 2023
Debt Disclosure [Abstract]
Schedule of Long-term Debt Instruments	The following table summarizes the carrying value of the Company’s debt securities issued and outstanding as of the periods indicated: Issuer Maturity March 31, 2023 December 31, 2022 3.65% Senior Notes, due 2026 (2)(3) Voya Financial, Inc. 06/15/2026 $ 445 $ 445 5.7% Senior Notes, due 2043 (2)(3) Voya Financial, Inc. 07/15/2043 396 396 4.8% Senior Notes, due 2046 (2)(3) Voya Financial, Inc. 06/15/2046 297 297 4.7% Fixed-to-Floating Rate Junior Subordinated Notes, due 2048 (1) Voya Financial, Inc. 01/23/2048 336 336 5.65% Fixed-to-Floating Rate Junior Subordinated Notes, due 2053 (4) Voya Financial, Inc. 05/15/2053 388 388 7.25% Voya Holdings Inc. debentures, due 2023 (1) Voya Holdings, Inc. 08/15/2023 140 140 7.63% Voya Holdings Inc. debentures, due 2026 (1) Voya Holdings, Inc. 08/15/2026 139 139 6.97% Voya Holdings Inc. debentures, due 2036 (1) Voya Holdings, Inc. 08/15/2036 79 79 8.42% Equitable of Iowa Companies Capital Trust II Notes, due 2027 Equitable of Iowa Capital Trust II 04/01/2027 13 13 1.00% Windsor Property Loan Voya Retirement Insurance and Annuity Company 06/14/2027 2 2 1.25% Notes, due 2023 Benefitfocus, Inc. 12/15/2023 2 — Subtotal 2,237 2,235 Less: Current portion of long-term debt 143 141 Total $ 2,094 $ 2,094 (1) Guaranteed by ING Group. (2) Interest is paid semi-annually in arrears. (3) Guaranteed by Voya Holdings. (4) See the Junior Subordinated Notes section below.

Commitments and Contingencies (

Commitments and Contingencies (Tables)	3 Months Ended
	Mar. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
Schedule of Restricted Assets	The components of the fair value of the restricted assets were as follows as of the dates indicated: March 31, 2023 December 31, 2022 Fixed maturity collateral pledged to FHLB (1) $ 1,811 $ 1,791 FHLB restricted stock (2) 69 67 Other fixed maturities-state deposits 40 38 Cash and cash equivalents 29 27 Securities pledged (3) 1,226 1,162 Total restricted assets $ 3,175 $ 3,085 (1) Included in Fixed maturities, available for sale, at fair value on the Condensed Consolidated Balance Sheets. (2) Included in Other investments on the Condensed Consolidated Balance Sheets. (3) Includes the fair value of loaned securities of $976 and $907 as of March 31, 2023 and December 31, 2022, respectively. In addition, as of March 31, 2023 and December 31, 2022, the Company delivered securities as collateral of $137 and $142 and repurchase agreements of $113 and $113, respectively. Loaned securities and securities delivered as collateral are included in Securities pledged on the Condensed Consolidated Balance Sheets.

Consolidated and Nonconsolida_2

Consolidated and Nonconsolidated Investment Entities (Tables)	3 Months Ended
	Mar. 31, 2023
Consolidated Investment Entities [Abstract]
Fair Value, by Balance Sheet Grouping	The carrying values and estimated fair values of the Company's financial instruments as of the dates indicated: March 31, 2023 December 31, 2022 Carrying Fair Carrying Fair Assets: Fixed maturities, including securities pledged $ 30,468 $ 30,468 $ 30,357 $ 30,357 Equity securities 308 308 336 336 Mortgage loans on real estate 5,346 5,078 5,445 5,149 Policy loans 359 359 363 363 Cash, cash equivalents, short-term investments and short-term investments under securities loan agreements 2,003 2,003 2,454 2,454 Derivatives 342 342 422 422 Embedded derivatives on reinsurance 72 72 95 95 Other investments 70 70 68 68 Assets held in separate accounts 84,569 84,569 80,174 80,174 Liabilities: Investment contract liabilities: Funding agreements without fixed maturities and deferred annuities (1) $ 34,958 $ 36,635 $ 35,707 $ 36,385 Funding agreements with fixed maturities 1,360 1,358 1,285 1,281 Supplementary contracts, immediate annuities and other 701 640 727 636 Stabilizer and MCGs 3 3 6 6 Derivatives 376 376 389 389 Embedded derivative on reinsurance 49 49 46 46 Short-term debt 143 144 141 142 Long-term debt 2,094 1,935 2,094 1,935 (1) Certain amounts included in Funding agreements without fixed maturities and deferred annuities are also reflected within the Stabilizer and MCGs section of the table above. The following table summarizes the fair value hierarchy levels of consolidated investment entities as of March 31, 2023: Level 1 Level 2 Level 3 NAV Total Assets VIEs Cash and cash equivalents $ 100 $ — $ — $ — $ 100 Corporate loans — 1,232 — — 1,232 Limited partnerships/corporations — — — 3,009 3,009 Total assets $ 100 $ 1,232 $ — $ 3,009 $ 4,341 Liabilities VIEs CLO notes $ — $ 1,256 $ — $ — $ 1,256 Total liabilities $ — $ 1,256 $ — $ — $ 1,256 The following table summarizes the fair value hierarchy levels of consolidated investment entities as of December 31, 2022: Level 1 Level 2 Level 3 NAV Total Assets VIEs Cash and cash equivalents $ 88 $ — $ — $ — $ 88 Corporate loans — 1,293 — — 1,293 Limited partnerships/corporations — — — 2,802 2,802 Total assets $ 88 $ 1,293 $ — $ 2,802 $ 4,183 Liabilities VIEs CLO notes $ — $ 1,234 $ — $ — $ 1,234 Total liabilities $ — $ 1,234 $ — $ — $ 1,234

Intangible Assets, Goodwill and

Intangible Assets, Goodwill and Other (Tables)	3 Months Ended
	Mar. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	The changes in the carrying amount of goodwill reported in the Company's operating segments were as follows: Wealth Solutions Health Solutions Investment Management Consolidated Balance as of January 1, 2022 $ 17 $ 24 $ 31 $ 72 Additions from business combinations — — 255 255 Balance as of December 31, 2022 $ 17 $ 24 $ 286 $ 327 Additions from business combinations — 319 — 319 Balance as of March 31, 2023 $ 17 $ 343 $ 286 $ 646
Schedule of Indefinite-Lived Intangible Assets	The following table presents other intangible assets as of the dates indicated: Weighted March 31, 2023 December 31, 2022 Gross Accumulated Net Gross Accumulated Net Indefinite-life intangibles: Right to manage client assets N/A $ 345 $ — $ 345 $ 345 $ — $ 345 Management contract rights N/A 5 — 5 5 — 5 Total indefinite-life intangibles $ 350 $ — $ 350 $ 350 $ — $ 350 Finite-life intangibles: Management contract rights 19 years $ 741 $ 557 $ 184 $ 741 $ 554 $ 187 Customer relationship lists 17 years 324 114 210 135 111 24 Trademarks 8 years 15 — 15 — — — Computer software 4 years 457 311 146 502 432 70 Total intangible assets $ 1,887 $ 982 $ 905 $ 1,728 $ 1,097 $ 631
Schedule of Finite-Lived Intangible Assets	The following table presents other intangible assets as of the dates indicated: Weighted March 31, 2023 December 31, 2022 Gross Accumulated Net Gross Accumulated Net Indefinite-life intangibles: Right to manage client assets N/A $ 345 $ — $ 345 $ 345 $ — $ 345 Management contract rights N/A 5 — 5 5 — 5 Total indefinite-life intangibles $ 350 $ — $ 350 $ 350 $ — $ 350 Finite-life intangibles: Management contract rights 19 years $ 741 $ 557 $ 184 $ 741 $ 554 $ 187 Customer relationship lists 17 years 324 114 210 135 111 24 Trademarks 8 years 15 — 15 — — — Computer software 4 years 457 311 146 502 432 70 Total intangible assets $ 1,887 $ 982 $ 905 $ 1,728 $ 1,097 $ 631

Segments (Tables)

Segments (Tables)	3 Months Ended
	Mar. 31, 2023
Segment Reporting [Abstract]
Reconciliation of Operating Earnings Before Income Taxes from Segments to Consolidated	The summary below reconciles Adjusted operating earnings before income taxes for the segments to Income (loss) before income taxes for the periods indicated: Three Months Ended March 31, 2023 2022 Adjusted operating earnings before income taxes by segment: Wealth Solutions $ 132 $ 228 Health Solutions 94 21 Investment Management 42 39 Corporate (69) (68) Total including Allianz noncontrolling interest 200 221 Less: Earning (loss) attributable to Allianz noncontrolling interest 8 — Total $ 192 $ 221 Adjustments: Net investment gains (losses) (9) (112) Income (loss) related to businesses exited or to be exited through reinsurance or divestment (33) (36) Income (loss) attributable to noncontrolling interests 46 43 Dividend payments made to preferred shareholders 14 14 Other adjustments (70) (8) Total adjustments to income (loss) before income taxes (51) (99) Income (loss) before income taxes $ 141 $ 122
Reconciliation of Revenue from Segments to Total Revenues	The summary below reconciles Adjusted operating revenues for the segments to Total revenues for the periods indicated: Three Months Ended March 31, 2023 2022 Adjusted operating revenues by segment: Wealth Solutions $ 684 $ 756 Health Solutions 774 647 Investment Management 229 178 Corporate 11 22 Total $ 1,697 $ 1,603 Adjustments: Net investment gains (losses) (14) (120) Revenues related to businesses exited or to be exited through reinsurance or divestment 30 (54) Revenues attributable to noncontrolling interests 60 48 Other adjustments 60 28 Total adjustments to revenues 137 (97) Total revenues $ 1,835 $ 1,506
Schedule of Intersegment Revenues Included in Investment Management Segment	The Investment Management segment revenues include the following intersegment revenues, primarily consisting of asset-based management and administration fees for the periods indicated: Three Months Ended March 31, 2023 2022 Investment Management intersegment revenues $ 22 $ 22
Summary of Financial Information for Segments	The summary below presents Total assets for the Company’s segments as of the dates indicated: March 31, 2023 December 31, 2022 Wealth Solutions $ 115,777 $ 111,701 Health Solutions 3,335 2,668 Investment Management 1,635 1,611 Corporate 26,333 26,712 Total assets, before consolidation (1) 147,080 142,692 Consolidation of investment entities 4,128 3,914 Total assets $ 151,208 $ 146,606 (1) Total assets, before consolidation includes the Company's direct investments in CIEs prior to consolidation, which are accounted for using the equity method or fair value option.

Business, Basis of Presentati_4

Business, Basis of Presentation and Significant Accounting Policies - Narrative (Details) $ in Millions	3 Months Ended
	Mar. 31, 2023 USD ($) segment	Mar. 31, 2022 USD ($)	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)
Number of operating segments | segment	3
Net realized capital gains (losses)	$ (16)	$ (288)
Payments to Acquire Businesses, Gross	558
Goodwill	646		$ 327	$ 72
Finite-Lived Intangible Assets, Gross	1,887		1,728
Amortization of Intangible Assets	20	$ 11
Benefitfocus
Finite-Lived Intangible Assets, Gross	70
Amortization of Intangible Assets	29
Benefitfocus
Payments to Acquire Businesses, Gross	583
Benefitfocus
Payments for Merger Related Costs	595
Other Payments to Acquire Businesses	25
Cash Acquired from Acquisition	49
Goodwill	319
Finite-Lived Intangible Assets, Gross	275
Deferred Tax Assets, Other	45
Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Lease Obligation	91
Customer Relationships
Finite-Lived Intangible Assets, Gross	324		$ 135
Finite-Lived Customer Relationships, Gross	$ 190
Finite-Lived Intangible Asset, Useful Life	17 years
Intangible Assets, Amortization Period
Finite-Lived Intangible Asset, Useful Life	15 years
Intangible Assets, Amortization Period | Benefitfocus
Finite-Lived Intangible Asset, Useful Life	5 years
VIM Holdings
Noncontrolling Interest, Ownership Percentage by Parent	76%
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners	24%

Business, Basis of Presentati_5

Business, Basis of Presentation and Significant Accounting Policies - Adoption of New Pronouncements (Details) - USD ($) $ in Millions		3 Months Ended
	Dec. 31, 2020	Mar. 31, 2023	Dec. 31, 2022	Mar. 31, 2022	Dec. 31, 2021	Jan. 01, 2021
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Deferred Policy Acquisition Cost		$ 2,333	$ 2,363
Present Value of Future Insurance Profits, Net		430	439		$ 473
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest		5,521	4,831	$ 7,184
Finite-Lived Intangible Assets, Gross		1,887	1,728
Wealth Solutions
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Deferred Policy Acquisition Cost		692	691		691
Employee Benefits, Group
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Liability for Future Policy Benefit, Expected Future Policy Benefit, before Reinsurance, after Discount Rate Change		901	881		1,048
Employee Benefits, Voluntary
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Liability for Future Policy Benefit, Expected Future Policy Benefit, before Reinsurance, after Discount Rate Change		297	285		359
business exited
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Deferred Policy Acquisition Cost		1,016	1,043		1,158
Liability for Future Policy Benefit, Expected Future Policy Benefit, before Reinsurance, after Discount Rate Change		$ 8,767	8,639		11,444
Previously Reported
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Present Value of Future Insurance Profits, Net	$ 70
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	11,178		4,831		9,668
Previously Reported | Wealth Solutions
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Deferred Policy Acquisition Cost	119
Previously Reported | Employee Benefits, Group
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Liability for Future Policy Benefit, Expected Future Policy Benefit, before Reinsurance, after Discount Rate Change	822
Previously Reported | Employee Benefits, Voluntary
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Liability for Future Policy Benefit, Expected Future Policy Benefit, before Reinsurance, after Discount Rate Change	188
Previously Reported | business exited
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Deferred Policy Acquisition Cost	1,186
Liability for Future Policy Benefit, Expected Future Policy Benefit, before Reinsurance, after Discount Rate Change	5,448
Revision of Prior Period, Adjustment
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Present Value of Future Insurance Profits, Net						$ 705
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest						11,336
Revision of Prior Period, Adjustment | Wealth Solutions
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Deferred Policy Acquisition Cost						690
Revision of Prior Period, Adjustment | Employee Benefits, Group
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Liability for Future Policy Benefit, Expected Future Policy Benefit, before Reinsurance, after Discount Rate Change						947
Liability for Future Policy Benefit, Remeasurement Gain (Loss)	118
Revision of Prior Period, Adjustment | Employee Benefits, Voluntary
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Liability for Future Policy Benefit, Expected Future Policy Benefit, before Reinsurance, after Discount Rate Change						274
Liability for Future Policy Benefit, Remeasurement Gain (Loss)	83
Revision of Prior Period, Adjustment | business exited
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Deferred Policy Acquisition Cost						1,290
Liability for Future Policy Benefit, Expected Future Policy Benefit, before Reinsurance, after Discount Rate Change						6,427
Liability for Future Policy Benefit, Remeasurement Gain (Loss)	1,362
Effect of Modified Retrospective Application Accounting Standards Update 2018-12 [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest						$ 158
Effect of Modified Retrospective Application Accounting Standards Update 2018-12 [Member] | Employee Benefits, Group
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Liability for Future Policy Benefit, Expected Future Policy Benefit, before Reinsurance, after Discount Rate Change	7
Effect of Modified Retrospective Application Accounting Standards Update 2018-12 [Member] | Employee Benefits, Voluntary
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Liability for Future Policy Benefit, Expected Future Policy Benefit, before Reinsurance, after Discount Rate Change	3
Effect of Modified Retrospective Application Accounting Standards Update 2018-12 [Member] | business exited
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Liability for Future Policy Benefit, Expected Future Policy Benefit, before Reinsurance, after Discount Rate Change	3
Intangible Assets, Amortization Period
Finite-Lived Intangible Asset, Useful Life		15 years
Accumulated Other Comprehensive Income (Loss)
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest		$ (2,545)		(160)
Accumulated Other Comprehensive Income (Loss) | Previously Reported
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest			(3,055)		1,807
Accumulated Other Comprehensive Income (Loss) | Revision of Prior Period, Adjustment
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Liability for Future Policy Benefits, Period Increase (Decrease)	635
Liability for Future Policy Benefit, Remeasurement Gain (Loss)	(1,065)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	1,328
Accumulated Other Comprehensive Income (Loss) | Revision of Prior Period, Adjustment | Wealth Solutions
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Deferred Policy Acquisition Cost	571
Accumulated Other Comprehensive Income (Loss) | Revision of Prior Period, Adjustment | Employee Benefits, Group
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Liability for Future Policy Benefit, Expected Future Policy Benefit, before Reinsurance, after Discount Rate Change	0
Accumulated Other Comprehensive Income (Loss) | Revision of Prior Period, Adjustment | Employee Benefits, Voluntary
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Liability for Future Policy Benefit, Expected Future Policy Benefit, before Reinsurance, after Discount Rate Change	0
Accumulated Other Comprehensive Income (Loss) | Revision of Prior Period, Adjustment | business exited
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Deferred Policy Acquisition Cost	104
Liability for Future Policy Benefit, Expected Future Policy Benefit, before Reinsurance, after Discount Rate Change	(386)
Accumulated Other Comprehensive Income (Loss) | Effect of Modified Retrospective Application Accounting Standards Update 2018-12 [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	263
Retained Earnings, Unappropriated [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest		(118)	$ (201)	$ (1,102)	$ (1,170)
Retained Earnings, Unappropriated [Member] | Revision of Prior Period, Adjustment
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Market Risk Benefit, after Increase (Decrease) from Instrument-Specific Credit Risk	(132)
Other Adjustments	27
Retained Earnings, Unappropriated [Member] | Effect of Modified Retrospective Application Accounting Standards Update 2018-12 [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	$ (105)
Benefitfocus
Finite-Lived Intangible Assets, Gross		$ 275

Investments (excluding Consol_3

Investments (excluding Consolidated Investment Entities) - Fixed Maturities (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Available-for-sale Securities, Including Securities Pledged [Line Items]
Fixed maturities, amortized cost	$ 29,534	$ 30,202
Securities pledged, amortized costs	1,347	1,303
Fixed maturities, allowance for credit losses	12
U.S. Treasuries
Available-for-sale Securities, Including Securities Pledged [Line Items]
Fixed maturities, amortized cost	428	590
Gross Unrealized Capital Gains	15	12
Gross Unrealized Capital Losses	11	21
Embedded Derivatives	0	0
Fixed maturities, available-for-sale, at fair value	432	581
Fixed maturities, allowance for credit losses	0	0
U.S. Government agencies and authorities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Fixed maturities, amortized cost	54	58
Gross Unrealized Capital Gains	4	3
Gross Unrealized Capital Losses	1	2
Embedded Derivatives	0	0
Fixed maturities, available-for-sale, at fair value	57	59
Fixed maturities, allowance for credit losses	0	0
State, municipalities and political subdivisions
Available-for-sale Securities, Including Securities Pledged [Line Items]
Fixed maturities, amortized cost	949	978
Gross Unrealized Capital Gains	2	1
Gross Unrealized Capital Losses	98	134
Embedded Derivatives	0	0
Fixed maturities, available-for-sale, at fair value	853	845
Fixed maturities, allowance for credit losses	0	0
U.S. corporate public securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Fixed maturities, amortized cost	9,132	9,343
Gross Unrealized Capital Gains	156	97
Gross Unrealized Capital Losses	998	1,239
Embedded Derivatives	0	0
Fixed maturities, available-for-sale, at fair value	8,290	8,201
Fixed maturities, allowance for credit losses	0	0
U.S. corporate private securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Fixed maturities, amortized cost	5,088	5,087
Gross Unrealized Capital Gains	32	14
Gross Unrealized Capital Losses	340	409
Embedded Derivatives	0	0
Fixed maturities, available-for-sale, at fair value	4,780	4,692
Fixed maturities, allowance for credit losses	0	0
Foreign corporate public securities and foreign governments
Available-for-sale Securities, Including Securities Pledged [Line Items]
Fixed maturities, amortized cost	3,259	3,343
Gross Unrealized Capital Gains	38	18
Gross Unrealized Capital Losses	331	403
Embedded Derivatives	0	0
Fixed maturities, available-for-sale, at fair value	2,957	2,949
Fixed maturities, allowance for credit losses	9	9
Foreign corporate private securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Fixed maturities, amortized cost	3,151	3,254
Gross Unrealized Capital Gains	14	7
Gross Unrealized Capital Losses	171	225
Embedded Derivatives	0	0
Fixed maturities, available-for-sale, at fair value	2,992	3,034
Fixed maturities, allowance for credit losses	2	2
Residential mortgage-backed
Available-for-sale Securities, Including Securities Pledged [Line Items]
Fixed maturities, amortized cost	4,190	4,230
Gross Unrealized Capital Gains	40	34
Gross Unrealized Capital Losses	257	290
Embedded Derivatives	4	3
Fixed maturities, available-for-sale, at fair value	3,977	3,977
Fixed maturities, allowance for credit losses	0	0
Commercial mortgage-backed securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Fixed maturities, amortized cost	4,415	4,466
Gross Unrealized Capital Gains	1	2
Gross Unrealized Capital Losses	574	585
Embedded Derivatives	0	0
Fixed maturities, available-for-sale, at fair value	3,842	3,883
Fixed maturities, allowance for credit losses	0	0
Other asset-backed securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Fixed maturities, amortized cost	2,439	2,307
Gross Unrealized Capital Gains	7	3
Gross Unrealized Capital Losses	157	173
Embedded Derivatives	0	0
Fixed maturities, available-for-sale, at fair value	2,288	2,136
Fixed maturities, allowance for credit losses	1	1
Fixed maturities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Fixed maturities, amortized cost	33,105	33,656
Gross Unrealized Capital Gains	309	191
Gross Unrealized Capital Losses	2,938	3,481
Embedded Derivatives	4	3
Fixed maturities, available-for-sale, at fair value	30,468	30,357
Total fixed maturities, less securities pledged, Amortized Cost	31,758	32,353
Total fixed maturities, less securities pledged, Gross Unrealized Capital Gains	309	188
Total fixed maturities, less securities pledged, Gross Unrealized Capital Losses	2,817	3,337
Total fixed maturities, less securities pledged, Fair Value	29,242	29,195
Fixed maturities, allowance for credit losses	12	12
Collateral Pledged
Available-for-sale Securities, Including Securities Pledged [Line Items]
Securities pledged	1,226	1,162
Collateral Pledged | Fixed maturities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Embedded Derivatives	0	0
Securities pledged, amortized costs	1,347	1,303
Securities pledged, Gross Unrealized Capital Gains	0	3
Securities pledged, Gross Unrealized Capital Losses	121	144
Securities pledged	1,226	1,162
Fixed maturities, allowance for credit losses	$ 0	$ 0

Investments (excluding Consol_4

Investments (excluding Consolidated Investment Entities) - Debt Maturities (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Available-for-sale Securities, Including Securities Pledged [Line Items]
Fixed maturities, amortized cost	$ 29,534	$ 30,202
Communications
Available-for-sale Securities, Including Securities Pledged [Line Items]
Fixed maturities, amortized cost	1,184	1,156
Fixed maturities, available-for-sale, at fair value	1,110	1,042
Gross Unrealized Capital Gains	27	16
Gross Unrealized Capital Losses	101	130
Financial
Available-for-sale Securities, Including Securities Pledged [Line Items]
Fixed maturities, amortized cost	4,008	4,153
Fixed maturities, available-for-sale, at fair value	3,631	3,693
Gross Unrealized Capital Gains	48	31
Gross Unrealized Capital Losses	425	491
Industrial and other companies
Available-for-sale Securities, Including Securities Pledged [Line Items]
Fixed maturities, amortized cost	8,136	8,379
Fixed maturities, available-for-sale, at fair value	7,448	7,452
Gross Unrealized Capital Gains	60	26
Gross Unrealized Capital Losses	748	953
Energy
Available-for-sale Securities, Including Securities Pledged [Line Items]
Fixed maturities, amortized cost	1,987	1,979
Fixed maturities, available-for-sale, at fair value	1,915	1,858
Gross Unrealized Capital Gains	55	39
Gross Unrealized Capital Losses	127	160
Utilities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Fixed maturities, amortized cost	3,648	3,664
Fixed maturities, available-for-sale, at fair value	3,402	3,330
Gross Unrealized Capital Gains	40	21
Gross Unrealized Capital Losses	286	355
Transportation
Available-for-sale Securities, Including Securities Pledged [Line Items]
Fixed maturities, amortized cost	1,115	1,165
Fixed maturities, available-for-sale, at fair value	1,020	1,039
Gross Unrealized Capital Gains	5	2
Gross Unrealized Capital Losses	100	128
Total
Available-for-sale Securities, Including Securities Pledged [Line Items]
Fixed maturities, amortized cost	20,078	20,496
Fixed maturities, available-for-sale, at fair value	18,526	18,414
Gross Unrealized Capital Gains	235	135
Gross Unrealized Capital Losses	1,787	2,217
Fixed maturities
Available-for-sale Securities, Including Securities Pledged [Line Items]
One year or less, Amortized Cost	679
One year or less, Fair Value	676
After one year through five years, Amortized Cost	4,276
After one year through five years, Fair Value	4,086
After five years through ten years, Amortized Cost	4,206
After five years through ten years, Fair Value	4,014
After ten years, Amortized Cost	12,900
After ten years, Fair Value	11,585
Fixed maturities, amortized cost	33,105	33,656
Fixed maturities, available-for-sale, at fair value	30,468	30,357
Gross Unrealized Capital Gains	309	191
Gross Unrealized Capital Losses	2,938	3,481
Mortgage-backed securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Without single maturity date, Amortized Cost	8,605
Without single maturity date, Fair Value	7,819
Other asset-backed securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Without single maturity date, Amortized Cost	2,439
Without single maturity date, Fair Value	2,288
Fixed maturities, amortized cost	2,439	2,307
Fixed maturities, available-for-sale, at fair value	2,288	2,136
Gross Unrealized Capital Gains	7	3
Gross Unrealized Capital Losses	$ 157	$ 173

Investments (excluding Consol_5

Investments (excluding Consolidated Investment Entities) - Composition of US and Foreign Corporate Securities (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Schedule of Available for Sale, including Securities Pledged [Line Items]
Fixed maturities, amortized cost	$ 29,534	$ 30,202
Securities pledged
Schedule of Available for Sale, including Securities Pledged [Line Items]
Securities pledged under repurchase agreements, carrying value	$ 113	$ 113
Mortgage-backed securities
Schedule of Available for Sale, including Securities Pledged [Line Items]
Percent collateralized mortgage backed securities including interest-only strip or principal-only strip	45.20%	41.60%
Fixed maturities
Schedule of Available for Sale, including Securities Pledged [Line Items]
Fixed maturities, amortized cost	$ 33,105	$ 33,656
Gross Unrealized Capital Gains	309	191
Gross Unrealized Capital Losses	2,938	3,481
Fixed maturities, available-for-sale, at fair value	30,468	30,357
Collateral Pledged
Schedule of Available for Sale, including Securities Pledged [Line Items]
Securities Sold under Agreements to Repurchase, Asset	0
Communications
Schedule of Available for Sale, including Securities Pledged [Line Items]
Fixed maturities, amortized cost	1,184	1,156
Gross Unrealized Capital Gains	27	16
Gross Unrealized Capital Losses	101	130
Fixed maturities, available-for-sale, at fair value	1,110	1,042
Financial
Schedule of Available for Sale, including Securities Pledged [Line Items]
Fixed maturities, amortized cost	4,008	4,153
Gross Unrealized Capital Gains	48	31
Gross Unrealized Capital Losses	425	491
Fixed maturities, available-for-sale, at fair value	3,631	3,693
Industrial and other companies
Schedule of Available for Sale, including Securities Pledged [Line Items]
Fixed maturities, amortized cost	8,136	8,379
Gross Unrealized Capital Gains	60	26
Gross Unrealized Capital Losses	748	953
Fixed maturities, available-for-sale, at fair value	7,448	7,452
Energy
Schedule of Available for Sale, including Securities Pledged [Line Items]
Fixed maturities, amortized cost	1,987	1,979
Gross Unrealized Capital Gains	55	39
Gross Unrealized Capital Losses	127	160
Fixed maturities, available-for-sale, at fair value	1,915	1,858
Utilities
Schedule of Available for Sale, including Securities Pledged [Line Items]
Fixed maturities, amortized cost	3,648	3,664
Gross Unrealized Capital Gains	40	21
Gross Unrealized Capital Losses	286	355
Fixed maturities, available-for-sale, at fair value	3,402	3,330
Transportation
Schedule of Available for Sale, including Securities Pledged [Line Items]
Fixed maturities, amortized cost	1,115	1,165
Gross Unrealized Capital Gains	5	2
Gross Unrealized Capital Losses	100	128
Fixed maturities, available-for-sale, at fair value	1,020	1,039
Total
Schedule of Available for Sale, including Securities Pledged [Line Items]
Fixed maturities, amortized cost	20,078	20,496
Gross Unrealized Capital Gains	235	135
Gross Unrealized Capital Losses	1,787	2,217
Fixed maturities, available-for-sale, at fair value	$ 18,526	$ 18,414

Investments (excluding Consol_6

Investments (excluding Consolidated Investment Entities) - Fixed Maturities and Equity Securities, Repurchase Agreements and Securities Lending (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Available-for-sale Securities, Including Securities Pledged [Line Items]
Initial collateral required, percent of market value of loaned securities	102%
Securities received as collateral	$ 125	$ 135
Payables under securities loan and repurchase agreements, including collateral held	$ 1,328	1,302
Single issuer in excess of total equity	no
Collateral Pledged
Available-for-sale Securities, Including Securities Pledged [Line Items]
Securities pledged	$ 1,226	1,162
Securities pledged as collateral
Available-for-sale Securities, Including Securities Pledged [Line Items]
Securities pledged under repurchase agreements, carrying value	113	113
Fair value of loaned securities	976	907
Short-term Investments
Available-for-sale Securities, Including Securities Pledged [Line Items]
Securities received as collateral	879	807
Cash collateral, included in Payables
Available-for-sale Securities, Including Securities Pledged [Line Items]
Payables under securities loan and repurchase agreements, including collateral held	$ 879	$ 807
Mortgage-backed securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Percent collateralized mortgage backed securities including interest-only strip or principal-only strip	45.20%	41.60%
U.S. Treasuries
Available-for-sale Securities, Including Securities Pledged [Line Items]
Payables under securities loan and repurchase agreements, including collateral held	$ 7	$ 53
U.S. corporate public securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Payables under securities loan and repurchase agreements, including collateral held	700	604
Foreign corporate public securities and foreign governments
Available-for-sale Securities, Including Securities Pledged [Line Items]
Payables under securities loan and repurchase agreements, including collateral held	297	285
Payables under securities loan agreements
Available-for-sale Securities, Including Securities Pledged [Line Items]
Payables under securities loan and repurchase agreements, including collateral held	1,004	942
Fixed maturities | Collateral Pledged
Available-for-sale Securities, Including Securities Pledged [Line Items]
Securities pledged	$ 1,226	$ 1,162

Investments (excluding Consol_7

Investments (excluding Consolidated Investment Entities) - Allowance for Credit Losses (Details) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Allowance for Loan and Lease Losses [Roll Forward]
Beginning Balance	$ 12	$ 58
Credit losses on securities for which credit losses were not previously recorded		9
Reductions for securities sold during the period	(2)	(57)
Increase (decrease) on securities with allowance recorded in previous period	2	2
Ending Balance	12	12
Fixed maturities, allowance for credit losses	12
Residential mortgage-backed
Allowance for Loan and Lease Losses [Roll Forward]
Beginning Balance	0	1
Credit losses on securities for which credit losses were not previously recorded		0
Reductions for securities sold during the period		0
Increase (decrease) on securities with allowance recorded in previous period		(1)
Ending Balance		0
Fixed maturities, allowance for credit losses	0	0
Commercial mortgage-backed securities
Allowance for Loan and Lease Losses [Roll Forward]
Fixed maturities, allowance for credit losses	0	0
Foreign corporate public securities and foreign governments
Allowance for Loan and Lease Losses [Roll Forward]
Beginning Balance	9	0
Credit losses on securities for which credit losses were not previously recorded		9
Reductions for securities sold during the period	2	0
Increase (decrease) on securities with allowance recorded in previous period	2	0
Ending Balance	9	9
Fixed maturities, allowance for credit losses	9	9
Foreign corporate private securities
Allowance for Loan and Lease Losses [Roll Forward]
Beginning Balance	2	56
Credit losses on securities for which credit losses were not previously recorded		0
Reductions for securities sold during the period	0	(57)
Increase (decrease) on securities with allowance recorded in previous period	0	3
Ending Balance	2	2
Fixed maturities, allowance for credit losses	2	2
Other asset-backed securities
Allowance for Loan and Lease Losses [Roll Forward]
Beginning Balance	1	1
Credit losses on securities for which credit losses were not previously recorded		0
Reductions for securities sold during the period	0	0
Increase (decrease) on securities with allowance recorded in previous period	0	0
Ending Balance	$ 1	$ 1

Investments (excluding Consol_8

Investments (excluding Consolidated Investment Entities) - Unrealized Capital Losses (Details) $ in Millions	Mar. 31, 2023 USD ($) security	Dec. 31, 2022 USD ($) security
Available-for-sale Securities, Including Securities Pledged [Line Items]
Twelve months or less below amortized cost, Fair Value	$ 11,829	$ 20,391
Twelve months or less below amortized cost, Unrealized Capital Loss	$ 739	$ 2,349
Twelve months or less below amortized cost, total number of securities in an unrealized loss position | security	2,040	3,633
More than twelve months below amortized cost, Fair Value	$ 11,382	$ 4,363
More than twelve months below amortized cost, Unrealized Capital Loss	$ 2,199	$ 1,132
More than twelve months below amortized cost, total number of securities in an unrealized loss position | security	2,563	1,187
Total, Fair Value	$ 23,211	$ 24,754
Total Unrealized Capital Losses	$ 2,938	$ 3,481
Total, Number of securities | security	4,603	4,820
U.S. Treasuries
Available-for-sale Securities, Including Securities Pledged [Line Items]
Twelve months or less below amortized cost, Fair Value	$ 106	$ 197
Twelve months or less below amortized cost, Unrealized Capital Loss	$ 1	$ 19
Twelve months or less below amortized cost, total number of securities in an unrealized loss position | security	10	19
More than twelve months below amortized cost, Fair Value	$ 47	$ 9
More than twelve months below amortized cost, Unrealized Capital Loss	$ 10	$ 2
More than twelve months below amortized cost, total number of securities in an unrealized loss position | security	13	7
Total, Fair Value	$ 153	$ 206
Total Unrealized Capital Losses	$ 11	$ 21
Total, Number of securities | security	23	26
State, municipalities and political subdivisions
Available-for-sale Securities, Including Securities Pledged [Line Items]
Twelve months or less below amortized cost, Fair Value	$ 573	$ 751
Twelve months or less below amortized cost, Unrealized Capital Loss	$ 44	$ 121
Twelve months or less below amortized cost, total number of securities in an unrealized loss position | security	206	284
More than twelve months below amortized cost, Fair Value	$ 209	$ 30
More than twelve months below amortized cost, Unrealized Capital Loss	$ 54	$ 13
More than twelve months below amortized cost, total number of securities in an unrealized loss position | security	82	17
Total, Fair Value	$ 782	$ 781
Total Unrealized Capital Losses	$ 98	$ 134
Total, Number of securities | security	288	301
U.S. corporate public securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Twelve months or less below amortized cost, Fair Value	$ 3,181	$ 5,479
Twelve months or less below amortized cost, Unrealized Capital Loss	$ 220	$ 792
Twelve months or less below amortized cost, total number of securities in an unrealized loss position | security	558	1,054
More than twelve months below amortized cost, Fair Value	$ 2,864	$ 1,137
More than twelve months below amortized cost, Unrealized Capital Loss	$ 778	$ 447
More than twelve months below amortized cost, total number of securities in an unrealized loss position | security	733	347
Total, Fair Value	$ 6,045	$ 6,616
Total Unrealized Capital Losses	$ 998	$ 1,239
Total, Number of securities | security	1,291	1,401
U.S. corporate private securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Twelve months or less below amortized cost, Fair Value	$ 2,268	$ 3,569
Twelve months or less below amortized cost, Unrealized Capital Loss	$ 113	$ 322
Twelve months or less below amortized cost, total number of securities in an unrealized loss position | security	243	375
More than twelve months below amortized cost, Fair Value	$ 1,552	$ 458
More than twelve months below amortized cost, Unrealized Capital Loss	$ 227	$ 87
More than twelve months below amortized cost, total number of securities in an unrealized loss position | security	152	32
Total, Fair Value	$ 3,820	$ 4,027
Total Unrealized Capital Losses	$ 340	$ 409
Total, Number of securities | security	395	407
Foreign corporate public securities and foreign governments
Available-for-sale Securities, Including Securities Pledged [Line Items]
Twelve months or less below amortized cost, Fair Value	$ 1,185	$ 2,050
Twelve months or less below amortized cost, Unrealized Capital Loss	$ 76	$ 260
Twelve months or less below amortized cost, total number of securities in an unrealized loss position | security	205	371
More than twelve months below amortized cost, Fair Value	$ 1,008	$ 391
More than twelve months below amortized cost, Unrealized Capital Loss	$ 255	$ 143
More than twelve months below amortized cost, total number of securities in an unrealized loss position | security	230	97
Total, Fair Value	$ 2,193	$ 2,441
Total Unrealized Capital Losses	$ 331	$ 403
Total, Number of securities | security	435	468
Foreign corporate private securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Twelve months or less below amortized cost, Fair Value	$ 1,834	$ 2,728
Twelve months or less below amortized cost, Unrealized Capital Loss	$ 75	$ 211
Twelve months or less below amortized cost, total number of securities in an unrealized loss position | security	138	217
More than twelve months below amortized cost, Fair Value	$ 793	$ 65
More than twelve months below amortized cost, Unrealized Capital Loss	$ 96	$ 14
More than twelve months below amortized cost, total number of securities in an unrealized loss position | security	68	6
Total, Fair Value	$ 2,627	$ 2,793
Total Unrealized Capital Losses	$ 171	$ 225
Total, Number of securities | security	206	223
Residential mortgage-backed
Available-for-sale Securities, Including Securities Pledged [Line Items]
Twelve months or less below amortized cost, Fair Value	$ 782	$ 1,538
Twelve months or less below amortized cost, Unrealized Capital Loss	$ 43	$ 128
Twelve months or less below amortized cost, total number of securities in an unrealized loss position | security	329	536
More than twelve months below amortized cost, Fair Value	$ 964	$ 562
More than twelve months below amortized cost, Unrealized Capital Loss	$ 214	$ 162
More than twelve months below amortized cost, total number of securities in an unrealized loss position | security	447	283
Total, Fair Value	$ 1,746	$ 2,100
Total Unrealized Capital Losses	$ 257	$ 290
Total, Number of securities | security	776	819
Commercial mortgage-backed securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Twelve months or less below amortized cost, Fair Value	$ 1,346	$ 2,628
Twelve months or less below amortized cost, Unrealized Capital Loss	$ 141	$ 390
Twelve months or less below amortized cost, total number of securities in an unrealized loss position | security	213	441
More than twelve months below amortized cost, Fair Value	$ 2,410	$ 1,133
More than twelve months below amortized cost, Unrealized Capital Loss	$ 433	$ 195
More than twelve months below amortized cost, total number of securities in an unrealized loss position | security	438	207
Total, Fair Value	$ 3,756	$ 3,761
Total Unrealized Capital Losses	$ 574	$ 585
Total, Number of securities | security	651	648
Other asset-backed securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Twelve months or less below amortized cost, Fair Value	$ 554	$ 1,430
Twelve months or less below amortized cost, Unrealized Capital Loss	$ 26	$ 104
Twelve months or less below amortized cost, total number of securities in an unrealized loss position | security	138	334
More than twelve months below amortized cost, Fair Value	$ 1,532	$ 578
More than twelve months below amortized cost, Unrealized Capital Loss	$ 131	$ 69
More than twelve months below amortized cost, total number of securities in an unrealized loss position | security	399	191
Total, Fair Value	$ 2,086	$ 2,008
Total Unrealized Capital Losses	$ 157	$ 173
Total, Number of securities | security	537	525
U.S. Government agencies and authorities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Twelve months or less below amortized cost, Fair Value	$ 0	$ 21
Twelve months or less below amortized cost, Unrealized Capital Loss	$ 0	$ 2
Twelve months or less below amortized cost, total number of securities in an unrealized loss position | security	0	2
More than twelve months below amortized cost, Fair Value	$ 3	$ 0
More than twelve months below amortized cost, Unrealized Capital Loss	$ 1	$ 0
More than twelve months below amortized cost, total number of securities in an unrealized loss position | security	1	0
Total, Fair Value	$ 3	$ 21
Total Unrealized Capital Losses	$ 1	$ 2
Total, Number of securities | security	1	2

Investments (excluding Consol_9

Investments (excluding Consolidated Investment Entities) - Unrealized Capital Losses 1 (Details) $ in Millions	3 Months Ended
	Mar. 31, 2023 USD ($) security	Dec. 31, 2022 USD ($) security
Available-for-sale Securities, Including Securities Pledged [Line Items]
Available-for-sale Securities, change in loss position	$ 543
Total Unrealized Capital Losses	2,938	$ 3,481
More than twelve months below amortized cost, Unrealized Capital Loss	$ 2,199	$ 1,132
More than twelve months below amortized cost, total number of securities in an unrealized loss position | security	2,563	1,187
Commercial mortgage-backed securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Total Unrealized Capital Losses	$ 574	$ 585
More than twelve months below amortized cost, Unrealized Capital Loss	$ 433	$ 195
More than twelve months below amortized cost, total number of securities in an unrealized loss position | security	438	207
Fair value decline below amortized cost greater than 20%
Available-for-sale Securities, Including Securities Pledged [Line Items]
More than twelve months below amortized cost, Unrealized Capital Loss	$ 41
More than twelve months below amortized cost, total number of securities in an unrealized loss position | security	68

Investments (excluding Conso_10

Investments (excluding Consolidated Investment Entities) - OTTI (Details) $ in Millions	3 Months Ended
	Mar. 31, 2023 USD ($) security	Mar. 31, 2022 USD ($) security	Dec. 31, 2022 USD ($) security
Available-for-sale Securities, Including Securities Pledged [Line Items]
Impairment	$ 0	$ 7
No. of Securities | security	2	13
Available-for-sale Securities, Including Securities Pledged, Continuous Unrealized Loss Position Twelve Months or Less, Fair Value	$ 11,829		$ 20,391
Available-for-sale Securities, Including Securities Pledged, Continuous Unrealized Loss Position Twelve Months or Less, Accumulated Loss	$ 739		$ 2,349
Twelve months or less below amortized cost, total number of securities in an unrealized loss position | security	2,040		3,633
More than twelve months below amortized cost, Fair Value	$ 11,382		$ 4,363
More than twelve months below amortized cost, Unrealized Capital Loss	$ 2,199		$ 1,132
More than twelve months below amortized cost, total number of securities in an unrealized loss position | security	2,563		1,187
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	$ 23,211		$ 24,754
Total Unrealized Capital Losses	$ 2,938		$ 3,481
Total, Number of securities | security	4,603		4,820
Allowance for Credit Losses [Line Items]
Impairment	$ 0	$ 7
No. of Securities | security	2	13
Residential mortgage-backed
Available-for-sale Securities, Including Securities Pledged [Line Items]
Impairment	$ 0	$ 7
No. of Securities | security	2	13
Available-for-sale Securities, Including Securities Pledged, Continuous Unrealized Loss Position Twelve Months or Less, Fair Value	$ 782		$ 1,538
Available-for-sale Securities, Including Securities Pledged, Continuous Unrealized Loss Position Twelve Months or Less, Accumulated Loss	$ 43		$ 128
Twelve months or less below amortized cost, total number of securities in an unrealized loss position | security	329		536
More than twelve months below amortized cost, Fair Value	$ 964		$ 562
More than twelve months below amortized cost, Unrealized Capital Loss	$ 214		$ 162
More than twelve months below amortized cost, total number of securities in an unrealized loss position | security	447		283
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	$ 1,746		$ 2,100
Total Unrealized Capital Losses	$ 257		$ 290
Total, Number of securities | security	776		819
Allowance for Credit Losses [Line Items]
Impairment	$ 0	$ 7
No. of Securities | security	2	13
Commercial mortgage-backed securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Available-for-sale Securities, Including Securities Pledged, Continuous Unrealized Loss Position Twelve Months or Less, Fair Value	$ 1,346		$ 2,628
Available-for-sale Securities, Including Securities Pledged, Continuous Unrealized Loss Position Twelve Months or Less, Accumulated Loss	$ 141		$ 390
Twelve months or less below amortized cost, total number of securities in an unrealized loss position | security	213		441
More than twelve months below amortized cost, Fair Value	$ 2,410		$ 1,133
More than twelve months below amortized cost, Unrealized Capital Loss	$ 433		$ 195
More than twelve months below amortized cost, total number of securities in an unrealized loss position | security	438		207
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	$ 3,756		$ 3,761
Total Unrealized Capital Losses	$ 574		$ 585
Total, Number of securities | security	651		648
U.S. Treasuries
Available-for-sale Securities, Including Securities Pledged [Line Items]
Available-for-sale Securities, Including Securities Pledged, Continuous Unrealized Loss Position Twelve Months or Less, Fair Value	$ 106		$ 197
Available-for-sale Securities, Including Securities Pledged, Continuous Unrealized Loss Position Twelve Months or Less, Accumulated Loss	$ 1		$ 19
Twelve months or less below amortized cost, total number of securities in an unrealized loss position | security	10		19
More than twelve months below amortized cost, Fair Value	$ 47		$ 9
More than twelve months below amortized cost, Unrealized Capital Loss	$ 10		$ 2
More than twelve months below amortized cost, total number of securities in an unrealized loss position | security	13		7
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	$ 153		$ 206
Total Unrealized Capital Losses	$ 11		$ 21
Total, Number of securities | security	23		26
U.S. Government agencies and authorities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Available-for-sale Securities, Including Securities Pledged, Continuous Unrealized Loss Position Twelve Months or Less, Fair Value	$ 0		$ 21
Available-for-sale Securities, Including Securities Pledged, Continuous Unrealized Loss Position Twelve Months or Less, Accumulated Loss	$ 0		$ 2
Twelve months or less below amortized cost, total number of securities in an unrealized loss position | security	0		2
More than twelve months below amortized cost, Fair Value	$ 3		$ 0
More than twelve months below amortized cost, Unrealized Capital Loss	$ 1		$ 0
More than twelve months below amortized cost, total number of securities in an unrealized loss position | security	1		0
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	$ 3		$ 21
Total Unrealized Capital Losses	$ 1		$ 2
Total, Number of securities | security	1		2
State, municipalities and political subdivisions
Available-for-sale Securities, Including Securities Pledged [Line Items]
Available-for-sale Securities, Including Securities Pledged, Continuous Unrealized Loss Position Twelve Months or Less, Fair Value	$ 573		$ 751
Available-for-sale Securities, Including Securities Pledged, Continuous Unrealized Loss Position Twelve Months or Less, Accumulated Loss	$ 44		$ 121
Twelve months or less below amortized cost, total number of securities in an unrealized loss position | security	206		284
More than twelve months below amortized cost, Fair Value	$ 209		$ 30
More than twelve months below amortized cost, Unrealized Capital Loss	$ 54		$ 13
More than twelve months below amortized cost, total number of securities in an unrealized loss position | security	82		17
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	$ 782		$ 781
Total Unrealized Capital Losses	$ 98		$ 134
Total, Number of securities | security	288		301
U.S. corporate public securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Available-for-sale Securities, Including Securities Pledged, Continuous Unrealized Loss Position Twelve Months or Less, Fair Value	$ 3,181		$ 5,479
Available-for-sale Securities, Including Securities Pledged, Continuous Unrealized Loss Position Twelve Months or Less, Accumulated Loss	$ 220		$ 792
Twelve months or less below amortized cost, total number of securities in an unrealized loss position | security	558		1,054
More than twelve months below amortized cost, Fair Value	$ 2,864		$ 1,137
More than twelve months below amortized cost, Unrealized Capital Loss	$ 778		$ 447
More than twelve months below amortized cost, total number of securities in an unrealized loss position | security	733		347
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	$ 6,045		$ 6,616
Total Unrealized Capital Losses	$ 998		$ 1,239
Total, Number of securities | security	1,291		1,401
U.S. corporate private securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Available-for-sale Securities, Including Securities Pledged, Continuous Unrealized Loss Position Twelve Months or Less, Fair Value	$ 2,268		$ 3,569
Available-for-sale Securities, Including Securities Pledged, Continuous Unrealized Loss Position Twelve Months or Less, Accumulated Loss	$ 113		$ 322
Twelve months or less below amortized cost, total number of securities in an unrealized loss position | security	243		375
More than twelve months below amortized cost, Fair Value	$ 1,552		$ 458
More than twelve months below amortized cost, Unrealized Capital Loss	$ 227		$ 87
More than twelve months below amortized cost, total number of securities in an unrealized loss position | security	152		32
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	$ 3,820		$ 4,027
Total Unrealized Capital Losses	$ 340		$ 409
Total, Number of securities | security	395		407
Foreign corporate public securities and foreign governments
Available-for-sale Securities, Including Securities Pledged [Line Items]
Available-for-sale Securities, Including Securities Pledged, Continuous Unrealized Loss Position Twelve Months or Less, Fair Value	$ 1,185		$ 2,050
Available-for-sale Securities, Including Securities Pledged, Continuous Unrealized Loss Position Twelve Months or Less, Accumulated Loss	$ 76		$ 260
Twelve months or less below amortized cost, total number of securities in an unrealized loss position | security	205		371
More than twelve months below amortized cost, Fair Value	$ 1,008		$ 391
More than twelve months below amortized cost, Unrealized Capital Loss	$ 255		$ 143
More than twelve months below amortized cost, total number of securities in an unrealized loss position | security	230		97
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	$ 2,193		$ 2,441
Total Unrealized Capital Losses	$ 331		$ 403
Total, Number of securities | security	435		468
Foreign corporate private securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Available-for-sale Securities, Including Securities Pledged, Continuous Unrealized Loss Position Twelve Months or Less, Fair Value	$ 1,834		$ 2,728
Available-for-sale Securities, Including Securities Pledged, Continuous Unrealized Loss Position Twelve Months or Less, Accumulated Loss	$ 75		$ 211
Twelve months or less below amortized cost, total number of securities in an unrealized loss position | security	138		217
More than twelve months below amortized cost, Fair Value	$ 793		$ 65
More than twelve months below amortized cost, Unrealized Capital Loss	$ 96		$ 14
More than twelve months below amortized cost, total number of securities in an unrealized loss position | security	68		6
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	$ 2,627		$ 2,793
Total Unrealized Capital Losses	$ 171		$ 225
Total, Number of securities | security	206		223
Other asset-backed securities
Available-for-sale Securities, Including Securities Pledged [Line Items]
Available-for-sale Securities, Including Securities Pledged, Continuous Unrealized Loss Position Twelve Months or Less, Fair Value	$ 554		$ 1,430
Available-for-sale Securities, Including Securities Pledged, Continuous Unrealized Loss Position Twelve Months or Less, Accumulated Loss	$ 26		$ 104
Twelve months or less below amortized cost, total number of securities in an unrealized loss position | security	138		334
More than twelve months below amortized cost, Fair Value	$ 1,532		$ 578
More than twelve months below amortized cost, Unrealized Capital Loss	$ 131		$ 69
More than twelve months below amortized cost, total number of securities in an unrealized loss position | security	399		191
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	$ 2,086		$ 2,008
Total Unrealized Capital Losses	$ 157		$ 173
Total, Number of securities | security	537		525

Investments (excluding Conso_11

Investments (excluding Consolidated Investment Entities) - Troubled Debt Restructuring (Details) $ in Millions	3 Months Ended	12 Months Ended
	Mar. 31, 2023 USD ($) loan	Dec. 31, 2022 USD ($)
Financing Receivable, Troubled Debt Restructuring [Line Items]
Fixed maturities, allowance for credit losses	$ 12
Increase (decrease) on securities with allowance recorded in previous period	2	$ 2
Reductions for securities sold during the period	2	57
Residential mortgage-backed
Financing Receivable, Troubled Debt Restructuring [Line Items]
Fixed maturities, allowance for credit losses	0	0
Increase (decrease) on securities with allowance recorded in previous period		(1)
Reductions for securities sold during the period		0
Other asset-backed securities
Financing Receivable, Troubled Debt Restructuring [Line Items]
Increase (decrease) on securities with allowance recorded in previous period	0	0
Reductions for securities sold during the period	0	0
Commercial mortgage-backed securities
Financing Receivable, Troubled Debt Restructuring [Line Items]
Fixed maturities, allowance for credit losses	0	0
Foreign corporate public securities and foreign governments
Financing Receivable, Troubled Debt Restructuring [Line Items]
Fixed maturities, allowance for credit losses	9	9
Increase (decrease) on securities with allowance recorded in previous period	2	0
Reductions for securities sold during the period	(2)	0
Foreign corporate private securities
Financing Receivable, Troubled Debt Restructuring [Line Items]
Fixed maturities, allowance for credit losses	2	2
Increase (decrease) on securities with allowance recorded in previous period	0	3
Reductions for securities sold during the period	0	57
U.S. corporate public securities
Financing Receivable, Troubled Debt Restructuring [Line Items]
Fixed maturities, allowance for credit losses	$ 0	$ 0
Commercial mortgage loans
Financing Receivable, Troubled Debt Restructuring [Line Items]
Troubled debt restructuring, number of contracts | loan	0

Investments (excluding Conso_12

Investments (excluding Consolidated Investment Entities) - Loans by Loan to Value (Details) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Schedule of Loans by Loan to Value Ratio [Line Items]
Targeted maximum amount of mortgage loans lended, percent of estimated fair value of underlying real estate	75%
Benchmark loan to value ratio, greater than indicates unpaid loan amount exceeds underlying collateral	100%
Benchmark ratio	100%
Commercial mortgage loans	$ 5,346	$ 5,445
0% - 50%
Schedule of Loans by Loan to Value Ratio [Line Items]
Loan to value ratio, minimum	0%	0%
Loan to value ratio, maximum	50%	50%
Commercial mortgage loans	$ 3,585	$ 3,605
50% - 60%
Schedule of Loans by Loan to Value Ratio [Line Items]
Loan to value ratio, minimum	50%	50%
Loan to value ratio, maximum	60%	60%
Commercial mortgage loans	$ 1,362	$ 1,418
60% - 70%
Schedule of Loans by Loan to Value Ratio [Line Items]
Loan to value ratio, minimum	60%	60%
Loan to value ratio, maximum	70%	70%
Commercial mortgage loans	$ 389	$ 402
70% - 80%
Schedule of Loans by Loan to Value Ratio [Line Items]
Loan to value ratio, minimum	70%	70%
Loan to value ratio, maximum	80%	80%
Commercial mortgage loans	$ 10	$ 20
80% and above
Schedule of Loans by Loan to Value Ratio [Line Items]
Loan to value ratio, minimum	80%	80%
Commercial mortgage loans	$ 0	$ 0
Year of Origination 2023
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	58
Year of Origination 2023 | 0% - 50%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	58
Year of Origination 2023 | 50% - 60%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	0
Year of Origination 2023 | 60% - 70%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	0
Year of Origination 2023 | 70% - 80%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	0
Year of Origination 2023 | 80% and above
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	0
Year of Origination 2022
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	647	635
Year of Origination 2022 | 0% - 50%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	246	250
Year of Origination 2022 | 50% - 60%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	337	320
Year of Origination 2022 | 60% - 70%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	64	65
Year of Origination 2022 | 70% - 80%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2022 | 80% and above
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2021
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	735	777
Year of Origination 2021 | 0% - 50%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	236	240
Year of Origination 2021 | 50% - 60%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	246	272
Year of Origination 2021 | 60% - 70%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	253	255
Year of Origination 2021 | 70% - 80%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	0	10
Year of Origination 2021 | 80% and above
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2020
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	343	363
Year of Origination 2020 | 0% - 50%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	150	119
Year of Origination 2020 | 50% - 60%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	169	209
Year of Origination 2020 | 60% - 70%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	14	25
Year of Origination 2020 | 70% - 80%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	10	10
Year of Origination 2020 | 80% and above
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2019
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	347	350
Year of Origination 2019 | 0% - 50%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	225	227
Year of Origination 2019 | 50% - 60%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	93	94
Year of Origination 2019 | 60% - 70%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	29	29
Year of Origination 2019 | 70% - 80%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2019 | 80% and above
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2018
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	204	206
Year of Origination 2018 | 0% - 50%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	161	163
Year of Origination 2018 | 50% - 60%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	40	41
Year of Origination 2018 | 60% - 70%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	3	2
Year of Origination 2018 | 70% - 80%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2018 | 80% and above
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2017
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	3,012	3,114
Year of Origination 2017 | 0% - 50%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	2,509	2,606
Year of Origination 2017 | 50% - 60%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	477	482
Year of Origination 2017 | 60% - 70%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	26	26
Year of Origination 2017 | 70% - 80%
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2017 | 80% and above
Schedule of Loans by Loan to Value Ratio [Line Items]
Commercial mortgage loans	$ 0	$ 0

Investments (excluding Conso_13

Investments (excluding Consolidated Investment Entities) - Loans by Debt Service Coverage Ratio (Details) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	$ 5,346	$ 5,445
>1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Debt Service Coverage Ratio, minimum	150%	150%
>1.25x - 1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Debt Service Coverage Ratio, minimum	125%	125%
Debt Service Coverage Ratio, maximum	150%	150%
>1.0x - 1.25x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Debt Service Coverage Ratio, minimum	100%	100%
Debt Service Coverage Ratio, maximum	125%	125%
Less than 1.0x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Debt Service Coverage Ratio, maximum	100%	100%
Year of Origination 2023
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	$ 58
Year of Origination 2023 | >1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	51
Year of Origination 2023 | >1.25x - 1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	7
Year of Origination 2023 | >1.0x - 1.25x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	0
Year of Origination 2023 | Less than 1.0x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	0
Year of Origination 2023 | Total
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	58
Year of Origination 2022
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	647	$ 635
Year of Origination 2022 | >1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	278	331
Year of Origination 2022 | >1.25x - 1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	96	100
Year of Origination 2022 | >1.0x - 1.25x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	187	181
Year of Origination 2022 | Less than 1.0x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	86	23
Year of Origination 2022 | Total
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	647	635
Year of Origination 2021
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	735	777
Year of Origination 2021 | >1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	265	273
Year of Origination 2021 | >1.25x - 1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	26	33
Year of Origination 2021 | >1.0x - 1.25x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	113	269
Year of Origination 2021 | Less than 1.0x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	331	202
Year of Origination 2021 | Total
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	735	777
Year of Origination 2020
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	343	363
Year of Origination 2020 | >1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	242	259
Year of Origination 2020 | >1.25x - 1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	27	11
Year of Origination 2020 | >1.0x - 1.25x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	5	11
Year of Origination 2020 | Less than 1.0x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	69	82
Year of Origination 2020 | Total
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	343	363
Year of Origination 2019
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	347	350
Year of Origination 2019 | >1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	220	222
Year of Origination 2019 | >1.25x - 1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	45	54
Year of Origination 2019 | >1.0x - 1.25x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	75	67
Year of Origination 2019 | Less than 1.0x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	7	7
Year of Origination 2019 | Total
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	347	350
Year of Origination 2018
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	204	206
Year of Origination 2018 | >1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	122	128
Year of Origination 2018 | >1.25x - 1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	26	27
Year of Origination 2018 | >1.0x - 1.25x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	56	51
Year of Origination 2018 | Less than 1.0x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2018 | Total
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	204	206
Year of Origination 2017
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	3,012	3,114
Year of Origination 2017 | >1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	2,091	2,172
Year of Origination 2017 | >1.25x - 1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	446	454
Year of Origination 2017 | >1.0x - 1.25x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	226	226
Year of Origination 2017 | Less than 1.0x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	249	262
Year of Origination 2017 | Total
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	3,012	3,114
Total | >1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	3,269	3,385
Total | >1.25x - 1.5x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	673	679
Total | >1.0x - 1.25x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	662	805
Total | Less than 1.0x
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	742	576
Total | Total
Schedule of Loans by Debt Service Coverage Ratio [Line Items]
Commercial mortgage loans	$ 5,346	$ 5,445

Investments (excluding Conso_14

Investments (excluding Consolidated Investment Entities) - Loans by U.S. Region (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Open Option Contracts Written [Line Items]
Commercial mortgage loans	$ 5,346	$ 5,445
Year of Origination 2023
Open Option Contracts Written [Line Items]
Commercial mortgage loans	58
Year of Origination 2023 | Pacific
Open Option Contracts Written [Line Items]
Commercial mortgage loans	20
Year of Origination 2023 | South Atlantic
Open Option Contracts Written [Line Items]
Commercial mortgage loans	0
Year of Origination 2023 | Middle Atlantic
Open Option Contracts Written [Line Items]
Commercial mortgage loans	4
Year of Origination 2023 | West South Central
Open Option Contracts Written [Line Items]
Commercial mortgage loans	0
Year of Origination 2023 | Mountain
Open Option Contracts Written [Line Items]
Commercial mortgage loans	0
Year of Origination 2023 | East North Central
Open Option Contracts Written [Line Items]
Commercial mortgage loans	31
Year of Origination 2023 | New England
Open Option Contracts Written [Line Items]
Commercial mortgage loans	3
Year of Origination 2023 | West North Central
Open Option Contracts Written [Line Items]
Commercial mortgage loans	0
Year of Origination 2023 | East South Central
Open Option Contracts Written [Line Items]
Commercial mortgage loans	0
Year of Origination 2023 | Total
Open Option Contracts Written [Line Items]
Commercial mortgage loans	58
Year of Origination 2022
Open Option Contracts Written [Line Items]
Commercial mortgage loans	647	635
Year of Origination 2022 | Pacific
Open Option Contracts Written [Line Items]
Commercial mortgage loans	140	140
Year of Origination 2022 | South Atlantic
Open Option Contracts Written [Line Items]
Commercial mortgage loans	129	129
Year of Origination 2022 | Middle Atlantic
Open Option Contracts Written [Line Items]
Commercial mortgage loans	48	48
Year of Origination 2022 | West South Central
Open Option Contracts Written [Line Items]
Commercial mortgage loans	99	98
Year of Origination 2022 | Mountain
Open Option Contracts Written [Line Items]
Commercial mortgage loans	114	114
Year of Origination 2022 | East North Central
Open Option Contracts Written [Line Items]
Commercial mortgage loans	93	82
Year of Origination 2022 | New England
Open Option Contracts Written [Line Items]
Commercial mortgage loans	4	4
Year of Origination 2022 | West North Central
Open Option Contracts Written [Line Items]
Commercial mortgage loans	1	1
Year of Origination 2022 | East South Central
Open Option Contracts Written [Line Items]
Commercial mortgage loans	19	19
Year of Origination 2022 | Total
Open Option Contracts Written [Line Items]
Commercial mortgage loans	647	635
Year of Origination 2021
Open Option Contracts Written [Line Items]
Commercial mortgage loans	735	777
Year of Origination 2021 | Pacific
Open Option Contracts Written [Line Items]
Commercial mortgage loans	98	99
Year of Origination 2021 | South Atlantic
Open Option Contracts Written [Line Items]
Commercial mortgage loans	63	72
Year of Origination 2021 | Middle Atlantic
Open Option Contracts Written [Line Items]
Commercial mortgage loans	131	134
Year of Origination 2021 | West South Central
Open Option Contracts Written [Line Items]
Commercial mortgage loans	145	143
Year of Origination 2021 | Mountain
Open Option Contracts Written [Line Items]
Commercial mortgage loans	112	112
Year of Origination 2021 | East North Central
Open Option Contracts Written [Line Items]
Commercial mortgage loans	127	138
Year of Origination 2021 | New England
Open Option Contracts Written [Line Items]
Commercial mortgage loans	9	9
Year of Origination 2021 | West North Central
Open Option Contracts Written [Line Items]
Commercial mortgage loans	48	48
Year of Origination 2021 | East South Central
Open Option Contracts Written [Line Items]
Commercial mortgage loans	2	22
Year of Origination 2021 | Total
Open Option Contracts Written [Line Items]
Commercial mortgage loans	735	777
Year of Origination 2020
Open Option Contracts Written [Line Items]
Commercial mortgage loans	343	363
Year of Origination 2020 | Pacific
Open Option Contracts Written [Line Items]
Commercial mortgage loans	74	74
Year of Origination 2020 | South Atlantic
Open Option Contracts Written [Line Items]
Commercial mortgage loans	161	170
Year of Origination 2020 | Middle Atlantic
Open Option Contracts Written [Line Items]
Commercial mortgage loans	17	18
Year of Origination 2020 | West South Central
Open Option Contracts Written [Line Items]
Commercial mortgage loans	16	16
Year of Origination 2020 | Mountain
Open Option Contracts Written [Line Items]
Commercial mortgage loans	12	12
Year of Origination 2020 | East North Central
Open Option Contracts Written [Line Items]
Commercial mortgage loans	40	39
Year of Origination 2020 | New England
Open Option Contracts Written [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2020 | West North Central
Open Option Contracts Written [Line Items]
Commercial mortgage loans	7	7
Year of Origination 2020 | East South Central
Open Option Contracts Written [Line Items]
Commercial mortgage loans	16	27
Year of Origination 2020 | Total
Open Option Contracts Written [Line Items]
Commercial mortgage loans	343	363
Year of Origination 2019
Open Option Contracts Written [Line Items]
Commercial mortgage loans	347	350
Year of Origination 2019 | Pacific
Open Option Contracts Written [Line Items]
Commercial mortgage loans	57	58
Year of Origination 2019 | South Atlantic
Open Option Contracts Written [Line Items]
Commercial mortgage loans	105	106
Year of Origination 2019 | Middle Atlantic
Open Option Contracts Written [Line Items]
Commercial mortgage loans	10	10
Year of Origination 2019 | West South Central
Open Option Contracts Written [Line Items]
Commercial mortgage loans	76	77
Year of Origination 2019 | Mountain
Open Option Contracts Written [Line Items]
Commercial mortgage loans	46	46
Year of Origination 2019 | East North Central
Open Option Contracts Written [Line Items]
Commercial mortgage loans	5	5
Year of Origination 2019 | New England
Open Option Contracts Written [Line Items]
Commercial mortgage loans	14	14
Year of Origination 2019 | West North Central
Open Option Contracts Written [Line Items]
Commercial mortgage loans	13	13
Year of Origination 2019 | East South Central
Open Option Contracts Written [Line Items]
Commercial mortgage loans	21	21
Year of Origination 2019 | Total
Open Option Contracts Written [Line Items]
Commercial mortgage loans	347	350
Year of Origination 2018
Open Option Contracts Written [Line Items]
Commercial mortgage loans	204	206
Year of Origination 2018 | Pacific
Open Option Contracts Written [Line Items]
Commercial mortgage loans	50	50
Year of Origination 2018 | South Atlantic
Open Option Contracts Written [Line Items]
Commercial mortgage loans	61	62
Year of Origination 2018 | Middle Atlantic
Open Option Contracts Written [Line Items]
Commercial mortgage loans	54	55
Year of Origination 2018 | West South Central
Open Option Contracts Written [Line Items]
Commercial mortgage loans	9	10
Year of Origination 2018 | Mountain
Open Option Contracts Written [Line Items]
Commercial mortgage loans	14	14
Year of Origination 2018 | East North Central
Open Option Contracts Written [Line Items]
Commercial mortgage loans	10	10
Year of Origination 2018 | New England
Open Option Contracts Written [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2018 | West North Central
Open Option Contracts Written [Line Items]
Commercial mortgage loans	6	5
Year of Origination 2018 | East South Central
Open Option Contracts Written [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2018 | Total
Open Option Contracts Written [Line Items]
Commercial mortgage loans	204	206
Year of Origination 2017
Open Option Contracts Written [Line Items]
Commercial mortgage loans	3,012	3,114
Year of Origination 2017 | Pacific
Open Option Contracts Written [Line Items]
Commercial mortgage loans	767	777
Year of Origination 2017 | South Atlantic
Open Option Contracts Written [Line Items]
Commercial mortgage loans	602	623
Year of Origination 2017 | Middle Atlantic
Open Option Contracts Written [Line Items]
Commercial mortgage loans	748	759
Year of Origination 2017 | West South Central
Open Option Contracts Written [Line Items]
Commercial mortgage loans	222	248
Year of Origination 2017 | Mountain
Open Option Contracts Written [Line Items]
Commercial mortgage loans	210	227
Year of Origination 2017 | East North Central
Open Option Contracts Written [Line Items]
Commercial mortgage loans	242	257
Year of Origination 2017 | New England
Open Option Contracts Written [Line Items]
Commercial mortgage loans	49	49
Year of Origination 2017 | West North Central
Open Option Contracts Written [Line Items]
Commercial mortgage loans	147	149
Year of Origination 2017 | East South Central
Open Option Contracts Written [Line Items]
Commercial mortgage loans	25	25
Year of Origination 2017 | Total
Open Option Contracts Written [Line Items]
Commercial mortgage loans	3,012	3,114
Total | Pacific
Open Option Contracts Written [Line Items]
Commercial mortgage loans	1,206	1,198
Total | South Atlantic
Open Option Contracts Written [Line Items]
Commercial mortgage loans	1,121	1,162
Total | Middle Atlantic
Open Option Contracts Written [Line Items]
Commercial mortgage loans	1,012	1,024
Total | West South Central
Open Option Contracts Written [Line Items]
Commercial mortgage loans	567	592
Total | Mountain
Open Option Contracts Written [Line Items]
Commercial mortgage loans	508	525
Total | East North Central
Open Option Contracts Written [Line Items]
Commercial mortgage loans	548	531
Total | New England
Open Option Contracts Written [Line Items]
Commercial mortgage loans	79	76
Total | West North Central
Open Option Contracts Written [Line Items]
Commercial mortgage loans	222	223
Total | East South Central
Open Option Contracts Written [Line Items]
Commercial mortgage loans	83	114
Total | Total
Open Option Contracts Written [Line Items]
Commercial mortgage loans	$ 5,346	$ 5,445

Investments (excluding Conso_15

Investments (excluding Consolidated Investment Entities) - Loans by Property Type (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Investment Holdings [Line Items]
Commercial mortgage loans	$ 5,346	$ 5,445
Year of Origination 2023
Investment Holdings [Line Items]
Commercial mortgage loans	58
Year of Origination 2023 | Retail
Investment Holdings [Line Items]
Commercial mortgage loans	15
Year of Origination 2023 | Industrial
Investment Holdings [Line Items]
Commercial mortgage loans	3
Year of Origination 2023 | Apartments
Investment Holdings [Line Items]
Commercial mortgage loans	20
Year of Origination 2023 | Office
Investment Holdings [Line Items]
Commercial mortgage loans	20
Year of Origination 2023 | Hotel/Motel
Investment Holdings [Line Items]
Commercial mortgage loans	0
Year of Origination 2023 | Other
Investment Holdings [Line Items]
Commercial mortgage loans	0
Year of Origination 2023 | Mixed Use
Investment Holdings [Line Items]
Commercial mortgage loans	0
Year of Origination 2023 | Total
Investment Holdings [Line Items]
Commercial mortgage loans	58
Year of Origination 2022
Investment Holdings [Line Items]
Commercial mortgage loans	647	635
Year of Origination 2022 | Retail
Investment Holdings [Line Items]
Commercial mortgage loans	79	79
Year of Origination 2022 | Industrial
Investment Holdings [Line Items]
Commercial mortgage loans	265	255
Year of Origination 2022 | Apartments
Investment Holdings [Line Items]
Commercial mortgage loans	249	247
Year of Origination 2022 | Office
Investment Holdings [Line Items]
Commercial mortgage loans	34	34
Year of Origination 2022 | Hotel/Motel
Investment Holdings [Line Items]
Commercial mortgage loans	10	10
Year of Origination 2022 | Other
Investment Holdings [Line Items]
Commercial mortgage loans	10	10
Year of Origination 2022 | Mixed Use
Investment Holdings [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2022 | Total
Investment Holdings [Line Items]
Commercial mortgage loans	647	635
Year of Origination 2021
Investment Holdings [Line Items]
Commercial mortgage loans	735	777
Year of Origination 2021 | Retail
Investment Holdings [Line Items]
Commercial mortgage loans	37	37
Year of Origination 2021 | Industrial
Investment Holdings [Line Items]
Commercial mortgage loans	165	168
Year of Origination 2021 | Apartments
Investment Holdings [Line Items]
Commercial mortgage loans	381	420
Year of Origination 2021 | Office
Investment Holdings [Line Items]
Commercial mortgage loans	125	125
Year of Origination 2021 | Hotel/Motel
Investment Holdings [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2021 | Other
Investment Holdings [Line Items]
Commercial mortgage loans	18	18
Year of Origination 2021 | Mixed Use
Investment Holdings [Line Items]
Commercial mortgage loans	9	9
Year of Origination 2021 | Total
Investment Holdings [Line Items]
Commercial mortgage loans	735	777
Year of Origination 2020
Investment Holdings [Line Items]
Commercial mortgage loans	343	363
Year of Origination 2020 | Retail
Investment Holdings [Line Items]
Commercial mortgage loans	58	58
Year of Origination 2020 | Industrial
Investment Holdings [Line Items]
Commercial mortgage loans	60	61
Year of Origination 2020 | Apartments
Investment Holdings [Line Items]
Commercial mortgage loans	82	93
Year of Origination 2020 | Office
Investment Holdings [Line Items]
Commercial mortgage loans	143	151
Year of Origination 2020 | Hotel/Motel
Investment Holdings [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2020 | Other
Investment Holdings [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2020 | Mixed Use
Investment Holdings [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2020 | Total
Investment Holdings [Line Items]
Commercial mortgage loans	343	363
Year of Origination 2019
Investment Holdings [Line Items]
Commercial mortgage loans	347	350
Year of Origination 2019 | Retail
Investment Holdings [Line Items]
Commercial mortgage loans	45	46
Year of Origination 2019 | Industrial
Investment Holdings [Line Items]
Commercial mortgage loans	85	85
Year of Origination 2019 | Apartments
Investment Holdings [Line Items]
Commercial mortgage loans	164	165
Year of Origination 2019 | Office
Investment Holdings [Line Items]
Commercial mortgage loans	40	40
Year of Origination 2019 | Hotel/Motel
Investment Holdings [Line Items]
Commercial mortgage loans	13	14
Year of Origination 2019 | Other
Investment Holdings [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2019 | Mixed Use
Investment Holdings [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2019 | Total
Investment Holdings [Line Items]
Commercial mortgage loans	347	350
Year of Origination 2018
Investment Holdings [Line Items]
Commercial mortgage loans	204	206
Year of Origination 2018 | Retail
Investment Holdings [Line Items]
Commercial mortgage loans	37	37
Year of Origination 2018 | Industrial
Investment Holdings [Line Items]
Commercial mortgage loans	83	84
Year of Origination 2018 | Apartments
Investment Holdings [Line Items]
Commercial mortgage loans	55	56
Year of Origination 2018 | Office
Investment Holdings [Line Items]
Commercial mortgage loans	12	12
Year of Origination 2018 | Hotel/Motel
Investment Holdings [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2018 | Other
Investment Holdings [Line Items]
Commercial mortgage loans	17	17
Year of Origination 2018 | Mixed Use
Investment Holdings [Line Items]
Commercial mortgage loans	0	0
Year of Origination 2018 | Total
Investment Holdings [Line Items]
Commercial mortgage loans	204	206
Year of Origination 2017
Investment Holdings [Line Items]
Commercial mortgage loans	3,012	3,114
Year of Origination 2017 | Retail
Investment Holdings [Line Items]
Commercial mortgage loans	858	888
Year of Origination 2017 | Industrial
Investment Holdings [Line Items]
Commercial mortgage loans	742	757
Year of Origination 2017 | Apartments
Investment Holdings [Line Items]
Commercial mortgage loans	639	679
Year of Origination 2017 | Office
Investment Holdings [Line Items]
Commercial mortgage loans	500	513
Year of Origination 2017 | Hotel/Motel
Investment Holdings [Line Items]
Commercial mortgage loans	68	69
Year of Origination 2017 | Other
Investment Holdings [Line Items]
Commercial mortgage loans	154	156
Year of Origination 2017 | Mixed Use
Investment Holdings [Line Items]
Commercial mortgage loans	51	52
Year of Origination 2017 | Total
Investment Holdings [Line Items]
Commercial mortgage loans	3,012	3,114
Total | Retail
Investment Holdings [Line Items]
Commercial mortgage loans	1,129	1,145
Total | Industrial
Investment Holdings [Line Items]
Commercial mortgage loans	1,403	1,410
Total | Apartments
Investment Holdings [Line Items]
Commercial mortgage loans	1,590	1,660
Total | Office
Investment Holdings [Line Items]
Commercial mortgage loans	874	875
Total | Hotel/Motel
Investment Holdings [Line Items]
Commercial mortgage loans	91	93
Total | Other
Investment Holdings [Line Items]
Commercial mortgage loans	199	201
Total | Mixed Use
Investment Holdings [Line Items]
Commercial mortgage loans	60	61
Total | Total
Investment Holdings [Line Items]
Commercial mortgage loans	$ 5,346	$ 5,445

Investments (excluding Conso_16

Investments (excluding Consolidated Investment Entities) - Allowance for Losses for Commercial Mortgage Loans (Details) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Allowance for Loan and Lease Losses [Roll Forward]
Beginning Balance	$ 12	$ 58
Credit losses on securities for which credit losses were not previously recorded		9
Increase (decrease) on securities with allowance recorded in previous period	2	2
Ending Balance	12	12
Commercial Portfolio Segment
Allowance for Loan and Lease Losses [Roll Forward]
Beginning Balance	18	15
Credit losses on securities for which credit losses were not previously recorded	0	3
Increase (decrease) on securities with allowance recorded in previous period	(1)	0
Provision for expected credit losses	17	18
Write-offs	0	0
Recoveries of amounts previously written-off	0	0
Ending Balance	$ 17	$ 18

Investments (excluding Conso_17

Investments (excluding Consolidated Investment Entities) - Past due commercial mortgage loans (Details) - USD ($)	3 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Financing Receivable, Past Due [Line Items]
Financing Receivable, 90 Days or More Past Due, Still Accruing	$ 0
Financing Receivable, Nonaccrual, Interest Income	0
Current
Financing Receivable, Past Due [Line Items]
Past due commercial mortgage loans	5,346,000,000	$ 5,445,000,000
30-59 days past due
Financing Receivable, Past Due [Line Items]
Past due commercial mortgage loans	0	0
60-89 days past due
Financing Receivable, Past Due [Line Items]
Past due commercial mortgage loans	0	0
Greater than 90 days past due
Financing Receivable, Past Due [Line Items]
Past due commercial mortgage loans	0	0
Total
Financing Receivable, Past Due [Line Items]
Past due commercial mortgage loans	$ 5,346,000,000	$ 5,445,000,000

Investments (excluding Conso_18

Investments (excluding Consolidated Investment Entities) - Net Investment Income (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Schedule of Investment Income, Reported Amounts, by Category [Line Items]
Gross investment income	$ 563	$ 645
Less: Investment expenses	18	15
Net investment income	545	630
Fixed maturities
Schedule of Investment Income, Reported Amounts, by Category [Line Items]
Gross investment income	458	479
Investments in fixed maturities that did not produce net investment income	12		$ 11
Equity securities
Schedule of Investment Income, Reported Amounts, by Category [Line Items]
Gross investment income	7	4
Mortgage loans on real estate
Schedule of Investment Income, Reported Amounts, by Category [Line Items]
Gross investment income	61	59
Policy loans
Schedule of Investment Income, Reported Amounts, by Category [Line Items]
Gross investment income	6	6
Short-term investments and cash equivalents
Schedule of Investment Income, Reported Amounts, by Category [Line Items]
Gross investment income	9	1
Limited partnerships and other
Schedule of Investment Income, Reported Amounts, by Category [Line Items]
Gross investment income	$ 22	$ 96

Investments (excluding Conso_19

Investments (excluding Consolidated Investment Entities) - Net Realized Capital Gains (Losses) (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Realized Gain/(Losses) [Line Items]
Net realized capital gains (losses)	$ (16)	$ (288)
Fixed maturities
Realized Gain/(Losses) [Line Items]
Net realized capital gains (losses)	1	(4)
Other derivatives, net
Realized Gain/(Losses) [Line Items]
Net realized capital gains (losses)	0	5
Standalone derivatives
Realized Gain/(Losses) [Line Items]
Net realized capital gains (losses)	0	1
Managed custody guarantees
Realized Gain/(Losses) [Line Items]
Net realized capital gains (losses)	3	(3)
Derivatives
Realized Gain/(Losses) [Line Items]
Net realized capital gains (losses)	(54)	94
Mortgage loans on real estate
Realized Gain/(Losses) [Line Items]
Net realized capital gains (losses)	0	4
Other investments
Realized Gain/(Losses) [Line Items]
Net realized capital gains (losses)	(1)	1
Fixed maturities, available-for-sale, including securities pledged
Realized Gain/(Losses) [Line Items]
Net realized capital gains (losses)	1	(73)
Fixed maturities, at fair value option
Realized Gain/(Losses) [Line Items]
Net realized capital gains (losses)	36	(305)
Equity securities, at fair value
Realized Gain/(Losses) [Line Items]
Net realized capital gains (losses)	$ (2)	$ (8)

Investments (excluding Conso_20

Investments (excluding Consolidated Investment Entities) (Details) - Gross gains/(losses) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Gain (Loss) on Securities [Line Items]
Proceeds on sales	$ 1,306	$ 1,249
Gross gains	20	15
Gross losses	$ 25	$ 32

Derivative Financial Instrume_3

Derivative Financial Instruments - Notional and Fair Values (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Derivative [Line Items]
Derivative Asset, Fair Value, Gross Asset	$ 418	$ 520
Derivative Liability, Fair Value, Gross Liability	428	441
Credit contracts
Derivative [Line Items]
Notional Amount	188	174
Not Designated as Hedging Instrument | Credit contracts
Derivative [Line Items]
Notional Amount	188	174
Not Designated as Hedging Instrument | Derivatives | Credit contracts
Derivative [Line Items]
Derivative Asset, Fair Value, Gross Asset	0	0
Derivative Liability, Fair Value, Gross Liability	4	2
Foreign exchange contracts
Derivative [Line Items]
Notional Amount	1,018	959
Foreign exchange contracts | Not Designated as Hedging Instrument
Derivative [Line Items]
Notional Amount	185	160
Foreign exchange contracts | Not Designated as Hedging Instrument | Derivatives
Derivative [Line Items]
Derivative Asset, Fair Value, Gross Asset	3	9
Derivative Liability, Fair Value, Gross Liability	1	2
Foreign exchange contracts | Fair Value Hedging | Designated as Hedging Instrument
Derivative [Line Items]
Notional Amount	88	81
Foreign exchange contracts | Fair Value Hedging | Designated as Hedging Instrument | Derivatives
Derivative [Line Items]
Derivative Asset, Fair Value, Gross Asset	0	0
Derivative Liability, Fair Value, Gross Liability	0	6
Foreign exchange contracts | Cash Flow Hedging | Designated as Hedging Instrument
Derivative [Line Items]
Notional Amount	745	718
Foreign exchange contracts | Cash Flow Hedging | Designated as Hedging Instrument | Derivatives
Derivative [Line Items]
Derivative Asset, Fair Value, Gross Asset	59	71
Derivative Liability, Fair Value, Gross Liability	2	2
Interest rate contracts
Derivative [Line Items]
Notional Amount	13,458	13,328
Interest rate contracts | Not Designated as Hedging Instrument
Derivative [Line Items]
Notional Amount	16,564	18,304
Interest rate contracts | Not Designated as Hedging Instrument | Derivatives
Derivative [Line Items]
Derivative Asset, Fair Value, Gross Asset	276	341
Derivative Liability, Fair Value, Gross Liability	367	376
Interest rate contracts | Cash Flow Hedging | Designated as Hedging Instrument
Derivative [Line Items]
Notional Amount	22	22
Interest rate contracts | Cash Flow Hedging | Designated as Hedging Instrument | Derivatives
Derivative [Line Items]
Derivative Asset, Fair Value, Gross Asset	0	0
Derivative Liability, Fair Value, Gross Liability	0	0
Equity contracts
Derivative [Line Items]
Notional Amount	220	201
Equity contracts | Not Designated as Hedging Instrument
Derivative [Line Items]
Notional Amount	268	248
Equity contracts | Not Designated as Hedging Instrument | Derivatives
Derivative [Line Items]
Derivative Asset, Fair Value, Gross Asset	4	1
Derivative Liability, Fair Value, Gross Liability	2	1
Fixed maturities | Not Designated as Hedging Instrument
Derivative [Line Items]
Derivative Asset, Fair Value, Gross Asset	4	3
Derivative Liability, Fair Value, Gross Liability	0	0
Embedded derivative on reinsurance | Not Designated as Hedging Instrument
Derivative [Line Items]
Derivative Asset, Fair Value, Gross Asset	72	95
Derivative Liability, Fair Value, Gross Liability		46
Derivative Liability, Not Subject to Master Netting Arrangement	49
Managed custody guarantees | Not Designated as Hedging Instrument
Derivative [Line Items]
Derivative Asset, Fair Value, Gross Asset	0	0
Derivative Liability, Fair Value, Gross Liability	$ 3	$ 6

Derivative Financial Instrume_4

Derivative Financial Instruments - Offsetting Assets and Liabilities (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Offsetting Assets and Liabilities [Line Items]
Asset Fair Value	$ 342	$ 420
Liability Fair Value	373	389
Counterparty netting, Assets	(241)	(295)
Counterparty netting, Liabilities	(241)	(295)
Cash collateral netting, Assets	(92)	(64)
Cash collateral netting, Liabilities	(126)	(88)
Securities collateral netting, Assets	(6)	(6)
Securities collateral netting, Liabilities	(2)	(1)
Net receivables/payables, Assets	3	55
Net receivables/payables, Liabilities	4	5
Equity contracts
Offsetting Assets and Liabilities [Line Items]
Notional Amount	220	201
Asset Fair Value	4	1
Liability Fair Value	1	1
Foreign exchange contracts
Offsetting Assets and Liabilities [Line Items]
Notional Amount	1,018	959
Asset Fair Value	62	80
Liability Fair Value	3	10
Interest rate contracts
Offsetting Assets and Liabilities [Line Items]
Notional Amount	13,458	13,328
Asset Fair Value	276	339
Liability Fair Value	365	376
Credit contracts
Offsetting Assets and Liabilities [Line Items]
Notional Amount	188	174
Asset Fair Value	0	0
Liability Fair Value	$ 4	$ 2

Derivative Financial Instrume_5

Derivative Financial Instruments - Collateral and Credit Default Swaps (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Securities pledged as collateral
Derivatives, Fair Value [Line Items]
Securities held as collateral	$ 7	$ 7
Collateral Securities Repledged, Delivered, or Used	137	142
Over the counter | Cash collateral, included in Payables
Derivatives, Fair Value [Line Items]
Securities held as collateral	96	56
Cleared derivative contract | Cash collateral, included in Payables
Derivatives, Fair Value [Line Items]
Securities held as collateral	$ 126	$ 79

Derivative Financial Instrume_6

Derivative Financial Instruments - Effect of Derivatives (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Derivative Instruments, Gain (Loss) [Line Items]
Net investment income	$ 545	$ 630
Other net gains (losses)	(16)
Net realized capital gains (losses)	(16)	(288)
Gain (loss) on derivative, net	(75)	176
Not Designated as Hedging Instrument | Credit contracts
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative, net	(1)	0
Interest rate contracts | Not Designated as Hedging Instrument
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative, net	(56)	100
Interest rate contracts | Cash Flow Hedging | Designated as Hedging Instrument | Other Comprehensive Income (Loss)
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income	0	(1)
Interest rate contracts | Cash Flow Hedging | Designated as Hedging Instrument | Net investment income
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income	0	0
Foreign exchange contracts | Not Designated as Hedging Instrument
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative, net	1	(1)
Foreign exchange contracts | Cash Flow Hedging | Designated as Hedging Instrument | Other Comprehensive Income (Loss)
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income	(12)	7
Foreign exchange contracts | Cash Flow Hedging | Designated as Hedging Instrument | Net investment income
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Income	3	3
Gain (loss) on derivative, net	3	3
Foreign exchange contracts | Cash Flow Hedging | Designated as Hedging Instrument | Net gains/(losses)
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative, net	0	0
Foreign exchange contracts | Fair Value Hedging | Net investment income
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative, net	0	0
Foreign exchange contracts | Fair Value Hedging | Net gains/(losses)
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative, net	2	(2)
Foreign exchange contracts | Fair Value Hedging | Designated as Hedging Instrument | Net investment income
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative, net	0	0
Foreign exchange contracts | Fair Value Hedging | Designated as Hedging Instrument | Net gains/(losses)
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative, net	(1)	2
Embedded derivative on reinsurance
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative, net	(26)	92
Embedded derivative on reinsurance | Level 3 | Measured at fair value on a recurring basis
Derivative Instruments, Gain (Loss) [Line Items]
Fair Value, Assets and Liabilities Measured on Recurring Basis, Gain (Loss) Included in Earnings	1	0
Total Realized/Unrealized Gains (Losses) Included in Net income	0	1
Equity contracts | Not Designated as Hedging Instrument
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative, net	3	(8)
Fixed maturities
Derivative Instruments, Gain (Loss) [Line Items]
Net realized capital gains (losses)	1	(4)
Gain (loss) on derivative, net	1	(4)
Managed Custody Guarantees
Derivative Instruments, Gain (Loss) [Line Items]
Gain (loss) on derivative, net	$ 3	$ (3)

Fair Value Measurements (excl_3

Fair Value Measurements (excluding Consolidated Investment Entities) - Fair Value Measurement (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets held in separate accounts	$ 84,569	$ 80,174
Total assets	151,208	146,606
Derivatives	376	389
Total liabilities	145,521	141,609
Fixed maturities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	30,468	30,357
U.S. Treasuries
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	432	581
U.S. Government agencies and authorities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	57	59
State, municipalities and political subdivisions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	853	845
U.S. corporate public securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	8,290	8,201
U.S. corporate private securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	4,780	4,692
Foreign corporate public securities and foreign governments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	2,957	2,949
Foreign corporate private securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	2,992	3,034
Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	3,977	3,977
Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	3,842	3,883
Other asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	2,288	2,136
Measured at fair value on a recurring basis
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	30,468	30,357
Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements	2,003	2,454
Assets held in separate accounts	84,569	80,174
Total assets	$ 117,762	$ 113,838
Percentage of Level to total	100%	100%
Contingent consideration	$ 112	$ 112
Total liabilities	540	553
Measured at fair value on a recurring basis | Managed custody guarantees
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Guaranteed benefit derivatives	3	6
Measured at fair value on a recurring basis | Interest rate contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	276	341
Derivatives	367	376
Measured at fair value on a recurring basis | Foreign exchange contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	62	80
Derivatives	3	10
Measured at fair value on a recurring basis | Equity contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	4	1
Derivatives	2	1
Measured at fair value on a recurring basis | Embedded derivative on reinsurance
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	72	95
Embedded derivative on reinsurance	49	46
Measured at fair value on a recurring basis | Credit contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	4	2
Measured at fair value on a recurring basis | U.S. Treasuries
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	432	581
Measured at fair value on a recurring basis | U.S. Government agencies and authorities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	57	59
Measured at fair value on a recurring basis | State, municipalities and political subdivisions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	853	845
Measured at fair value on a recurring basis | U.S. corporate public securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	8,290	8,201
Measured at fair value on a recurring basis | U.S. corporate private securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	4,780	4,692
Measured at fair value on a recurring basis | Foreign corporate public securities and foreign governments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	2,957	2,949
Measured at fair value on a recurring basis | Foreign corporate private securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	2,992	3,034
Measured at fair value on a recurring basis | Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	3,977	3,977
Measured at fair value on a recurring basis | Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	3,842	3,883
Measured at fair value on a recurring basis | Other asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	2,288	2,136
Measured at fair value on a recurring basis | Equity securities, at fair value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity securities	308	336
Measured at fair value on a recurring basis | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	373	433
Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements	1,982	2,430
Assets held in separate accounts	78,617	74,600
Total assets	$ 81,091	$ 77,605
Percentage of Level to total	69%	68%
Contingent consideration	$ 0	$ 0
Total liabilities	2	3
Measured at fair value on a recurring basis | Level 1 | Managed custody guarantees
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Guaranteed benefit derivatives	0	0
Measured at fair value on a recurring basis | Level 1 | Interest rate contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	3	2
Derivatives	1	3
Measured at fair value on a recurring basis | Level 1 | Foreign exchange contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	0	0
Derivatives	0	0
Measured at fair value on a recurring basis | Level 1 | Equity contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	0	0
Derivatives	1	0
Measured at fair value on a recurring basis | Level 1 | Embedded derivative on reinsurance
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	0	0
Embedded derivative on reinsurance	0	0
Measured at fair value on a recurring basis | Level 1 | Credit contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	0	0
Measured at fair value on a recurring basis | Level 1 | U.S. Treasuries
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	373	433
Measured at fair value on a recurring basis | Level 1 | U.S. Government agencies and authorities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	0	0
Measured at fair value on a recurring basis | Level 1 | State, municipalities and political subdivisions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	0	0
Measured at fair value on a recurring basis | Level 1 | U.S. corporate public securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	0	0
Measured at fair value on a recurring basis | Level 1 | U.S. corporate private securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	0	0
Measured at fair value on a recurring basis | Level 1 | Foreign corporate public securities and foreign governments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	0	0
Measured at fair value on a recurring basis | Level 1 | Foreign corporate private securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	0	0
Measured at fair value on a recurring basis | Level 1 | Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	0	0
Measured at fair value on a recurring basis | Level 1 | Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	0	0
Measured at fair value on a recurring basis | Level 1 | Other asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	0	0
Measured at fair value on a recurring basis | Level 1 | Equity securities, at fair value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity securities	116	140
Measured at fair value on a recurring basis | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	27,699	27,575
Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements	21	24
Assets held in separate accounts	5,603	5,227
Total assets	$ 33,734	$ 33,341
Percentage of Level to total	29%	29%
Contingent consideration	$ 0	$ 0
Total liabilities	365	374
Measured at fair value on a recurring basis | Level 2 | Managed custody guarantees
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Guaranteed benefit derivatives	0	0
Measured at fair value on a recurring basis | Level 2 | Interest rate contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	273	339
Derivatives	366	373
Measured at fair value on a recurring basis | Level 2 | Foreign exchange contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	62	80
Derivatives	3	10
Measured at fair value on a recurring basis | Level 2 | Equity contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	4	1
Derivatives	1	1
Measured at fair value on a recurring basis | Level 2 | Embedded derivative on reinsurance
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	72	95
Embedded derivative on reinsurance	(9)	(12)
Measured at fair value on a recurring basis | Level 2 | Credit contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	4	2
Measured at fair value on a recurring basis | Level 2 | U.S. Treasuries
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	59	148
Measured at fair value on a recurring basis | Level 2 | U.S. Government agencies and authorities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	56	58
Measured at fair value on a recurring basis | Level 2 | State, municipalities and political subdivisions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	853	845
Measured at fair value on a recurring basis | Level 2 | U.S. corporate public securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	8,269	8,181
Measured at fair value on a recurring basis | Level 2 | U.S. corporate private securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	2,980	2,891
Measured at fair value on a recurring basis | Level 2 | Foreign corporate public securities and foreign governments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	2,957	2,946
Measured at fair value on a recurring basis | Level 2 | Foreign corporate private securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	2,551	2,602
Measured at fair value on a recurring basis | Level 2 | Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	3,921	3,949
Measured at fair value on a recurring basis | Level 2 | Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	3,842	3,883
Measured at fair value on a recurring basis | Level 2 | Other asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	2,211	2,072
Measured at fair value on a recurring basis | Level 2 | Equity securities, at fair value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity securities	0	0
Measured at fair value on a recurring basis | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	2,396	2,349
Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements	0	0
Assets held in separate accounts	349	347
Total assets	$ 2,937	$ 2,892
Percentage of Level to total	2%	3%
Contingent consideration	$ 112	$ 112
Total liabilities	173	176
Measured at fair value on a recurring basis | Level 3 | Managed custody guarantees
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Guaranteed benefit derivatives	3	6
Measured at fair value on a recurring basis | Level 3 | Interest rate contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	0	0
Derivatives	0	0
Measured at fair value on a recurring basis | Level 3 | Foreign exchange contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	0	0
Derivatives	0	0
Measured at fair value on a recurring basis | Level 3 | Equity contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	0	0
Derivatives	0	0
Measured at fair value on a recurring basis | Level 3 | Embedded derivative on reinsurance
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	0	0
Embedded derivative on reinsurance	58	58
Measured at fair value on a recurring basis | Level 3 | Credit contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	0	0
Measured at fair value on a recurring basis | Level 3 | U.S. Treasuries
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	0	0
Measured at fair value on a recurring basis | Level 3 | U.S. Government agencies and authorities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	1	1
Measured at fair value on a recurring basis | Level 3 | State, municipalities and political subdivisions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	0	0
Measured at fair value on a recurring basis | Level 3 | U.S. corporate public securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	21	20
Measured at fair value on a recurring basis | Level 3 | U.S. corporate private securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	1,800	1,801
Measured at fair value on a recurring basis | Level 3 | Foreign corporate public securities and foreign governments
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	0	3
Measured at fair value on a recurring basis | Level 3 | Foreign corporate private securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	441	432
Measured at fair value on a recurring basis | Level 3 | Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	56	28
Measured at fair value on a recurring basis | Level 3 | Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	0	0
Measured at fair value on a recurring basis | Level 3 | Other asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, available-for-sale, at fair value	77	64
Measured at fair value on a recurring basis | Level 3 | Equity securities, at fair value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity securities	$ 192	$ 196

Fair Value Measurements (excl_4

Fair Value Measurements (excluding Consolidated Investment Entities) - Level 3 Financial Instruments (Details) - Measured at fair value on a recurring basis - Level 3 - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Embedded derivative on reinsurance
Derivatives Rollforward:
Fair Value, Derivatives, beginning balance	$ (58)	$ (87)
Total Realized/Unrealized Gains (Losses) Included in Net income	0	1
Total Realized/Unrealized Gains (Losses) Included in OCI	0	0
Purchases	0	0
Issuances	0	0
Sales	0	0
Settlements	0	0
Transfers out of Level 3	0	0
Fair Value, Derivatives, ending balance	(58)	(86)
Change In Unrealized Gains (Losses) Included in Earnings	0	0
Change In Unrealized Gains (Losses) Included in OCI	0	0
Transfers in to Level 3	0	0
Managed custody guarantees
Derivatives Rollforward:
Fair Value, Derivatives, beginning balance	(6)	(20)
Total Realized/Unrealized Gains (Losses) Included in Net income	4	6
Total Realized/Unrealized Gains (Losses) Included in OCI	0	0
Purchases	0	0
Issuances	(1)	(1)
Sales	0	0
Settlements	0	0
Transfers out of Level 3	0	0
Fair Value, Derivatives, ending balance	(3)	(15)
Change In Unrealized Gains (Losses) Included in Earnings	0	0
Change In Unrealized Gains (Losses) Included in OCI	0	0
Transfers in to Level 3	0	0
Short-term investments and cash equivalents
Derivatives Rollforward:
Fair Value, Derivatives, beginning balance		0
Total Realized/Unrealized Gains (Losses) Included in Net income		0
Total Realized/Unrealized Gains (Losses) Included in OCI		0
Purchases		8
Issuances		0
Sales		0
Settlements		0
Transfers out of Level 3		0
Fair Value, Derivatives, ending balance		8
Change In Unrealized Gains (Losses) Included in Earnings		0
Change In Unrealized Gains (Losses) Included in OCI		0
Transfers in to Level 3		0
U.S. corporate public securities
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance		16
Total Realized/Unrealized Gains (Losses) Included in Net income		0
Total Realized/Unrealized Gains (Losses) Included in OCI		(2)
Purchases		21
Issuances		0
Sales		0
Settlements		0
Transfers out of Level 3		0
Fair Value, Assets, ending balance		71
Change In Unrealized Gains (Losses) Included in Earnings		0
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI		(2)
Transfers in to Level 3		36
U.S. corporate public securities | Available-for-sale Securities
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance	20
Total Realized/Unrealized Gains (Losses) Included in Net income	0
Total Realized/Unrealized Gains (Losses) Included in OCI	0
Purchases	1
Issuances	0
Sales	0
Settlements	0
Transfers out of Level 3	0
Fair Value, Assets, ending balance	21
Change In Unrealized Gains (Losses) Included in Earnings	0
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI	0
Transfers in to Level 3	0
U.S. corporate private securities
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance		1,910
Total Realized/Unrealized Gains (Losses) Included in Net income		(1)
Total Realized/Unrealized Gains (Losses) Included in OCI		(145)
Purchases		111
Issuances		0
Sales		0
Settlements		(61)
Transfers out of Level 3		(10)
Fair Value, Assets, ending balance		1,925
Change In Unrealized Gains (Losses) Included in Earnings		(1)
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI		(145)
Transfers in to Level 3		121
U.S. corporate private securities | Available-for-sale Securities
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance	1,801
Total Realized/Unrealized Gains (Losses) Included in Net income	1
Total Realized/Unrealized Gains (Losses) Included in OCI	34
Purchases	40
Issuances	0
Sales	0
Settlements	(76)
Transfers out of Level 3	0
Fair Value, Assets, ending balance	1,800
Change In Unrealized Gains (Losses) Included in Earnings	1
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI	34
Transfers in to Level 3	0
Foreign corporate public securities and foreign governments | Available-for-sale Securities
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance	3	0
Total Realized/Unrealized Gains (Losses) Included in Net income	0	0
Total Realized/Unrealized Gains (Losses) Included in OCI	0	0
Purchases	0	11
Issuances	0	0
Sales	0	0
Settlements	0	0
Transfers out of Level 3	(3)	0
Fair Value, Assets, ending balance	0	11
Change In Unrealized Gains (Losses) Included in Earnings	0	0
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI	0	0
Transfers in to Level 3	0	0
Foreign corporate private securities
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance		353
Total Realized/Unrealized Gains (Losses) Included in Net income		(18)
Total Realized/Unrealized Gains (Losses) Included in OCI		(24)
Purchases		50
Issuances		0
Sales		0
Settlements		(13)
Transfers out of Level 3		0
Fair Value, Assets, ending balance		496
Change In Unrealized Gains (Losses) Included in Earnings		0
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI		(24)
Transfers in to Level 3		148
Foreign corporate private securities | Available-for-sale Securities
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance	432
Total Realized/Unrealized Gains (Losses) Included in Net income	1
Total Realized/Unrealized Gains (Losses) Included in OCI	4
Purchases	57
Issuances	0
Sales	0
Settlements	(53)
Transfers out of Level 3	0
Fair Value, Assets, ending balance	441
Change In Unrealized Gains (Losses) Included in Earnings	1
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI	4
Transfers in to Level 3	0
Residential mortgage-backed securities
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance		43
Total Realized/Unrealized Gains (Losses) Included in Net income		(9)
Total Realized/Unrealized Gains (Losses) Included in OCI		0
Purchases		13
Issuances		0
Sales		0
Settlements		0
Transfers out of Level 3		(2)
Fair Value, Assets, ending balance		45
Change In Unrealized Gains (Losses) Included in Earnings		(9)
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI		0
Transfers in to Level 3		0
Residential mortgage-backed securities | Available-for-sale Securities
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance	28
Total Realized/Unrealized Gains (Losses) Included in Net income	0
Total Realized/Unrealized Gains (Losses) Included in OCI	0
Purchases	28
Issuances	0
Sales	0
Settlements	0
Transfers out of Level 3	0
Fair Value, Assets, ending balance	56
Change In Unrealized Gains (Losses) Included in Earnings	0
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI	0
Transfers in to Level 3	0
Commercial mortgage-backed securities
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance		44
Total Realized/Unrealized Gains (Losses) Included in Net income		0
Total Realized/Unrealized Gains (Losses) Included in OCI		(2)
Purchases		18
Issuances		0
Sales		(10)
Settlements		(1)
Transfers out of Level 3		0
Fair Value, Assets, ending balance		49
Change In Unrealized Gains (Losses) Included in Earnings		0
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI		(2)
Transfers in to Level 3		0
Asset-backed Securities [Member]
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance		2,366
Total Realized/Unrealized Gains (Losses) Included in Net income		(28)
Total Realized/Unrealized Gains (Losses) Included in OCI		(173)
Purchases		224
Issuances		0
Sales		(10)
Settlements		(75)
Transfers out of Level 3		(12)
Fair Value, Assets, ending balance		2,597
Change In Unrealized Gains (Losses) Included in Earnings		(10)
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI		(173)
Transfers in to Level 3		305
Asset-backed Securities [Member] | Available-for-sale Securities
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance	64
Total Realized/Unrealized Gains (Losses) Included in Net income	0
Total Realized/Unrealized Gains (Losses) Included in OCI	1
Purchases	34
Issuances	0
Sales	0
Settlements	(1)
Transfers out of Level 3	(21)
Fair Value, Assets, ending balance	77
Change In Unrealized Gains (Losses) Included in Earnings	0
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI	1
Transfers in to Level 3	0
Fixed maturities | Available-for-sale Securities
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance	2,349
Total Realized/Unrealized Gains (Losses) Included in Net income	2
Total Realized/Unrealized Gains (Losses) Included in OCI	39
Purchases	160
Issuances	0
Sales	0
Settlements	(130)
Transfers out of Level 3	(24)
Fair Value, Assets, ending balance	2,396
Change In Unrealized Gains (Losses) Included in Earnings	2
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI	39
Transfers in to Level 3	0
Equity securities, at fair value
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance	196	203
Total Realized/Unrealized Gains (Losses) Included in Net income	(4)	(10)
Total Realized/Unrealized Gains (Losses) Included in OCI	0	0
Purchases	0	0
Issuances	0	0
Sales	0	0
Settlements	0	0
Transfers out of Level 3	0	0
Fair Value, Assets, ending balance	192	203
Change In Unrealized Gains (Losses) Included in Earnings	(3)	(10)
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI	0	0
Transfers in to Level 3	0	10
US Government Agencies Debt Securities | Available-for-sale Securities
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance	1
Total Realized/Unrealized Gains (Losses) Included in Net income	0
Total Realized/Unrealized Gains (Losses) Included in OCI	0
Purchases	0
Issuances	0
Sales	0
Settlements	0
Transfers out of Level 3	0
Fair Value, Assets, ending balance	1
Change In Unrealized Gains (Losses) Included in Earnings	0
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI	0
Transfers in to Level 3	0
Contingent Consideration
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance	(112)	(11)
Total Realized/Unrealized Gains (Losses) Included in Net income	0	0
Total Realized/Unrealized Gains (Losses) Included in OCI	0	0
Purchases	0	0
Issuances	0	0
Sales	0	0
Settlements	0	0
Transfers out of Level 3	0	0
Fair Value, Assets, ending balance	(112)	(11)
Change In Unrealized Gains (Losses) Included in Earnings	0	0
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI	0	0
Transfers in to Level 3	0	0
Assets held in separate accounts
Fixed Maturities and Equity Securities Rollforward:
Fair Value, Assets, beginning balance	347	316
Total Realized/Unrealized Gains (Losses) Included in Net income	4	(14)
Total Realized/Unrealized Gains (Losses) Included in OCI	0	0
Purchases	0	65
Issuances	0	0
Sales	(2)	(1)
Settlements	0	0
Transfers out of Level 3	0	(38)
Fair Value, Assets, ending balance	349	334
Change In Unrealized Gains (Losses) Included in Earnings	0	0
Derivatives Rollforward:
Change In Unrealized Gains (Losses) Included in OCI	0	0
Transfers in to Level 3	$ 0	$ 6

Fair Value Measurements (excl_5

Fair Value Measurements (excluding Consolidated Investment Entities) - Other Financial Instruments (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets held in separate accounts	$ 84,569	$ 80,174
Derivatives	376	389
Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	30,468	30,357
Equity securities	308	336
Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements	2,003	2,454
Derivatives	342	422
Other investments	70	68
Assets held in separate accounts	84,569	80,174
Short-term debt	143	141
Long-term debt	2,094	2,094
Carrying Value | Derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	376	389
Carrying Value | Embedded derivative on reinsurance
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	72	95
Derivatives	49	46
Carrying Value | Managed custody guarantees
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	3	6
Carrying Value | Funding agreements without fixed maturities and deferred annuities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Guaranteed benefit derivatives	34,958	35,707
Carrying Value | Funding agreements with fixed maturities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Guaranteed benefit derivatives	1,360	1,285
Carrying Value | Supplementary contracts, immediate annuities and other
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Guaranteed benefit derivatives	701	727
Carrying Value | Mortgage loans on real estate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loans Receivable, Fair Value Disclosure	5,346	5,445
Carrying Value | Policy loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loans Receivable, Fair Value Disclosure	359	363
Estimate of Fair Value Measurement
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fixed maturities, including securities pledged	30,468	30,357
Equity securities	308	336
Cash and cash equivalents, short-term investments and short-term investments under securities loan agreements	2,003	2,454
Derivatives	342	422
Other investments	70	68
Assets held in separate accounts	84,569	80,174
Short-term debt	144	142
Long-term debt	1,935	1,935
Estimate of Fair Value Measurement | Derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	376	389
Estimate of Fair Value Measurement | Embedded derivative on reinsurance
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	72	95
Derivatives	49	46
Estimate of Fair Value Measurement | Managed custody guarantees
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivatives	3	6
Estimate of Fair Value Measurement | Funding agreements without fixed maturities and deferred annuities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Guaranteed benefit derivatives	36,635	36,385
Estimate of Fair Value Measurement | Funding agreements with fixed maturities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Guaranteed benefit derivatives	1,358	1,281
Estimate of Fair Value Measurement | Supplementary contracts, immediate annuities and other
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Guaranteed benefit derivatives	640	636
Estimate of Fair Value Measurement | Mortgage loans on real estate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loans Receivable, Fair Value Disclosure	5,078	5,149
Estimate of Fair Value Measurement | Policy loans
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loans Receivable, Fair Value Disclosure	$ 359	$ 363

Deferred Policy Acquisition C_3

Deferred Policy Acquisition Costs and Value of Business Acquired - DAC and VOBA Activity (Details) - USD ($) $ in Millions	3 Months Ended		12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]
Beginning balance	$ 2,363
Ending balance	2,333		$ 2,363
Movement Analysis Of Value of Business Acquired VOBA [Roll Forward]
Beginning balance	439	$ 473	473
Deferrals of commissions and expenses	1		5
Net amortization included in Condensed Consolidated Statements of Operations	10		39
Ending balance	430		439
Present Value of Future Insurance Profits, Impairment Loss	0	0
Wealth Solutions
Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]
Beginning balance	691	691	691
Deferrals of commissions and expenses	15		59
Net amortization included in the Consolidated Statements of Operations	14		59
Ending balance	692		691
business exited
Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]
Beginning balance	1,043	$ 1,158	1,158
Deferrals of commissions and expenses	0		0
Net amortization included in the Consolidated Statements of Operations	27		115
Ending balance	1,016		1,043
Other Segments
Movement Analysis of Deferred Policy Acquisition Costs [Roll Forward]
Beginning balance	190
Ending balance	$ 195		$ 190

Financial Services, Insurance_2

Financial Services, Insurance, ASU 2018-12 Transition (Details) $ in Millions	3 Months Ended		12 Months Ended
	Mar. 31, 2023 USD ($) yr	Mar. 31, 2022 USD ($)	Dec. 31, 2022 USD ($) yr	Dec. 31, 2021 USD ($)
Liability for Future Policy Benefit, Activity [Line Items]
Liability for Future Policy Benefit, before Reinsurance	$ 9,784		$ 9,719
Policyholder Account Balance [Line Items]
Interest credited to contract owner account balances	241	$ 233
Policyholder Account Balance	41,709		42,455
Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0001 to 0100
Policyholder Account Balance [Line Items]
Policyholder Account Balance	13,100		13,398
Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0100 to 0199
Policyholder Account Balance [Line Items]
Policyholder Account Balance	814		805
Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0200 to 0299
Policyholder Account Balance [Line Items]
Policyholder Account Balance	12,510		12,892
Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0300 to 0399
Policyholder Account Balance [Line Items]
Policyholder Account Balance	9,612		9,601
Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0400 and Greater
Policyholder Account Balance [Line Items]
Policyholder Account Balance	1,712		1,730
Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Renewable Beyond 12 Months
Policyholder Account Balance [Line Items]
Policyholder Account Balance	415		405
Total discretionary rate setting products
Policyholder Account Balance [Line Items]
Policyholder Account Balance	38,163		38,831
Policyholder Account Balance, at Guaranteed Minimum Crediting Rate
Policyholder Account Balance [Line Items]
Policyholder Account Balance	24,619		30,725
Policyholder Account Balance, at Guaranteed Minimum Crediting Rate | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0001 to 0100
Policyholder Account Balance [Line Items]
Policyholder Account Balance	234		5,848
Policyholder Account Balance, at Guaranteed Minimum Crediting Rate | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0100 to 0199
Policyholder Account Balance [Line Items]
Policyholder Account Balance	619		707
Policyholder Account Balance, at Guaranteed Minimum Crediting Rate | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0200 to 0299
Policyholder Account Balance [Line Items]
Policyholder Account Balance	12,269		12,677
Policyholder Account Balance, at Guaranteed Minimum Crediting Rate | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0300 to 0399
Policyholder Account Balance [Line Items]
Policyholder Account Balance	9,459		9,448
Policyholder Account Balance, at Guaranteed Minimum Crediting Rate | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0400 and Greater
Policyholder Account Balance [Line Items]
Policyholder Account Balance	1,626		1,643
Policyholder Account Balance, at Guaranteed Minimum Crediting Rate | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Renewable Beyond 12 Months
Policyholder Account Balance [Line Items]
Policyholder Account Balance	412		402
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0001 to 0050
Policyholder Account Balance [Line Items]
Policyholder Account Balance	7,754		3,315
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0001 to 0050 | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0001 to 0100
Policyholder Account Balance [Line Items]
Policyholder Account Balance	7,296		2,967
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0001 to 0050 | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0100 to 0199
Policyholder Account Balance [Line Items]
Policyholder Account Balance	141		52
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0001 to 0050 | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0200 to 0299
Policyholder Account Balance [Line Items]
Policyholder Account Balance	78		56
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0001 to 0050 | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0300 to 0399
Policyholder Account Balance [Line Items]
Policyholder Account Balance	153		153
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0001 to 0050 | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0400 and Greater
Policyholder Account Balance [Line Items]
Policyholder Account Balance	86		87
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0001 to 0050 | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Renewable Beyond 12 Months
Policyholder Account Balance [Line Items]
Policyholder Account Balance	0		0
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0051 to 0100
Policyholder Account Balance [Line Items]
Policyholder Account Balance	2,991		1,988
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0051 to 0100 | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0001 to 0100
Policyholder Account Balance [Line Items]
Policyholder Account Balance	2,899		1,907
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0051 to 0100 | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0100 to 0199
Policyholder Account Balance [Line Items]
Policyholder Account Balance	42		35
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0051 to 0100 | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0200 to 0299
Policyholder Account Balance [Line Items]
Policyholder Account Balance	50		46
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0051 to 0100 | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0300 to 0399
Policyholder Account Balance [Line Items]
Policyholder Account Balance	0		0
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0051 to 0100 | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0400 and Greater
Policyholder Account Balance [Line Items]
Policyholder Account Balance	0		0
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0051 to 0100 | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Renewable Beyond 12 Months
Policyholder Account Balance [Line Items]
Policyholder Account Balance	0		0
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0101 to 0150
Policyholder Account Balance [Line Items]
Policyholder Account Balance	1,258		1,224
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0101 to 0150 | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0001 to 0100
Policyholder Account Balance [Line Items]
Policyholder Account Balance	1,146		1,112
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0101 to 0150 | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0100 to 0199
Policyholder Account Balance [Line Items]
Policyholder Account Balance	2		2
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0101 to 0150 | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0200 to 0299
Policyholder Account Balance [Line Items]
Policyholder Account Balance	110		110
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0101 to 0150 | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0300 to 0399
Policyholder Account Balance [Line Items]
Policyholder Account Balance	0		0
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0101 to 0150 | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0400 and Greater
Policyholder Account Balance [Line Items]
Policyholder Account Balance	0		0
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0101 to 0150 | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Renewable Beyond 12 Months
Policyholder Account Balance [Line Items]
Policyholder Account Balance	0		0
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0151 to 0200
Policyholder Account Balance [Line Items]
Policyholder Account Balance	1,493		1,467
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0151 to 0200 | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0001 to 0100
Policyholder Account Balance [Line Items]
Policyholder Account Balance	1,487		1,462
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0151 to 0200 | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0100 to 0199
Policyholder Account Balance [Line Items]
Policyholder Account Balance	3		2
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0151 to 0200 | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0200 to 0299
Policyholder Account Balance [Line Items]
Policyholder Account Balance	0		0
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0151 to 0200 | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0300 to 0399
Policyholder Account Balance [Line Items]
Policyholder Account Balance	0		0
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0151 to 0200 | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0400 and Greater
Policyholder Account Balance [Line Items]
Policyholder Account Balance	0		0
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0151 to 0200 | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Renewable Beyond 12 Months
Policyholder Account Balance [Line Items]
Policyholder Account Balance	3		3
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0200 and Greater
Policyholder Account Balance [Line Items]
Policyholder Account Balance	48		112
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0200 and Greater | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0001 to 0100
Policyholder Account Balance [Line Items]
Policyholder Account Balance	38		102
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0200 and Greater | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0100 to 0199
Policyholder Account Balance [Line Items]
Policyholder Account Balance	7		7
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0200 and Greater | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0200 to 0299
Policyholder Account Balance [Line Items]
Policyholder Account Balance	3		3
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0200 and Greater | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0300 to 0399
Policyholder Account Balance [Line Items]
Policyholder Account Balance	0		0
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0200 and Greater | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Range from 0400 and Greater
Policyholder Account Balance [Line Items]
Policyholder Account Balance	0		0
Policyholder Account Balance, above Guaranteed Minimum Crediting Rate, Range from 0200 and Greater | Policyholder Account Balance, Guaranteed Minimum Crediting Rate, Renewable Beyond 12 Months
Policyholder Account Balance [Line Items]
Policyholder Account Balance	0		0
Employee Benefits, Group
Liability for Future Policy Benefit, Activity [Line Items]
Liability for Future Policy Benefit, Expected Net Premium, before Reinsurance, after Discount Rate Change	80		77	$ 93
Liability for Future Policy Benefit, Expected Net Premium, Original Discount Rate, before Cash Flow and Reinsurance	85		84	85
AOCI, Liability for Future Policy Benefit, Expected Net Premium, before Tax	(5)		(7)
Liability for Future Policy Benefit, Expected Net Premium, Cumulative Increase (Decrease) from Cash Flow Change			0	(7)
Liability for Future Policy Benefit, Expected Net Premium, Cumulative Increase (Decrease) of Actual Variance from Expected Experience			6	23
Liability for Future Policy Benefit, Expected Net Premium, Original Discount Rate, before Reinsurance, after Cash Flow Change			90	101
Liability for Future Policy Benefit, Expected Net Premium, Interest Income	1		2
Liability for Future Policy Benefit, Expected Net Premium, Net Premium Collected	(6)		(19)
Liability for Future Policy Benefit, Expected Future Policy Benefit, Original Discount Rate, before Cash Flow and Reinsurance	924		913	952
AOCI, Liability for Future Policy Benefit, Expected Future Policy Benefit, before Tax	(23)		(32)
Liability for Future Policy Benefit, Expected Future Policy Benefit, Cumulative Increase (Decrease) from Cash Flow Change			1	(43)
Liability for Future Policy Benefit, Expected Future Policy Benefit, Cumulative Increase (Decrease) of Actual Variance from Expected Experience			1	(27)
Liability for Future Policy Benefit, Expected Future Benefit, Original Discount Rate, before Reinsurance, after Cash Flow Change			915	882
Liability for Future Policy Benefit, Expected Future Policy Benefit, Issuance	35		139
Liability for Future Policy Benefit, Expected Future Policy Benefit, Interest Expense	6		25
Liability for Future Policy Benefit, Expected Future Policy Benefit, Benefit Payment	(32)		(133)
Liability for Future Policy Benefit, before Reinsurance	821		804
Liability for Future Policy Benefit, Reinsurance Recoverable, after Allowance	295		283
Liability for Future Policy Benefit, after Reinsurance	$ 526		$ 521
Liability for Future Policy Benefit, Weighted-Average Interest Accretion Rate	4%		4.10%
Liability for Future Policy Benefit, Current Weighted-Average Discount Rate	4.90%		5.20%
Liability for Future Policy Benefit, Expected Future Policy Benefit, before Reinsurance, after Discount Rate Change	$ 901		$ 881	1,048
Liability for Future Policy Benefit, Weighted-Average Duration [Axis] | yr	7		7
undiscounted expected gross premiums and future benefit payments [Line Items]
Liability for Future Policy Benefit, Expected Future Policy Benefit, Undiscounted, before Reinsurance	$ 1,152		$ 1,141
Liability for Future Policy Benefit, Expected Future Gross Premium, Discounted, before Reinsurance	231		231
Liability for Future Policy Benefit, Expected Future Gross Premium, Undiscounted, before Reinsurance	287		286
Liability for Future Policy Benefit, Expected Future Policy Benefit, Original Discount Rate, before Cash Flow and Reinsurance	924		913	952
Employee Benefits, Voluntary
Liability for Future Policy Benefit, Activity [Line Items]
Liability for Future Policy Benefit, Expected Net Premium, before Reinsurance, after Discount Rate Change	101		97	105
Liability for Future Policy Benefit, Expected Net Premium, Original Discount Rate, before Cash Flow and Reinsurance	102		100	92
AOCI, Liability for Future Policy Benefit, Expected Net Premium, before Tax	(1)		(3)
Liability for Future Policy Benefit, Expected Net Premium, Cumulative Increase (Decrease) from Cash Flow Change			0	0
Liability for Future Policy Benefit, Expected Net Premium, Cumulative Increase (Decrease) of Actual Variance from Expected Experience			5	20
Liability for Future Policy Benefit, Expected Net Premium, Original Discount Rate, before Reinsurance, after Cash Flow Change			105	112
Liability for Future Policy Benefit, Expected Net Premium, Interest Income	1		4
Liability for Future Policy Benefit, Expected Net Premium, Net Premium Collected	(4)		(16)
Liability for Future Policy Benefit, Expected Future Policy Benefit, Original Discount Rate, before Cash Flow and Reinsurance	296		294	290
AOCI, Liability for Future Policy Benefit, Expected Future Policy Benefit, before Tax	1		(9)
Liability for Future Policy Benefit, Expected Future Policy Benefit, Cumulative Increase (Decrease) from Cash Flow Change			0	(2)
Liability for Future Policy Benefit, Expected Future Policy Benefit, Cumulative Increase (Decrease) of Actual Variance from Expected Experience			5	11
Liability for Future Policy Benefit, Expected Future Benefit, Original Discount Rate, before Reinsurance, after Cash Flow Change			299	299
Liability for Future Policy Benefit, Expected Future Policy Benefit, Issuance	0		0
Liability for Future Policy Benefit, Expected Future Policy Benefit, Interest Expense	4		14
Liability for Future Policy Benefit, Expected Future Policy Benefit, Benefit Payment	(7)		(19)
Liability for Future Policy Benefit, before Reinsurance	196		188
Liability for Future Policy Benefit, Reinsurance Recoverable, after Allowance	0		0
Liability for Future Policy Benefit, after Reinsurance	$ 196		$ 188
Liability for Future Policy Benefit, Weighted-Average Interest Accretion Rate	5.30%		5.30%
Liability for Future Policy Benefit, Current Weighted-Average Discount Rate	5%		5.40%
Liability for Future Policy Benefit, Expected Future Policy Benefit, before Reinsurance, after Discount Rate Change	$ 297		$ 285	359
Liability for Future Policy Benefit, Weighted-Average Duration [Axis] | yr	14,000,000		14,000,000
undiscounted expected gross premiums and future benefit payments [Line Items]
Liability for Future Policy Benefit, Expected Future Policy Benefit, Undiscounted, before Reinsurance	$ 591		$ 588
Liability for Future Policy Benefit, Expected Future Gross Premium, Discounted, before Reinsurance	206		205
Liability for Future Policy Benefit, Expected Future Gross Premium, Undiscounted, before Reinsurance	312		307
Liability for Future Policy Benefit, Expected Future Policy Benefit, Original Discount Rate, before Cash Flow and Reinsurance	296		294	290
business exited
Liability for Future Policy Benefit, Activity [Line Items]
Liability for Future Policy Benefit, Expected Net Premium, before Reinsurance, after Discount Rate Change	4,337		4,244	5,634
Liability for Future Policy Benefit, Expected Net Premium, Original Discount Rate, before Cash Flow and Reinsurance	4,093		4,128	4,226
AOCI, Liability for Future Policy Benefit, Expected Net Premium, before Tax	244		116
Liability for Future Policy Benefit, Expected Net Premium, Cumulative Increase (Decrease) from Cash Flow Change			0	(69)
Liability for Future Policy Benefit, Expected Net Premium, Cumulative Increase (Decrease) of Actual Variance from Expected Experience			(10)	86
Liability for Future Policy Benefit, Expected Net Premium, Original Discount Rate, before Reinsurance, after Cash Flow Change			4,118	4,243
Liability for Future Policy Benefit, Expected Net Premium, Interest Income	57		230
Liability for Future Policy Benefit, Expected Net Premium, Net Premium Collected	(82)		(345)
Liability for Future Policy Benefit, Expected Future Policy Benefit, Original Discount Rate, before Cash Flow and Reinsurance	8,540		8,644	9,079
AOCI, Liability for Future Policy Benefit, Expected Future Policy Benefit, before Tax	227		(5)
Liability for Future Policy Benefit, Expected Future Policy Benefit, Cumulative Increase (Decrease) from Cash Flow Change			0	(77)
Liability for Future Policy Benefit, Expected Future Policy Benefit, Cumulative Increase (Decrease) of Actual Variance from Expected Experience			(9)	(52)
Liability for Future Policy Benefit, Expected Future Benefit, Original Discount Rate, before Reinsurance, after Cash Flow Change			8,635	8,950
Liability for Future Policy Benefit, Expected Future Policy Benefit, Issuance	4		13
Liability for Future Policy Benefit, Expected Future Policy Benefit, Interest Expense	110		458
Liability for Future Policy Benefit, Expected Future Policy Benefit, Benefit Payment	(209)		(777)
Liability for Future Policy Benefit, before Reinsurance	4,430		4,395
Liability for Future Policy Benefit, Reinsurance Recoverable, after Allowance	4,447		4,411
Liability for Future Policy Benefit, after Reinsurance	$ (17)		$ (16)
Liability for Future Policy Benefit, Weighted-Average Interest Accretion Rate	5%		5%
Liability for Future Policy Benefit, Current Weighted-Average Discount Rate	5.10%		5.70%
Liability for Future Policy Benefit, Expected Future Policy Benefit, before Reinsurance, after Discount Rate Change	$ 8,767		$ 8,639	11,444
Liability for Future Policy Benefit, Weighted-Average Duration [Axis] | yr	8,000,000		8,000,000
undiscounted expected gross premiums and future benefit payments [Line Items]
Liability for Future Policy Benefit, Expected Future Policy Benefit, Original Discount Rate, before Cash Flow and Reinsurance	$ 8,540		$ 8,644	9,079
Policyholder Account Balance [Line Items]
Policyholder Account Balance, Premium Received	76		310
Policyholder Account Balance, Policy Charge	(94)		(384)
Policyholder Account Balance, Surrender and Withdrawal	(120)		(281)
Policyholder Account Balance, Benefit Payment	(39)		(144)
Transfer to (from) Policyholder Account Balance (to) from Separate Account	0		0
Interest credited to contract owner account balances	36		150
Policyholder Account Balance, Increase (Decrease) from Other Change	$ 0		$ (37)
Policyholder Account Balance, Weighted Average Crediting Rate	2.50%		2.50%
Policyholder Account Balance, Net Amount at Risk	$ 847		$ 900
Policyholder Account Balance, Cash Surrender Value	1,730		1,824
Policyholder Account Balance	5,005		5,146	5,532
business exited, additional liability
Liability for Future Policy Benefit, Activity [Line Items]
Liability for Future Policy Benefit, Expected Future Policy Benefit, Cumulative Increase (Decrease) from Cash Flow Change			0	540
Liability for Future Policy Benefit, Expected Future Policy Benefit, Cumulative Increase (Decrease) of Actual Variance from Expected Experience			(50)	15
Liability for Future Policy Benefit, Expected Future Benefit, Original Discount Rate, before Reinsurance, after Cash Flow Change			2,057	2,270
Liability for Future Policy Benefit, Expected Future Policy Benefit, Interest Expense	21		80
Liability for Future Policy Benefit, Expected Future Policy Benefit, Benefit Payment	(108)		(427)
Liability for Future Policy Benefit, before Reinsurance	2,096		2,107
Liability for Future Policy Benefit, Reinsurance Recoverable, after Allowance	2,044		2,054
Liability for Future Policy Benefit, after Reinsurance	52		53
Liability for Future Policy Benefit, Expected Future Policy Benefit, Period Increase (Decrease)	$ 126		$ 184
Liability for Future Policy Benefit, Current Weighted-Average Discount Rate	4.10%		4.30%
Liability for Future Policy Benefit, Expected Future Policy Benefit, before Reinsurance, after Discount Rate Change			$ 2,107	1,715
Other Segments
Liability for Future Policy Benefit, Activity [Line Items]
Liability for Future Policy Benefit, before Reinsurance	$ 2,241		2,225
Policyholder Account Balance [Line Items]
Policyholder Account Balance	3,704		3,687
Wealth Solutions
Policyholder Account Balance [Line Items]
Policyholder Account Balance, Premium Received	615		2,962
Policyholder Account Balance, Policy Charge	(2)		(8)
Policyholder Account Balance, Surrender and Withdrawal	(1,506)		(4,280)
Policyholder Account Balance, Benefit Payment	(43)		(157)
Transfer to (from) Policyholder Account Balance (to) from Separate Account	93		1,174
Interest credited to contract owner account balances	219		874
Policyholder Account Balance, Increase (Decrease) from Other Change	$ 2		$ 13
Policyholder Account Balance, Weighted Average Crediting Rate	2.70%		2.60%
Policyholder Account Balance, Net Amount at Risk	$ 159		$ 199
Policyholder Account Balance, Cash Surrender Value	32,513		33,125
Policyholder Account Balance	$ 33,000		$ 33,622	$ 33,044

Reinsurance - Assets and Liabil

Reinsurance - Assets and Liabilities (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Assets
Premiums receivable, direct	$ 190	$ 172
Premiums Receivable, assumed	12	11
Premiums receivable, ceded	(237)	(212)
Premiums Receivable, net	(35)	(29)
Reinsurance recoverable, net of allowance for credit losses, ceded	12,473	12,455
Reinsurance recoverable, net of allowance for credit losses, net	12,473	12,455
Total assets, direct	190	172
Total assets, assumed	12	11
Total assets, ceded	12,236	12,243
Total assets, net	12,438	12,426
Liabilities
Future policy benefits and contract owner account balances, direct	50,470	51,137
Future policy benefits and contract owner account balances, assumed	1,023	1,037
Future policy benefits and contract owner account balances, net	51,493	52,174
Liability for funds withheld under reinsurance agreements, direct	111	104
Liability for funds withheld under reinsurance agreements, net	111	104
Total liabilities, direct	50,581	51,241
Total liabilities, assumed	1,023	1,037
Total liabilities, net	$ 51,604	$ 52,278

Reinsurance - Effect of Reinusa

Reinsurance - Effect of Reinusance (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Premiums Earned, Net [Abstract]
Direct Premiums Earned	$ 908	$ 808
Assumed Premiums Earned	10	9
Ceded Premiums Earned	233	209
Premiums	685	608
Policyholder Benefits and Claims Incurred, Net [Abstract]
Revenue from Contract with Customer, Including Assessed Tax	562	532
Assumed Insurance Commissions and Fees	4	5
Ceded Insurance Commissions And Fees	102	104
Fee income	464	433
Policyholder Benefits and Claims Incurred, Assumed and Ceded [Abstract]
Policyholder Benefits and Claims Incurred, Direct	1,108	976
Policyholder Benefits and Claims Incurred, Assumed	19	8
Policyholder Benefits and Claims Incurred, Ceded	376	340
Policyholder Interest and Other Benefits, Net	751	$ 644
Deposit asset	$ 1,400		$ 1,500

Separate Account Liability (Det

Separate Account Liability (Details) - USD ($) $ in Millions	3 Months Ended		12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022	Dec. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets held in separate accounts	$ 84,569		$ 80,174
Liabilities related to separate accounts	84,569		80,174
Wealth Solutions Stabilizer
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Separate Account, Liability, Policyholder Behavior	51
Wealth Solutions
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Liabilities related to separate accounts	80,922		76,348	$ 95,018
Separate Account, Liability, Policyholder Behavior	205		(1,377)
Separate Account, Liability, Policy Charge	(109)		(457)
Separate Account, Liability, Increase (Decrease) from Invested Performance	4,478	$ (16,838)
Separate Account, Liability, Increase (Decrease) from Other Change	0		2
Separate Account, Liability, Cash Surrender Value, Amount	73,451		69,121
Wealth Solutions | Wealth Solutions Stabilizer
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Liabilities related to separate accounts	7,438		7,196	8,091
Separate Account, Liability, Policyholder Behavior			(68)
Separate Account, Liability, Policy Charge	(8)		(34)
Separate Account, Liability, Increase (Decrease) from Invested Performance	199		(794)
Separate Account, Liability, Increase (Decrease) from Other Change	0		1
Wealth Solutions | Deferred Variable Annuity
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Liabilities related to separate accounts	73,484		69,152	$ 86,927
Separate Account, Liability, Policyholder Behavior	154		(1,309)
Separate Account, Liability, Policy Charge	(101)		(423)
Separate Account, Liability, Increase (Decrease) from Invested Performance	4,279		(16,044)
Separate Account, Liability, Increase (Decrease) from Other Change	0		1
Other Segments
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Liabilities related to separate accounts	3,647		3,826
U.S. Government agencies and authorities
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets held in separate accounts	1,308		1,586
Corporate Debt Securities
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets held in separate accounts	1,748		1,647
Separate Account, Cash and Cash Equivalents
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets held in separate accounts	530		311
Separate Account, Debt Security
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets held in separate accounts	716		660
Separate Account, Mortgage-Backed Security
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets held in separate accounts	3,395
Separate Account, Mortgage-Backed Security | Mortgage-Backed Securities, Issued by Private Enterprises
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets held in separate accounts			3,434
Separate Account, Equity Security
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets held in separate accounts	76,788		72,309
Asset-Backed Securities, Securitized Loans and Receivables
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets held in separate accounts	$ 84		$ 227

Share-based Incentive Compens_3

Share-based Incentive Compensation Plans - Narrative (Details)	Mar. 31, 2023 shares
2019 Omnibus Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares available for grant (in shares)	9,000,476

Share-based Incentive Compens_4

Share-based Incentive Compensation Plans - Compensation Cost (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation cost	$ 63	$ 46
Income tax benefit	15	15
After-tax share-based compensation expense	48	31
Restricted Stock Unit (RSU) awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation cost	37	22
Performance Stock Unit (PSU) awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation cost	$ 26	$ 24

Share-based Incentive Compens_5

Share-based Incentive Compensation Plans - Awards Outstanding (Details)	3 Months Ended
	Mar. 31, 2023 $ / shares shares
RSU awards
Number of Awards
Outstanding, beginning balance (in shares) | shares	1,500,000
Adjustment for PSU performance factor (in shares) | shares	0
Granted (in shares) | shares	1,500,000
Vested (in shares) | shares	(700,000)
Forfeited (in shares) | shares	0
Outstanding, ending balance (in shares) | shares	2,300,000
Weighted Average Grant Date Fair Value
Outstanding, beginning balance (usd per share) | $ / shares	$ 60.91
Adjustment for PSU performance factor (usd per share) | $ / shares	0
Granted (usd per share) | $ / shares	70.42
Vested (usd per share) | $ / shares	62.53
Forfeited (usd per share) | $ / shares	66.36
Outstanding, ending balance (usd per share) | $ / shares	$ 66.55
PSU awards
Number of Awards
Outstanding, beginning balance (in shares) | shares	2,100,000
Adjustment for PSU performance factor (in shares) | shares	(100,000)
Granted (in shares) | shares	800,000
Vested (in shares) | shares	(500,000)
Forfeited (in shares) | shares	0
Outstanding, ending balance (in shares) | shares	2,300,000
Weighted Average Grant Date Fair Value
Outstanding, beginning balance (usd per share) | $ / shares	$ 55.68
Adjustment for PSU performance factor (usd per share) | $ / shares	61.50
Granted (usd per share) | $ / shares	76.59
Vested (usd per share) | $ / shares	63.08
Forfeited (usd per share) | $ / shares	63.67
Outstanding, ending balance (usd per share) | $ / shares	$ 61.03
Stock options
Number of Awards
Outstanding, beginning balance (in shares) | shares	1,600,000
Granted (in shares) | shares	0
Exercised (in shares) | shares	(300,000)
Forfeited (in shares) | shares	0
Outstanding, ending balance (in shares) | shares	1,300,000
Vested, exercisable (in shares) | shares	1,300,000
Weighted Average Exercise Price
Outstanding, beginning balance (usd per share) | $ / shares	$ 43.05
Granted (usd per share) | $ / shares	0
Exercised (usd per share) | $ / shares	38.21
Forfeited (usd per share) | $ / shares	0
Outstanding, ending balance (usd per share) | $ / shares	44.25
Vested, exercisable, weighted average exercise price (usd per share) | $ / shares	$ 44.25

Shareholders' Equity - Common S

Shareholders' Equity - Common Stock Rollforward (Details) - shares	3 Months Ended	6 Months Ended
	Mar. 31, 2023	Jun. 30, 2022
Increase (Decrease) in Stockholders' Equity
Common stock, shares issued, beginning balance (in shares)	97,789,852
Common shares, beginning balance (in shares)	97,186,970
Common stock acquired - share repurchase (in shares)		11,700,000
Share-based compensation programs (in shares)	1,000,000	1,000,000
Treasury Stock retirement (in shares)		0
Common stock, shares issued, ending balance (in shares)	99,302,325
Common shares, ending balance (in shares)	98,180,167
Common Stock
Increase (Decrease) in Stockholders' Equity
Common stock, shares issued, beginning balance (in shares)	97,800,000	109,000,000
Common shares, beginning balance (in shares)	97,200,000	107,800,000
Common shares issued (in shares)	0	100,000
Common stock acquired - share repurchase (in shares)		0
Share-based compensation programs (in shares)	1,500,000	1,700,000
Treasury Stock retirement (in shares)		(13,000,000)
Common stock, shares issued, ending balance (in shares)	99,300,000
Treasury Stock
Increase (Decrease) in Stockholders' Equity
Common shares, held in treasury, beginning balance (in shares)	(600,000)	(1,200,000)
Common shares issued (in shares)	0	0
Common stock acquired - share repurchase (in shares)		11,700,000
Share-based compensation programs (in shares)	500,000	700,000
Treasury Stock retirement (in shares)		(13,000,000)
Common shares, held in treasury, ending balance (in shares)	1,100,000

Shareholders' Equity - Common_2

Shareholders' Equity - Common stock Dividends Declared (Details) - $ / shares	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Equity [Abstract]
Dividends declared per share of Common Stock (usd per share)	$ 0.200	$ 0.200

Shareholders' Equity - Narrativ

Shareholders' Equity - Narrative (Details)			3 Months Ended
	Mar. 29, 2021 $ / shares shares	May 07, 2013 USD ($) $ / shares shares	Mar. 31, 2023 USD ($) shares	Dec. 31, 2022 shares	Oct. 28, 2021 USD ($)
Equity [Abstract]
Amount authorized for repurchase					$ 500,000,000
Number of warrants issued and outstanding (in shares) | shares		26,050,846
Warrants issued allowing purchase of shares, percentage of common stock issued and outstanding		9.99%
Exercise price of warrants (usd per share) | $ / shares	$ 46.82	$ 48.75
Cash dividends, per share (usd per share) | $ / shares	$ 0.20	$ 0.01
Warrants net share settled, fair value		$ 94,000,000
Number of shares of common stock for which each warrant is exercisable (in shares) | shares	1.041295182
Preferred Stock, shares authorized (in shares) | shares			100,000,000	100,000,000
Preferred Stock, amount of preferred dividends in arrears			$ 0
Warrants agreement trading days- alternative			30
Warrant trading days- alternative max			45
Warrant trading days- agreement			10

Shareholders' Equity - Summary

Shareholders' Equity - Summary of Share Repurchases (Details) - USD ($) shares in Millions, $ in Millions	3 Months Ended	6 Months Ended
	Mar. 31, 2022	Jun. 30, 2022
Equity [Abstract]
Payment for share repurchases	$ 500
Common stock acquired - share repurchase (in shares)		11.7

Shareholders' Equity - Preferre

Shareholders' Equity - Preferred Stock (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Class of Stock [Line Items]
Aggregate (in shares)	$ 14	$ 14
Preferred Stock
Class of Stock [Line Items]
Preferred Stock, shares issued (in shares)	625,000		625,000
Preferred Stock, shares outstanding (in shares)	625,000		625,000
Series A Preferred Stock
Class of Stock [Line Items]
Dividend rate, percentage	0.06125%
Preferred Stock, shares issued (in shares)	325,000		325,000
Preferred Stock, shares outstanding (in shares)	325,000		325,000
Per Share (usd per share)	$ 30.625	$ 30.625
Aggregate (in shares)	$ 10	$ 10
Series B Preferred Stock
Class of Stock [Line Items]
Dividend rate, percentage	0.0535%
Preferred Stock, shares issued (in shares)	300,000		300,000
Preferred Stock, shares outstanding (in shares)	300,000		300,000
Per Share (usd per share)	$ 13.375	$ 13.375
Aggregate (in shares)	$ 4	$ 4

Earnings per Common Share (Deta

Earnings per Common Share (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Net income (loss) available to common shareholders:
Income (loss) from continuing operations	$ 129	$ 111
Less: Preferred stock dividends	14	14
Less: Net income (loss) attributable to noncontrolling interest	46	43
Net income (loss) available to common shareholders	$ 69	$ 54
Weighted average common shares outstanding
Basic (in shares)	97.7	106.1
Dilutive Effects:
Diluted (in shares)	109.6	117
Net income (loss) available to Voya Financial, Inc.'s common shareholders per common share:
Basic (usd per share)	$ 0.70	$ 0.51
Diluted (usd per share)	$ 0.63	$ 0.46
Warrant
Dilutive Effects:
Dilutive Effects (in shares)	8.9	8.2
RSU awards
Dilutive Effects:
Dilutive Effects (in shares)	1.2	1
PSU awards
Dilutive Effects:
Dilutive Effects (in shares)	1.2	1
Stock options
Dilutive Effects:
Dilutive Effects (in shares)	0.6	0.7

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Income (Loss) - Components of AOCI (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Dec. 31, 2022	Mar. 31, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]
Fixed maturities, net of impairment	$ (2,635)		$ 602
DAC/VOBA adjustment on available-for-sale securities	109		80
AOCI, Liability for Future Policy Benefit, before Tax	(855)		(1,044)
Deferred income tax asset (liability)	833		199
Total	(2,548)		(163)
Pension and other postretirement benefits liability, net of tax	3		3
AOCI	(2,545)	$ (3,055)	$ (160)
Other Contract
Accumulated Other Comprehensive Income (Loss) [Line Items]
Portion of AOCI expected to be reclassified into earnings within next 12 months	$ 17

Accumulated Other Comprehensi_4

Accumulated Other Comprehensive Income (Loss) - Changes in AOCI, including Reclassification Adjustments (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Available-for-sale securities, Before-Tax Amount:
Fixed maturities	$ 661	$ (2,663)
Adjustments for amounts recognized in Net realized capital gains (losses) in the Condensed Consolidated Statements of Operations	(1)	70
Change in unrealized gains/losses on available-for-sale securities	660	(2,593)
Available-for-sale securities, Income Tax:
Fixed maturities	(139)	559
Adjustments for amounts recognized in Net realized capital gains (losses) in the Condensed Consolidated Statements of Operations	0	(15)
Change in unrealized gains/losses on available-for-sale securities	(139)	544
Available-for-sale securities, After-Tax Amount:
Fixed maturities	522	(2,104)
Adjustments for amounts recognized in Net realized capital gains (losses) in the Condensed Consolidated Statements of Operations	(1)	55
Change in unrealized gains/losses on available-for-sale securities	521	(2,049)
Derivatives, Before-Tax Amount:
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax	(12)	5
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax	(5)	(5)
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax, Total	(17)	0
Derivatives, Income Tax:
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax	3	(1)
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax	1	1
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax, Total	(4)	0
Derivatives, After-Tax Amount:
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax	(9)	4
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, after Tax	(4)	(4)
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Total	(13)	0
AOCI, Liability for Future Policy Benefit, Expected Future Policy Benefit, before Tax	2	104
AOCI, Liability for Future Policy Benefit, Expected Future Policy Benefit, before Tax	0	(22)
OCI, Liability for Future Policy Benefit, Gain (Loss), after Reclassification Adjustment and Tax	2	82
Other Comprehensive Income (Loss), before Tax, Total	645	(2,489)
Other comprehensive income (loss), tax	(135)	522
Other comprehensive income (loss), after tax	$ 510	$ (1,967)

Income Taxes (Details)

Income Taxes (Details)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Income Tax Disclosure [Abstract]
Effective tax rate	8.50%	9%
Statutory tax rate	21%
Income Tax Contingency [Line Items]
Statutory tax rate	21%

Financing Agreements - Schedule

Financing Agreements - Schedule of Long-term Debt (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022	Mar. 17, 2015	May 16, 2013
Debt Instrument [Line Items]
Long-term debt	$ 2,237	$ 2,235
Less: Current portion of long-term debt	143	141
Total long-term debt, excluding current portion	$ 2,094	2,094
7.25% Voya Holdings Inc. debentures, due 2023 | Debentures
Debt Instrument [Line Items]
Annual interest rate on debt	7.25%
One Point Two Five Percent Convertible Senior Notes, due 2023 | Senior Notes
Debt Instrument [Line Items]
Annual interest rate on debt	1.25%
Senior Notes
Debt Instrument [Line Items]
Annual interest rate on debt			1.875%
Senior Notes | 3.65% Senior Notes, due 2026
Debt Instrument [Line Items]
Long-term debt	$ 445	445
Annual interest rate on debt	3.65%
Senior Notes | 5.7% Senior Notes, due 2043
Debt Instrument [Line Items]
Long-term debt	$ 396	396
Annual interest rate on debt	5.70%
Senior Notes | 4.8% Senior Notes, due 2046
Debt Instrument [Line Items]
Long-term debt	$ 297	297
Annual interest rate on debt	4.80%
Senior Notes | One Point Two Five Percent Convertible Senior Notes, due 2023
Debt Instrument [Line Items]
Long-term debt	$ 2	0
Junior Subordinated Notes | 4.7% Fixed-to-Floating Rate Junior Subordinated Notes, due 2048(1)
Debt Instrument [Line Items]
Long-term debt	$ 336	336
Annual interest rate on debt	4.70%
Junior Subordinated Notes | 5.65% Fixed-to-Floating Rate Junior Subordinated Notes, due 2053
Debt Instrument [Line Items]
Long-term debt	$ 388	388
Annual interest rate on debt	5.65%			5.65%
Debt Instrument, Face Amount	$ 393
Debentures | 7.25% Voya Holdings Inc. debentures, due 2023
Debt Instrument [Line Items]
Long-term debt	140	140
Debentures | 7.63% Voya Holdings Inc. debentures, due 2026
Debt Instrument [Line Items]
Long-term debt	$ 139	139
Annual interest rate on debt	7.63%
Debentures | 6.97% Voya Holdings Inc. debentures, due 2036
Debt Instrument [Line Items]
Long-term debt	$ 79	79
Annual interest rate on debt	6.97%
Notes payable, other | 8.42% Equitable of Iowa Companies Capital Trust II Notes, due 2027
Debt Instrument [Line Items]
Long-term debt	$ 13	13
Annual interest rate on debt	8.42%
Loans payable | 1.00% Windsor Property Loan
Debt Instrument [Line Items]
Long-term debt	$ 2	$ 2
Annual interest rate on debt	1%

Financing Agreements - Narrativ

Financing Agreements - Narrative (Details) - USD ($) $ in Millions		3 Months Ended
	Mar. 17, 2015	Mar. 31, 2023	May 03, 2023	May 01, 2023	Dec. 31, 2022	Nov. 01, 2019	May 16, 2013
Debt Instrument [Line Items]
Outstanding par amount of guaranteed debentures		$ 2,237			$ 2,235
Maximum borrowing capacity		700
Outstanding borrowings		163
Business Agreement, Processing and Operation Services Period	10 years
Put Option Agreement, Face Amount	$ 500
Line of Credit Facility, Remaining Borrowing Capacity		537
Payments of Financing Costs		0
Aetna Notes
Debt Instrument [Line Items]
Amount of letters of credit outstanding		163
Revolving Credit agreement
Debt Instrument [Line Items]
Maximum borrowing capacity		500
Minimum net worth required for compliance						$ 6,150
Revolving Credit agreement | Subsequent Event
Debt Instrument [Line Items]
Maximum borrowing capacity				$ 500
Minimum net worth required for compliance				4,998
Unsecured and Committed [Member] | Voya Financial, Inc.
Debt Instrument [Line Items]
Maximum borrowing capacity		500
Outstanding borrowings		0
Line of Credit Facility, Remaining Borrowing Capacity		500
Unsecured and Committed [Member] | Voya Financial, Inc. Three
Debt Instrument [Line Items]
Maximum borrowing capacity		200
Outstanding borrowings		163
Line of Credit Facility, Remaining Borrowing Capacity		37
Voya Holdings Debentures | Aetna Notes
Debt Instrument [Line Items]
Amount of collateral for credit facility		370
Amount of collateral deposited to a control account		207
Short-term Debt | Revolving Credit agreement | Subsequent Event
Debt Instrument [Line Items]
Maximum borrowing capacity				25
Debentures | Voya Holdings Debentures
Debt Instrument [Line Items]
Outstanding par amount of guaranteed debentures		358
Revolving Credit agreement
Debt Instrument [Line Items]
Amount of letters of credit outstanding		0
Outstanding borrowings		0
Senior Notes
Debt Instrument [Line Items]
Annual interest rate on debt	1.875%
Senior Notes | Pre-Capitalized Trust
Debt Instrument [Line Items]
Annual interest rate on debt	3.976%
Senior Notes | Pre-Capitalized Trust | Subsequent Event
Debt Instrument [Line Items]
Debt Instrument, Face Amount			$ 400	$ 400
Junior Subordinated Notes | 5.65% Fixed-to-Floating Rate Junior Subordinated Notes, due 2053
Debt Instrument [Line Items]
Outstanding par amount of guaranteed debentures		$ 388			$ 388
Annual interest rate on debt		5.65%					5.65%
Debt Instrument, Face Amount		$ 393

Commitments and Contingencies -

Commitments and Contingencies - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Loss Contingencies [Line Items]
Possible losses in excess of amounts accrued	$ 25
Potential future loss	126
Pledged Collateral	1,811		$ 1,791
Impairment of right-of-use asset	2	$ 3
Liability for Unpaid Claims and Claims Adjustment Expense, Net	47
Securities Loaned
Loss Contingencies [Line Items]
Securities Owned and Pledged as Collateral	137		142
Federal Home Loan Bank | Line of Credit
Loss Contingencies [Line Items]
Non-putable funding agreements issued to FHLB	1,360		1,279
Pledged Collateral	1,811		$ 1,791
Acquisition of mortgage loans
Loss Contingencies [Line Items]
Amount of purchase commitments	79
Purchase of limited partnership and private placement investments
Loss Contingencies [Line Items]
Amount of purchase commitments	1,000
Purchase of limited partnership and private placement investments | VOEs
Loss Contingencies [Line Items]
Amount of purchase commitments	$ 355

Commitments and Contingencies_2

Commitments and Contingencies - Restricted Assets (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Loss Contingencies [Line Items]
Fixed maturity collateral pledged to FHLB	$ 1,811	$ 1,791
FHLB restricted stock	69	67
Other fixed maturities-state deposits	40	38
Cash and cash equivalents	29	27
Total restricted assets	3,175	3,085
Collateral Pledged
Loss Contingencies [Line Items]
Securities pledged	1,226	1,162
Securities pledged as collateral
Loss Contingencies [Line Items]
Fair value of loaned securities	976	907
Securities pledged under repurchase agreements, carrying value	$ 113	$ 113

Consolidated and Nonconsolida_3

Consolidated and Nonconsolidated Investment Entities - General and Consolidated VIEs and VOEs and Nonconsolidated VIEs (Details) $ in Millions	3 Months Ended
	Mar. 31, 2023 USD ($) CLO fund	Dec. 31, 2022 USD ($) CLO
Variable Interest Entity [Line Items]
Consolidated collateral loan obligations | CLO	8	7
Limited Partnerships life	10 years
Consolidated funds | fund	10
Noncontrolling interest	$ 1,567	$ 1,482
Consolidated Investment Entities
Variable Interest Entity [Line Items]
Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount	$ 322	$ 288

Consolidated and Nonconsolida_4

Consolidated and Nonconsolidated Investment Entities - Components of the Consolidated Investment Entities (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Assets of Consolidated Investment Entities
Assets	$ 151,208	$ 146,606
Liabilities and Shareholders' Equity of Consolidated Investment Entities
Liabilities	145,521	141,609
Noncontrolling interest	1,567	1,482
Total liabilities, mezzanine equity and shareholders' equity	$ 151,208	$ 146,606

Consolidated and Nonconsolida_5

Consolidated and Nonconsolidated Investment Entities - Fair Value Measurement (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Variable Interest Entity [Line Items]
Revolving lines of credit capacity	$ 700
Outstanding borrowings	163
VOEs | Private Equity Funds
Variable Interest Entity [Line Items]
Revolving lines of credit capacity	$ 1,360	$ 1,366
Renewal period for term loan	3 years
Outstanding borrowings	$ 1,259	1,143
VOEs | Minimum | Private Equity Funds
Variable Interest Entity [Line Items]
Basis spread on notes	1.55%
Term of debt	16 months
VOEs | Maximum | Private Equity Funds
Variable Interest Entity [Line Items]
Basis spread on notes	2%
Term of debt	4 months
VOEs | LIBOR | Private Equity Funds
Variable Interest Entity [Line Items]
Description of variable rate basis	LIBOR
VOEs | EURIBOR | Private Equity Funds
Variable Interest Entity [Line Items]
Description of variable rate basis	EURIBOR
Senior secured corporate loans | VIEs
Variable Interest Entity [Line Items]
Unpaid principal exceeds fair value, amount	$ 59	$ 85
Default of collateral assets, percentage	1%
Weighted average maturity	12 years
Senior secured corporate loans | VIEs | Maximum
Variable Interest Entity [Line Items]
Basis spread on loans	10%
Senior secured corporate loans | VIEs | LIBOR
Variable Interest Entity [Line Items]
Description of variable rate basis	LIBOR
Senior secured corporate loans | VIEs | LIBOR | Minimum
Variable Interest Entity [Line Items]
Basis spread on notes	1%
Senior secured corporate loans | VIEs | LIBOR | Maximum
Variable Interest Entity [Line Items]
Basis spread on notes	8.80%
Senior secured corporate loans | VIEs | EURIBOR
Variable Interest Entity [Line Items]
Description of variable rate basis	EURIBOR
Senior secured corporate loans | VIEs | PRIME
Variable Interest Entity [Line Items]
Description of variable rate basis	PRIME
Senior secured corporate loans | VIEs | Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate
Variable Interest Entity [Line Items]
Description of variable rate basis	SOFR

Consolidated and Nonconsolida_6

Consolidated and Nonconsolidated Investment Entities - Fair Value Hierarchy (Details) - Measured at fair value on a recurring basis - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets, Net Asset Value (NAV)	$ 3,009	$ 2,802
Assets, Including NAV	4,341	4,183
Liabilities	1,256	1,234
VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets, Net Asset Value (NAV)	0	0
Cash and cash equivalents | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	100	88
Assets, Net Asset Value (NAV)	0	0
Corporate loans | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	1,232	1,293
Assets, Net Asset Value (NAV)	0	0
Limited partnerships/corporations | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets, Net Asset Value (NAV)	3,009	2,802
Assets, Including NAV	3,009	2,802
CLO notes | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets, Net Asset Value (NAV)	0	0
Liabilities	1,256	1,234
Level 1
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	100	88
Liabilities	0	0
Level 1 | Cash and cash equivalents | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	100	88
Level 1 | Corporate loans | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	0	0
Level 1 | Limited partnerships/corporations | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	0	0
Level 1 | CLO notes | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities	0	0
Level 2
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	1,232	1,293
Liabilities	1,256	1,234
Level 2 | Cash and cash equivalents | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	0	0
Level 2 | Corporate loans | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	1,232	1,293
Level 2 | Limited partnerships/corporations | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	0	0
Level 2 | CLO notes | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities	1,256	1,234
Level 3
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	0	0
Liabilities	0	0
Level 3 | Cash and cash equivalents | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	0	0
Level 3 | Corporate loans | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	0	0
Level 3 | Limited partnerships/corporations | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Assets	0	0
Level 3 | CLO notes | VIEs
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Liabilities	$ 0	$ 0

Consolidated and Nonconsolida_7

Consolidated and Nonconsolidated Investment Entities - Deconsolidation and Nonconsolidated VIEs (Details) $ in Millions	3 Months Ended
	Mar. 31, 2023 USD ($) loan	Dec. 31, 2022 USD ($)
Variable Interest Entity [Line Items]
Number of deconsolidated investment entities | loan	0
Total assets	$ 151,208	$ 146,606
VIEs, Not Primary Beneficiary
Variable Interest Entity [Line Items]
Amount of ownership interest in unconsolidated CLOs	398	364
VIEs, Not Primary Beneficiary | Limited Partnerships
Variable Interest Entity [Line Items]
Total assets	$ 1,794	$ 1,781

Goodwill and Other Intangible_2

Goodwill and Other Intangible Assets - Goodwill (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Goodwill [Roll Forward]
Goodwill, Beginning Balance	$ 327	$ 72
Additions from business combinations	319	255
Goodwill, Ending Balance	646
Wealth
Goodwill [Roll Forward]
Goodwill, Beginning Balance	17	17
Additions from business combinations	0	0
Goodwill, Ending Balance	17
Health Solutions
Goodwill [Roll Forward]
Goodwill, Beginning Balance	24	24
Additions from business combinations	319	0
Goodwill, Ending Balance	343
Investment Management
Goodwill [Roll Forward]
Goodwill, Beginning Balance	286	31
Additions from business combinations	0	$ 255
Goodwill, Ending Balance	$ 286

Goodwill and Other Intangible_3

Goodwill and Other Intangible Assets - Other Intangible Assets (Details) - USD ($) $ in Millions	3 Months Ended		12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Finite-Lived Intangible Assets [Line Items]
Indefinite-life intangibles, Gross Carrying Amount	$ 350		$ 350
Finite-life intangibles, Gross Carrying Amount	1,887		1,728
Finite-life intangibles, Accumulated Amortization	982		1,097
Finite-life intangibles, Net Carrying Amount	905		631
Amortization of Intangible Assets	$ 20	$ 11
Contractual Rights
Finite-Lived Intangible Assets [Line Items]
Finite-life intangibles, Weighted Average Amortization Lives	19 years
Finite-life intangibles, Gross Carrying Amount	$ 741		741
Finite-life intangibles, Accumulated Amortization	557		554
Finite-life intangibles, Net Carrying Amount	$ 184		187
Customer Relationships
Finite-Lived Intangible Assets [Line Items]
Finite-life intangibles, Weighted Average Amortization Lives	17 years
Finite-life intangibles, Gross Carrying Amount	$ 324		135
Finite-life intangibles, Accumulated Amortization	114		111
Finite-life intangibles, Net Carrying Amount	$ 210		24
Computer Software, Intangible Asset
Finite-Lived Intangible Assets [Line Items]
Finite-life intangibles, Weighted Average Amortization Lives	4 years
Finite-life intangibles, Gross Carrying Amount	$ 457		502
Finite-life intangibles, Accumulated Amortization	311		432
Finite-life intangibles, Net Carrying Amount	$ 146		70
Trademarks
Finite-Lived Intangible Assets [Line Items]
Finite-life intangibles, Weighted Average Amortization Lives	8 years
Finite-life intangibles, Gross Carrying Amount	$ 15		0
Finite-life intangibles, Accumulated Amortization	0		0
Finite-life intangibles, Net Carrying Amount	15		0
Customer Lists
Finite-Lived Intangible Assets [Line Items]
Indefinite-life intangibles, Gross Carrying Amount	345		345
Contractual Rights
Finite-Lived Intangible Assets [Line Items]
Indefinite-life intangibles, Gross Carrying Amount	$ 5		$ 5

Segments - Narrative (Details)

Segments - Narrative (Details)	3 Months Ended
	Mar. 31, 2023 segment
Segment Reporting [Abstract]
Number of operating segments	3

Segments - Operating Earnings B

Segments - Operating Earnings Before Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Segment Reporting Information [Line Items]
Total adjustments to income (loss) before income taxes	$ 141	$ 122
Income (loss) attributable to noncontrolling interests	46	43
Less: Preferred stock dividends	14	14
Adjustments
Segment Reporting Information [Line Items]
Total adjustments to income (loss) before income taxes	(51)	(99)
Net investment gains (losses) and related charges and adjustments	(9)	(112)
Income (loss) attributable to noncontrolling interests	46
Other adjustments	(70)	(8)
Income (loss) related to businesses exited or to be exited through reinsurance or divestment	(33)	(36)
Operating Segments
Segment Reporting Information [Line Items]
Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax	200	221
Adjusted operating earnings before income taxes	192	221
Net Income (Loss) Attributable to Redeemable Noncontrolling Interest	8	0
Operating Segments | Wealth Solutions
Segment Reporting Information [Line Items]
Adjusted operating earnings before income taxes	132	228
Operating Segments | Investment Management
Segment Reporting Information [Line Items]
Adjusted operating earnings before income taxes	42	39
Operating Segments | Health Solutions
Segment Reporting Information [Line Items]
Adjusted operating earnings before income taxes	94	21
Operating Segments | Corporate
Segment Reporting Information [Line Items]
Adjusted operating earnings before income taxes	$ (69)	$ (68)

Segments - Operating Revenues (

Segments - Operating Revenues (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Segment Reporting Information [Line Items]
Total revenues	$ 1,835	$ 1,506
Corporate
Segment Reporting Information [Line Items]
Total revenues	11	22
Adjustments
Segment Reporting Information [Line Items]
Total revenues	137	(97)
Net investment gains (losses) and related charges and adjustments	(14)	(120)
Revenues related to businesses exited or to be exited through reinsurance or divestment	30	(54)
Revenues attributable to noncontrolling interests	60	48
Other adjustments	60	28
Operating Segments
Segment Reporting Information [Line Items]
Total revenues	1,697	1,603
Operating Segments | Wealth Solutions
Segment Reporting Information [Line Items]
Total revenues	684	756
Operating Segments | Investment Management
Segment Reporting Information [Line Items]
Total revenues	229	178
Operating Segments | Health Solutions
Segment Reporting Information [Line Items]
Total revenues	774	647
Intersegment | Investment Management
Segment Reporting Information [Line Items]
Total revenues	$ 22	$ 22

Segments - Total Assets (Detail

Segments - Total Assets (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Segment Reporting Information [Line Items]
Total assets	$ 151,208	$ 146,606
Noncontrolling Interest
Segment Reporting Information [Line Items]
Total assets	4,128	3,914
Total | Parent
Segment Reporting Information [Line Items]
Total assets	147,080	142,692
Corporate
Segment Reporting Information [Line Items]
Total assets	26,333	26,712
Operating Segments | Wealth Solutions
Segment Reporting Information [Line Items]
Total assets	115,777	111,701
Operating Segments | Investment Management
Segment Reporting Information [Line Items]
Total assets	1,635	1,611
Operating Segments | Health Solutions
Segment Reporting Information [Line Items]
Total assets	$ 3,335	$ 2,668

Uncategorized Items - voya-2023

Label	Element	Value
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents	us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	$ 1,007,000,000